[{"synopsis":"The Jeffrey Modell Foundation offers a funding opportunity to&nbsp;alleviate disease, seek cures, and ultimately improve the quality of life of children affected with Primary Immunodeficiency throughout the world.&nbsp;The sponsor awards up to $25,000 per year, for up to 2 years, for each grant awarded.","id":"086733","spon_name":"Modell (Jeffrey) Foundation","NextDeadlineDate":null,"total_funding_limit":50000,"programurl":"https://info4pi.org/medical/research-grants/research-grants-1/","sponsor_type":"Foundations","prog_title":"Child Health Initiative to Lessen Disease through Research and Education Now (C.H.I.L.D.R.E.N.)","revision_date":"28-Sep-2022","deadline_note":"Applications for this program are currently accepted and reviewed on a rolling basis.","sponwebsite":"https://info4pi.org/","deadline_date":null,"contact":null,"contact_tel":null,"contact_email":"research@jmfworld.org"},{"synopsis":"<p>The New York Health Foundation (NYHealth) has a broad mission to improve the health of all New Yorkers. NYHealth&rsquo;s efforts are concentrated on specific priority areas, but to ensure flexibility and responsiveness to other important health issues, the Special Projects Fund supports projects that are outside of those areas. Projects pertaining to the Foundation&rsquo;s 2023 priority areas will be ineligible for funding through the Special Projects Fund: Healthy Food, Healthy Lives; Primary Care; or Veterans&rsquo; Health. All projects supported through this Request for Proposals (RFP) must have an impact on New Yorkers either at a local, regional, or statewide level. Special Projects Fund awards should be considered one-time, nonrenewable funding opportunities.<br /></p>","id":"001905","spon_name":"New York State Health Foundation","NextDeadlineDate":"12-Jan-2023","total_funding_limit":300000,"programurl":"https://nyhealthfoundation.org/rfp/2023-special-projects-fund/","sponsor_type":"Foundations","prog_title":"Special Projects Fund ","revision_date":"07-Oct-2022","deadline_note":"<p>Online inquiry forms are due October 12, 2022 at 1:00 p.m. for Round 1 and March 2, 2023 at 1:00 p.m. for Round 2.</p><p>Applications are accepted by invitation only.&nbsp; Round 1 applications will be due January 12, 2023 at 1:00 p.m. Round 2 applications will be due May 11, 2023 at 1:00 p.m. <br /></p>","sponwebsite":"https://nyshealthfoundation.org/apply-for-funding/","deadline_date":["02-Mar-2023 [LOI/Pre-App]","12-Jan-2023","11-May-2023"],"contact":null,"contact_tel":"212-664-7656","contact_email":"specialprojectsfund@nyhealthfoundation.org"},{"synopsis":"<p>The CATCH Planning Funds program provides grants of up to $10,000 for pediatricians and fellowship trainees to plan innovative, community-based initiatives that increase children&rsquo;s access to optimal health or well-being.</p>","id":"093531","spon_name":"American Academy of Pediatrics","NextDeadlineDate":"23-Jan-2023","total_funding_limit":10000,"programurl":"https://www.aap.org/en/advocacy/community-health-and-advocacy/community-access-to-child-health/catch-planning-implementation-and-residentgrants/","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Community Access to Child Health (CATCH) -- Planning Grants","revision_date":"02-Nov-2022","deadline_note":null,"sponwebsite":"https://www.aap.org/en/advocacy/community-health-and-advocacy/community-access-to-child-health/","deadline_date":["23-Jan-2023"],"contact":null,"contact_tel":"847-434-4916","contact_email":"catch@aap.org"},{"synopsis":"This award is to assist in the development of young faculty members engaged in disparities research in digestive diseases. The SSAT award of $20,000 per year for two years is meant to support health disparities/diversity investigators within 10 years of faculty appointment","id":"057947","spon_name":"Society for Surgery of the Alimentary Tract","NextDeadlineDate":"06-Feb-2023","total_funding_limit":20000,"programurl":"https://ssat.com/Grants/Health-Care.cgi","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Health Care Disparities Research Award (Temporarily Suspended)","revision_date":"01-Dec-2022","deadline_note":null,"sponwebsite":"https://ssat.com/","deadline_date":["06-Feb-2023"],"contact":null,"contact_tel":"978-927-8330","contact_email":null},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This funding opportunity announcement (FOA) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by (1) developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination; (2) promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally; (3) creating, providing, and disseminating innovative research programs and partnerships across institutions and communities to address health disparities and deliver the benefits of translational science to all; (4) creating and implementing scientific and operational innovations that increase the quality, safety, efficiency, effectiveness, and informativeness of clinical research; (5) providing a national resource for the rapid response to urgent public health needs; and (6) creating, providing, and disseminating CTS training for clinical research professionals of all disciplines on the research team.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Along with this solicitation for the UM1 CTSA hub application, NCATS plans to publish a separate, companion FOA that solicits applications for a&nbsp;<span style=\"text-decoration:underline;\">required</span>&nbsp;K12 Clinical Scientist Institutional Career Development Program Award (<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-TR-21-030.html\">NOT-TR-21-030</a>) ); both a UM1 hub application and the required K12 application must be submitted. If there is no companion K12 application submitted, the UM1 hub application will not be reviewed. However, if the UM1 application is funded and the companion K12 application is not funded, a resubmitted K12 application will be accepted. Additional companion FOAs solicit applications for optional training, career, and research education programs.</span></span></p>","id":"105762","spon_name":"National Center for Advancing Translational Sciences/NIH/DHHS","NextDeadlineDate":"13-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-293.html","sponsor_type":"US Federal","prog_title":"Clinical and Translational Science Award (UM1 Clinical Trial Optional)","revision_date":"25-Jul-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 13, 2022. The deadlines for receipt of standard applications under this announcement are: May 13, 2022; September 16, 2022; January 13, 2023; May 12, 2023; September 15, 2023; January 12, 2024; May 17, 2024; and September 13, 2024, by 5:00 PM local time of applicant organization. This program will expire on September 14, 2024.&nbsp;","sponwebsite":null,"deadline_date":["13-Sep-2024","15-Sep-2023","12-May-2023","12-Jan-2024","17-May-2024","13-Jan-2023"],"contact":"Erica Rosemond, Ph.D.","contact_tel":"301-594-8927","contact_email":"CTSAFOAQuestions@mail.nih.gov"},{"synopsis":"Evaluation of established as well as new diagnostic tests and their ultimate implementation by communities adversely affected by COVID-19 is critical to reducing the disease burden in the US.&nbsp; Clinicians, the public health community, advocates, policymakers, and the public require reliable, accurate information regarding the accessibility and effective utilization of COVID-19 diagnostic tests in underserved populations. This evaluation includes assessment of facilitators and barriers to utilization of current available tests such as nucleic acid detection, antigen detection, and antibody tests. Important implementation issues will include personal and community factors involved with obtaining and transporting the test, the optimal site and timing of tests, as well as returning information to individuals regarding the meaning of positive and negative test results. Information pertaining to post-test management, including the transmittal of action steps on receipt of a test result, possible isolation, participation in work or school, as well as conformance with local, state, and/or federal reporting requirements is also important. Given the number and variety of vulnerable populations, we anticipate that a range of testing methods will be necessary to understand how to best engage and test individuals in various underserved communities. As the number and types of commercially available tests increase, including point-of-care tests, the sponsor anticipates that both accessibility and challenges to their equitable utilization will need to be addressed.","id":"104960","spon_name":"RADx-UP Coordination and Data Collection Center (CDCC)","NextDeadlineDate":"23-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":200000,"programurl":"https://radx-up.org/apply-for-grant/","sponsor_type":"Miscellaneous Non-Federal","prog_title":"Rapid Research Pilot Program","revision_date":"24-Feb-2022","deadline_note":"<p></p><div>Submitting a letter of intent is not required, but is encouraged so that the sponsor can plan for the number of anticipated submissions.</div><div>&nbsp;</div><div>Deadlines are as follows:</div><div>&nbsp;</div><div>Letters of Interest must be received by April 22 for applications due May 13, 2022.</div><div>&nbsp;</div><div>Letters of Interest must be received by August 26 for applications due September 16, 2022.</div><div>&nbsp;</div><div>Letters of Interest must be received by December 23, 2022 for applications due January 13, 2023.</div><div>&nbsp;</div><div>&nbsp;</div><p></p>","sponwebsite":"https://radx-up.org","deadline_date":["23-Dec-2022 [Optional] [LOI/Pre-App]","13-Jan-2023"],"contact":null,"contact_tel":null,"contact_email":"RADx-UPMiniGrant-PilotProgramAdmin@dm.duke.edu"},{"synopsis":"The Hope Foundation&rsquo;s Secondary Data Analysis Program is aimed towards enabling Group researchers to collaborate with the SWOG Statistics and Data Management Center to conduct database analyses using SWOG clinical trial data alone or in combination with registry (i.e., SEER) or claims data (i.e., SEER-Medicare), or other potential linkages. These projects may assist investigators to support the research mission of SWOG. ","id":"081165","spon_name":"Hope Foundation for Cancer Research","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://www.thehopefoundation.org/funding-opportunities/secondary-data-analysis/","sponsor_type":"Foundations","prog_title":"SWOG Secondary Data Analysis Projects","revision_date":"22-Apr-2022","deadline_note":"Applicants may submit applications at any time.","sponwebsite":"https://www.thehopefoundation.org/funding-opportunities/","deadline_date":null,"contact":"Johanna Horn","contact_tel":"734-998-6888","contact_email":"jo@thehopefoundation.org"},{"synopsis":"The Emergency Medicine Foundation invites emergency medicine investigator-initiated human subjects research proposals that addresses the research priority of closing gaps in knowledge of reversal of anticoagulation.&nbsp;One $150,00 grant will be awarded.&nbsp;","id":"114021","spon_name":"Emergency Medicine Foundation","NextDeadlineDate":"20-Jan-2023","total_funding_limit":150000,"programurl":"https://www.emfoundation.org/grants/apply-for-a-grant/","sponsor_type":"Foundations","prog_title":"Coagulation and DOAC Reversal Agent Knowledge Gaps Grant","revision_date":"04-Nov-2022","deadline_note":"Applications are due&nbsp;January 20, 2023, by 6:00 pm EST.","sponwebsite":"https://www.emfoundation.org/","deadline_date":["20-Jan-2023"],"contact":"Cynthia Singh, MS","contact_tel":"469-499-0297","contact_email":"csingh@acep.org"},{"synopsis":"<p>The Society for Health Psychology (SfHP) of the American Psychological Association (APA) sponsors this award to support a&nbsp;graduate student research in health psychology for the category of health disparities.</p><p>There is one (1) award annually for $2,000 for graduate student research in health psychology for this category.&nbsp;</p>","id":"087141","spon_name":"American Psychological Association","NextDeadlineDate":"15-Jan-2023","total_funding_limit":2000,"programurl":"https://societyforhealthpsychology.org/councils-committees/student-council/graduate-student-research-awards-addressing-health-disparities/","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Society for Health Psychology -- Graduate Student Research Award to Address Health Disparities","revision_date":"20-Oct-2022","deadline_note":"Proposals will be reviewed on an annual basis and must be received by January 15, with notification of award made in late March.","sponwebsite":"https://societyforhealthpsychology.org/councils-committees/health-research-council/graduate-student-awards/","deadline_date":["15-Jan-2023"],"contact":null,"contact_tel":"804-752-4987","contact_email":"apadiv38.studentawards@gmail.com"},{"synopsis":"<p>The&nbsp;Pediatric Endocrine Society offers the EDI Specific Research Award to&nbsp;support the development of research and education in equity, diversity and inclusion involving pediatric endocrinology that will enhance pediatric endocrinologists&rsquo; ability to understand the needs of their patients and colleagues and deliver more equitable and inclusive education and services to a diverse population of trainees, colleagues, and patients.&nbsp;The award is up to $50,000 for one year.&nbsp;</p>","id":"113796","spon_name":"Pediatric Endocrine Society","NextDeadlineDate":"14-Dec-2022","total_funding_limit":50000,"programurl":"https://pedsendo.org/award/edi-specific-research-award/","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"EDI Specific Research Award","revision_date":"20-Oct-2022","deadline_note":"Applications are due December 14, 2022, 5 p.m. EST.","sponwebsite":"https://pedsendo.org/","deadline_date":["14-Dec-2022"],"contact":null,"contact_tel":"703-556-9222","contact_email":"info@pedsendo.org"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice is to highlight the interest of the National Cancer Institute (NCI) Division of Cancer Control and Population Sciences (DCCPS)&nbsp;in receiving applications to understand and address the full spectrum of factors that contribute to disparities in survivorship care, healthcare utilization, and health outcomes among childhood cancer survivors. Studies that focus on factors that extend beyond the individual (e.g., survivor, caregiver, clinician) to include an examination or intervention that involves healthcare teams, healthcare system, community, payer, and/or policy-level factors that contribute to disparities in health outcomes and result in inequitable survivorship care are strongly encouraged.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108323","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"28-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-CA-22-029.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors","revision_date":"10-Jan-2022","deadline_note":"This notice applies to due dates on or after&nbsp;<em>March 7, 2022</em>, and subsequent receipt dates through&nbsp;<em>October 9, 2024</em>.&nbsp;","sponwebsite":null,"deadline_date":["07-Mar-2023","08-Oct-2024","16-Feb-2023","25-May-2024","05-Jun-2023","26-Sep-2023","05-Nov-2023","28-Dec-2022","16-Jun-2023","07-Sep-2023","09-Oct-2023","05-Jun-2024","07-Jan-2024","05-Feb-2024","16-Oct-2023","25-Sep-2024","07-Jan-2023","28-Dec-2023","25-Jan-2023","05-Feb-2023","07-Mar-2024","07-May-2024","07-Jun-2023","05-Oct-2023","26-Aug-2023","26-Jan-2023","25-Jan-2024","16-Feb-2024","07-May-2023","25-Sep-2023","25-May-2023","16-Jun-2024","26-May-2023","26-Apr-2023","07-Jun-2024"],"contact":"Veronica Chollette, RN, MS","contact_tel":"240-276-6969","contact_email":"cholletv@mail.nih.gov"},{"synopsis":"&nbsp;<br /><p>This Funding Opportunity Announcement (FOA) solicits resource grant applications for projects that will bring useful, usable health information to health disparity populations and their health care providers. Access to useful, usable, understandable health information is an important factor when making health decisions. Proposed projects should exploit the capabilities of computer and information technology and health sciences libraries to bring health-related information to consumers and their health care providers.</p>","id":"098282","spon_name":"National Library of Medicine/NIH/DHHS","NextDeadlineDate":"17-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-283.html","sponsor_type":"US Federal","prog_title":"NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed)","revision_date":"02-Aug-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems Applications may be submitted on or after September 23, 2020. The deadlines for receipt of optional letters of intent are September 23, 2020; September 22, 2021; September 21, 2022; and January 17, 2023. The deadlines for receipt of full applications are October 23, 2020; October 22, 2021; October 21, 2022; and February 17, 2023, by 5:00 PM local time of applicant organization. The program will expire on February 18, 2023.&nbsp;","sponwebsite":null,"deadline_date":["17-Jan-2023 [Optional] [LOI/Pre-App]","17-Feb-2023"],"contact":"Dr. Alan VanBiervliet","contact_tel":"304-594-4882","contact_email":"vanbiervlietag@mail.nih.gov"},{"synopsis":"<p>Astellas and Pfizer (collectively, the Companies) are committed to supporting high quality, evidence-based Quality Improvement Grants (QI) that seek to improve the overall safety and quality of patient care and treatment for patients with Prostate Cancer (PC). The intent of this QI Call for Grant Applications (CGA) is to encourage the submission of proposals describing concepts and ideas to measurably improve the quality of care for patients with prostate cancer relative to guideline- based management for men with metastatic hormone sensitive prostate cancer (mHSPC) in health systems, cancer care centers, or networks. Proposals that have the most potential to directly impact the quality of care for patients with mHSPC in the US will be prioritized.&nbsp; Individual requests up to $200,000 will be considered for funding.&nbsp;</p>","id":"114188","spon_name":"Pfizer Pharmaceuticals","NextDeadlineDate":"13-Jan-2023","total_funding_limit":200000,"programurl":"https://www.pfizer.com/about/programs-policies/grants/competitive-grants","sponsor_type":"Industrial Groups/Organizations","prog_title":"Call for Independent Quality Improvement Grant Applications Oncology â€“ Prostate Cancer","revision_date":"16-Nov-2022","deadline_note":null,"sponwebsite":"https://www.pfizer.com/","deadline_date":["13-Jan-2023"],"contact":null,"contact_tel":null,"contact_email":"grants@astellas.com"},{"synopsis":"<p>The PKD Foundation will provide support for research on clinical interventions for the treatment of Polycystic Kidney Disease.&nbsp;Award amounts will equal $80,000 direct costs per year for two years, for a total grant award of $160,000.</p>","id":"066668","spon_name":"PKD Foundation for Research in Polycystic Kidney Disease","NextDeadlineDate":"16-Jan-2023","total_funding_limit":160000,"programurl":"https://pkdcure.org/research-medical-professionals/research-funding/apply-for-funding/pkd-foundation-research-rfa/","sponsor_type":"Foundations","prog_title":"Research Grant","revision_date":"06-Jul-2022","deadline_note":"Pre-applications are due August 15, 2022, 5 p.m. CST; if invited, full applications are due 16 January 2023.&nbsp;","sponwebsite":"https://pkdcure.org/research-medical-professionals/research-funding/apply-for-funding/","deadline_date":["16-Jan-2023"],"contact":null,"contact_tel":"816-931-2600","contact_email":"research@pkdcure.org"},{"synopsis":"<p>The RADx-UP CDCC Community Collaboration Mini-Grant Program is open to community serving organizations, faith-based organizations, and tribal nations and organizations to help advance capacity, training, support, and community experience with COVID-19 testing initiatives.</p><p>Duke University in partnership with the University of North Carolina, Chapel Hill, is serving as the Coordination and Data Collection Center (CDCC) for the National Institutes of Health (NIH)-supported Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) program. The goal of the program is to improve access to and uptake of diagnostic COVID-19 testing in underserved, COVID-19 medically, geographically, and socially vulnerable populations.</p>","id":"104958","spon_name":"RADx-UP Coordination and Data Collection Center (CDCC)","NextDeadlineDate":"23-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":50000,"programurl":"https://radx-up.org/apply-for-grant/","sponsor_type":"Miscellaneous Non-Federal","prog_title":"Community Collaboration Mini-Grant Program","revision_date":"24-Feb-2022","deadline_note":"<p>Submitting a letter of intent is not required, but is encouraged so that the sponsor can plan for the number of anticipated submissions.</p><p>Deadlines are as follows:</p><p>Letters of Interest must be received by April 22 for applications due May 13, 2022.</p><p>Letters of Interest must be received by August 26 for applications due September 16, 2022.</p><p>Letters of Interest must be received by December 23, 2022 for applications due January 13, 2023.</p><p>&nbsp;</p>","sponwebsite":"https://radx-up.org","deadline_date":["23-Dec-2022 [Optional] [LOI/Pre-App]","13-Jan-2023"],"contact":null,"contact_tel":null,"contact_email":"RADx-UPMiniGrant-PilotProgramAdmin@dm.duke.edu"},{"synopsis":"Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. The RWJF is interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.","id":"080615","spon_name":"Johnson (Robert Wood) Foundation","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://www.rwjf.org/en/library/funding-opportunities/2020/pioneering-ideas-2020-exploring-the-future-to-build-a-culture-of-health.html","sponsor_type":"Foundations","prog_title":"Pioneering Ideas - Exploring the Future to Build a Culture of Health","revision_date":"15-Apr-2022","deadline_note":"Submissions are accepted and reviewed on a rolling basis. ","sponwebsite":"https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html","deadline_date":null,"contact":null,"contact_tel":"1-877-843-7953","contact_email":"mail@rwjf.org"},{"synopsis":"Bristol-Myers Squibb supports programs and organizations that address unmet medical needs, help students grow through STEM education, and deliver basic human services to communities in which&nbsp;Bristol-Myers Squibb is located.<br />","id":"001818","spon_name":"Bristol-Myers Squibb Foundation, Inc.","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://www.bms.com/about-us/responsibility/supporting-our-communities.html","sponsor_type":"Foundations","prog_title":"Community Giving Program","revision_date":"06-Jul-2022","deadline_note":"<p>If the request is eligible for the sponsor&rsquo;s areas of interest, locations and meets the sponsor&rsquo;s corporate giving guidelines, you may submit a Letter of Request.<br /></p>For all community giving applications, it is strongly urged that applications be submitted at least 12 weeks in advance of the date of required funding.","sponwebsite":"https://www.bms.com/","deadline_date":null,"contact":null,"contact_tel":"800-332-2056","contact_email":null},{"synopsis":"<p>The sponsor gives grants to organisations in both the UK and world-wide. They are most interested in projects that help globally particularly in the areas of the disparity of opportunities and wealth and the unsustainable use of the world&rsquo;s natural resources. They want to help both the global community and the local community in Wales.</p>","id":"020499","spon_name":"Waterloo Foundation","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"http://www.waterloofoundation.org.uk/WorldDevelopmentAboutTheProgramme.html","sponsor_type":"Foundations","prog_title":"World Development Grants ","revision_date":"18-Jun-2022","deadline_note":"The Small Grants Programme and the Main Grants Programme will be open all year round without topic-specific deadlines.","sponwebsite":"http://www.waterloofoundation.org.uk/index.html","deadline_date":null,"contact":null,"contact_tel":"02920 838980","contact_email":"info@waterloofoundation.org.uk"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this funding opportunity announcement (FOA) is to test an innovative and pragmatic approach to address barriers to and facilitate greater use of diabetes self-management education and support (DSMES) by people living with diabetes mellitus. Research applications should engage key stakeholders in cultivating a practical and sustainable strategy with the potential for dissemination. The pilot trial of the proposed strategy should be designed to generate preliminary data in support of a future, full-scale trial to study broader dissemination and implementation to expand the use of DSMES.</span>","id":"101487","spon_name":"National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS","NextDeadlineDate":"22-May-2023 [Optional] [LOI/Pre-App]","total_funding_limit":600000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-032.html","sponsor_type":"US Federal","prog_title":"RFA-DK-20-032 -- Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)","revision_date":"25-Feb-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 22, 2021. The deadline for receipt of optional letters of intent is May 22, annually. The deadline for receipt of full applications is June 22 annually, by 5:00 PM local time of applicant organization. This FOA will expire on&nbsp;June 23, 2023.</p>","sponwebsite":null,"deadline_date":["22-May-2023 [Optional] [LOI/Pre-App]","22-Jun-2023"],"contact":"Henry B. Burch, M.D","contact_tel":"301-827-0827","contact_email":"henry.burch@nih.gov"},{"synopsis":"<p>The purpose of this NOFO is to:</p><ol><li>conduct epidemiological studies to examine IBD&rsquo;s natural history, social and psychological factors contributing to IBD, health disparities, and effectiveness of management strategies through multidisciplinary partnerships and collaborations with healthcare providers and researchers specific to IBD.</li><li>translate the scientific knowledge on IBD by conducting and evaluating activities for patients and providers to: &bull; increase awareness and education to improve time to diagnosis and beginning of effective disease management, &bull; enhance IBD management (e.g., patients&rsquo; self-management, integrated clinical care) to improve overall health and quality of life, and &bull; address health disparities (e.g., race and ethnicity), including social determinants impacting outcomes, through tailored interventions to improve IBD diagnosis, management, and outcomes.</li></ol>","id":"113695","spon_name":"National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS","NextDeadlineDate":"08-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":3750000,"programurl":"https://www.grants.gov/web/grants/view-opportunity.html?oppId=341189","sponsor_type":"US Federal","prog_title":"Improving Health Outcomes for Patients with Inflammatory Bowel Disease","revision_date":"13-Oct-2022","deadline_note":"The deadline for receipt of optional letters of intent is December 8, 2022. The deadline for receipt of full applications is January 9, 2023.","sponwebsite":null,"deadline_date":["08-Dec-2022 [Optional] [LOI/Pre-App]","09-Jan-2023"],"contact":"Natalie Brown, MPH, Scientific Program Official","contact_tel":"404-639-4601","contact_email":"researchnofo@cdc.gov"},{"synopsis":"The National Institute of Nursing Research (NINR) is committed to training the next generation of nurse scientists at all levels of education and encouraging training in important new areas of nursing research.<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"102700","spon_name":"National Institute of Nursing Research/NIH/DHHS","NextDeadlineDate":"08-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-NR-21-001.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): NINR Priority Areas for Training and Career Development Awards","revision_date":"04-Oct-2021","deadline_note":"<p>Please direct all inquiries to the Scientific/Research, Peer Review, and Financial/Grants Management contacts in Section VII of the listed funding opportunity announcements.</p><p>This notice applies to due dates on or after May 25, 2021 and subsequent receipt dates through September 07, 2023.&nbsp;</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["07-Sep-2023","25-Jan-2023","07-May-2023","12-Feb-2023","12-Jun-2023","25-May-2023","08-Aug-2023","08-Dec-2022","07-Jan-2023","08-Apr-2023"],"contact":null,"contact_tel":null,"contact_email":null},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) supports pilot work for subsequent &nbsp;studies testing the effectiveness of strategies to deliver evidence-based mental health services, treatment interventions, and/or preventive interventions (EBPs) in low-resourced mental health specialty and non-specialty settings within the United States. The FOA targets settings where EBPs are not currently delivered or delivered with fidelity, such that there are disparities in mental health and related functional outcomes (e.g., employment, educational attainment, stable housing, integration in the community, treatment of comorbid substance use disorders) for the population(s) served. Implementation strategies should identify and use innovative approaches to remediate barriers to provision, receipt, and/or benefit from EBPs and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations. Research generating new information about factors causing/reducing disparities is strongly encouraged, including due consideration for the needs of individuals across the life span. Applications proposing definitive tests of an implementation strategy should respond to the&nbsp;companion R01 announcement&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-284.html\">PAR-21-284</a>.</span></span>","id":"105881","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-283.html","sponsor_type":"US Federal","prog_title":"Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )","revision_date":"08-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 05, 2021. The deadline for receipt of optional letters of intent is September 05, 2021. The deadlines for receipt of full applications are: February 5, June 5, and October 5 annually, by&nbsp;&nbsp;5:00 PM local time of applicant organization. This FOA will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["05-Jun-2023","05-Feb-2023","05-Oct-2023","05-Feb-2024","05-Jun-2024"],"contact":"Denise Pintello, Ph.D.","contact_tel":"301-451-1481","contact_email":"denise.pintello@nih.gov"},{"synopsis":"The Community Access to Child Health (CATCH) Program is a national initiative of the American Academy of Pediatrics (AAP) that supports pediatricians to lead innovative, community-based initiatives that increase children&rsquo;s access to optimal health or well-being. Grants up to $2,000 are awarded annually on a competitive basis to pediatric residents who plan to build broad-based community partnerships to address unmet child health needs.&nbsp;","id":"033153","spon_name":"American Academy of Pediatrics","NextDeadlineDate":"23-Jan-2023","total_funding_limit":2000,"programurl":"https://www.aap.org/en/advocacy/community-health-and-advocacy/community-access-to-child-health/catch-planning-implementation-and-residentgrants/","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Community Access to Child Health (CATCH) -- Resident Grants","revision_date":"03-Nov-2022","deadline_note":"Applications are due&nbsp;January 23, 2023 at 11:59 pm CST.","sponwebsite":"https://www.aap.org/","deadline_date":["23-Jan-2023"],"contact":null,"contact_tel":"800-433-9016","contact_email":"catch@aap.org"},{"synopsis":"This one-year award, with funding of up to $50,000, supports actionable science that will translate to reducing health and/or healthcare disparities.&nbsp;","id":"106341","spon_name":"American College of Gastroenterology","NextDeadlineDate":"05-Dec-2022","total_funding_limit":50000,"programurl":"https://webfiles.gi.org/docs/institute/23HERA-rfa-web.pdf","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Health Equity Research Award","revision_date":"05-Sep-2022","deadline_note":null,"sponwebsite":"https://gi.org/acg-institute/research-awards/","deadline_date":["05-Dec-2022"],"contact":null,"contact_tel":null,"contact_email":"research@gi.org"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to highlight that the National Institute on Aging (NIA) is interested in receiving grant applications focused on pain, pain management, and opioids related to aging or older adults and within NIA&rsquo;s mission areas. This NOSI invites research applications that focus on improving the understanding of mechanisms underlying pain experience with aging; enhancing assessment, prevention, and management strategies for pain in older adults; and improving health equity of aging populations suffering with pain. New applications, resubmissions, competing renewals, and competing revisions to existing awards are all encouraged through this NOSI. For administrative supplements focused on pain, pain management, and opioids related to aging or older adults and within NIA&rsquo;s mission areas, please see&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-22-005.html\">NOT-AG-22-005</a>.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108054","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"08-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-22-004.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research on Pain, Pain Management, and Opioids in Aging","revision_date":"27-Dec-2021","deadline_note":"This notice applies to application receipt dates on or after&nbsp;<strong>February 5,&nbsp;</strong><strong>2022&nbsp;</strong>and subsequent receipt dates through&nbsp;<strong>January 7, 2025</strong>.","sponwebsite":null,"deadline_date":["05-Jun-2024","16-Jun-2023","25-Sep-2023","12-Jun-2024","16-Feb-2024","12-Dec-2022","12-Feb-2024","12-Oct-2024","08-Aug-2023","25-Apr-2023","07-May-2023","25-Sep-2024","25-Jan-2024","07-Jan-2024","07-Jan-2023","07-Sep-2024","25-May-2023","25-Jan-2023","05-Apr-2024","05-Jan-2024","05-Sep-2024","07-Sep-2023","05-Sep-2023","05-Feb-2023","16-Feb-2023","25-Jun-2023","25-Feb-2024","08-Apr-2024","25-Oct-2023","05-Feb-2024","07-May-2024","05-Jun-2023","08-Dec-2025","08-Aug-2024","08-Apr-2023","25-Feb-2023","12-Apr-2023","25-May-2024","12-Aug-2023","25-Jun-2024","12-Oct-2023","12-Jun-2023","08-Dec-2022","25-Oct-2024","05-Apr-2023","05-Jan-2025","16-Jun-2024","05-Jan-2023","05-Oct-2023","12-Feb-2023","12-Dec-2023","08-Dec-2023","16-Oct-2023"],"contact":"Devon Oskvig, Ph.D.","contact_tel":"301-827-5899","contact_email":"devon.oskvig@nih.gov"},{"synopsis":"<p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This NIDCR Small Grant Program for New Investigators supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in oral, dental and craniofacial research. This R03 program supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent investigator&shy; initiated Research Project Grant (R01) or equivalent application.</span></p><s2s></s2s>","id":"100931","spon_name":"National Institute of Dental and Craniofacial Research/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":200000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-084.html","sponsor_type":"US Federal","prog_title":"NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)","revision_date":"22-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 08, 2021. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on January 8, 2024.","sponwebsite":null,"deadline_date":["16-Oct-2023","16-Jun-2023","07-Jan-2024","07-Jan-2023","16-Feb-2023","07-May-2023","07-Sep-2023"],"contact":"Preethi Chander, PhD","contact_tel":"301-827-4620","contact_email":"preethi.chander@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this Notice of Special Interest (NOSI)<em>&nbsp;</em>is to promote intervention research through investigator-initiated applications that aim to study ways to mitigate financial hardship for individuals impacted by a cancer diagnosis, including patients receiving cancer treatment, survivors, and caregivers.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108832","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-CA-22-045.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI):  Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes","revision_date":"04-Feb-2022","deadline_note":"This notice applies to due dates on or after April 1, 2022 and subsequent receipt dates through March 1, 2024.&nbsp;","sponwebsite":null,"deadline_date":["25-Jan-2023","07-Jan-2023","05-Nov-2023","16-Oct-2023","07-Mar-2023","07-Oct-2023","25-May-2023","05-Oct-2023","16-Jun-2023","16-Oct-2023","25-Jan-2024","16-Feb-2023","05-Jun-2023","07-Oct-2023","05-Feb-2023","05-Feb-2024","16-Feb-2024","07-Jun-2023","25-Sep-2023"],"contact":"Kathleen Castro, RN, MS, AOCN","contact_tel":"240-276-6834","contact_email":"kathleen.castro@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome (DS). This Notice of Special Interest (NOSI) announces NIH support for exploratory/developmental grant (R21) applications that are focused on community-based participatory research (CBPR) in DS to address health disparities and that meet programmatic objectives for the INCLUDE Project.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"112791","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-142.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities With a Focus on Addressing Diverse Representation in Research On Down Syndrome (R21 Clinical Trial Optional)","revision_date":"06-Aug-2022","deadline_note":"This notice applies to due dates on or after<span style=\"color:#184e80;\">&nbsp;October 16, 2022&nbsp;</span>and subsequent receipt dates through March 17, 2025.","sponwebsite":null,"deadline_date":["07-May-2024","16-Jun-2024","16-Feb-2024","16-Feb-2025","07-Jan-2025","07-Jan-2023","07-Jan-2024","07-May-2023","16-Jun-2023","07-Sep-2023","16-Feb-2023","16-Oct-2024","16-Oct-2023","07-Sep-2024"],"contact":"Sujata Bardhan, Ph.D.","contact_tel":"301-435-0471","contact_email":"sujata.bardhan@nih.gov"},{"synopsis":"The National Kidney Foundation (NKF) seeks proposals that are primed to influence health equity related to kidney health at a community level. If successful, projects would have a measurable impact in preventing, reducing, or eliminating kidney health disparities and advancing health equity in local communities or populations at risk for and overburdened with kidney diseases. Proposals must seek to improve access to kidney care, kidney disease management, and patient outcomes.<br />","id":"107632","spon_name":"National Kidney Foundation","NextDeadlineDate":"13-Feb-2023","total_funding_limit":75000,"programurl":"https://www.kidney.org/sites/default/files/kidney_health_equity_community_engagement_award_-_updated_9.26.2022.pdf","sponsor_type":"Foundations","prog_title":"Kidney Health Equity Community Engagement Award","revision_date":"15-Nov-2022","deadline_note":null,"sponwebsite":"https://www.kidney.org/professionals/research/awards","deadline_date":["13-Feb-2023"],"contact":null,"contact_tel":"855-653-2273","contact_email":"research@kidney.org "},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 1 diabetes research (SEIC-T1D). A primary goal of the SEIC-T1D is to accelerate equitable engagement of diverse stakeholders (specifically people from&nbsp;<a href=\"https://www.nimhd.nih.gov/about/overview/\" rel=\"noreferrer noopener\" target=\"_blank\">NIH designated health disparities populations</a>) in T1D research; particularly those from communities that experience diabetes-related health disparities and live within the healthcare and social systems that negatively impact community members&rsquo; and patients&rsquo; health. The SEIC-T1D will provide highly specialized research resources to support investigators by fully embedding communities, people living with T1D, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T1D will also establish a network consisting of diverse, multidisciplinary research investigators with expertise in T1D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T1D early detection and treatment.</span></span>","id":"112567","spon_name":"National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS","NextDeadlineDate":"20-Dec-2022","total_funding_limit":7500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-019.html","sponsor_type":"US Federal","prog_title":"RFA-DK-22-019 -- Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)","revision_date":"17-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 20, 2022. The deadline for receipt of optional letters of intent is November 20, 2022. The deadline for receipt of full applications is December 20, 2022, by 5:00 PM local time of applicant organization.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["20-Dec-2022"],"contact":"Miranda Broadney, M.D., M.P.H.","contact_tel":"301-594-6841","contact_email":"Miranda.Broadney@nih.gov"},{"synopsis":"The Emergency Medicine Foundation invites proposals for the Health Disparities Grant that promotes&nbsp;research that improves health care access, delivery, utilization, quality, and outcomes of those affected by health disparities, including racial and ethnic minority populations; non-English speaking populations; lesbian, gay, bisexual and transgender (LGBT) populations; persons with limited health literacy; socioeconomically disadvantaged populations; and other groups impacted by health disparities.","id":"114205","spon_name":"Emergency Medicine Foundation","NextDeadlineDate":"20-Jan-2023","total_funding_limit":50000,"programurl":"https://www.emfoundation.org/grants/apply-for-a-grant/","sponsor_type":"Foundations","prog_title":"Health Disparities Research Grant","revision_date":"16-Nov-2022","deadline_note":"Applications are due&nbsp;January 20, 2023, by 6:00 pm EST.","sponwebsite":"https://www.emfoundation.org/","deadline_date":["20-Jan-2023"],"contact":"Cynthia Singh, MS","contact_tel":"469-499-0297","contact_email":"csingh@acep.org"},{"synopsis":"This grant program&nbsp;seeks to incorporate diversity, health care equity, and inclusion in internal medicine training to increase interprofessional efforts and build a more trustworthy health system.","id":"053763","spon_name":"Alliance for Academic Internal Medicine","NextDeadlineDate":"09-Jan-2023 [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://www.im.org/resources/innovation-grants","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Innovation Grants (Building Trust Through DEI)","revision_date":"28-Nov-2022","deadline_note":"Those who are interested in applying for a grant should submit a letter of intent by&nbsp;<strong>January 9, 2023</strong>. A committee appointed by the sponsoring organizations will review the submitted letters of intent and invite a formal proposal from selected applicants from February - April 2023.&nbsp;","sponwebsite":"https://www.im.org/","deadline_date":["09-Jan-2023 [LOI/Pre-App]"],"contact":null,"contact_tel":"703-341-4540","contact_email":"innovationgrants@im.org"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this funding opportunity announcement (FOA) is to enhance the participation of individuals from diverse backgrounds, including those from groups that are nationally underrepresented in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity. The NHLBI's T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, and hematologic diseases, and sleep disorders. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.</span></p>","id":"104079","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"29-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":1610000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-22-001.html","sponsor_type":"US Federal","prog_title":"RFA-HL-22-001 -- T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)","revision_date":"12-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 13, 2021.&nbsp;The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: September 13, 2021; February 28, 2022; September 13, 2022; February 28, 2023; September 13, 2023; and February 28, 2024, by 5:00pm local time of the applicant organization.","sponwebsite":null,"deadline_date":["28-Feb-2023","29-Jan-2024 [Optional] [LOI/Pre-App]","29-Jan-2023 [Optional] [LOI/Pre-App]","14-Aug-2023 [Optional] [LOI/Pre-App]","28-Feb-2024","13-Sep-2023"],"contact":"Traci Mondoro, PhD","contact_tel":"301-435-0050","contact_email":"NHLBI_Blood_Training@nhlbi.nih.gov"},{"synopsis":"<p>AstraZeneca Canada provides support to organizations with a focus on projects and initiatives that meet the following criteria:</p><ul><li>Improve healthcare in their local communities;</li><li>Promote science education and skills among young people;</li><li>Support Chronic Disease Prevention programs for adolescents; and,</li><li>Are connected to the giving and volunteer activities of their employees.</li></ul>","id":"004291","spon_name":"AstraZeneca Canada","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://www.astrazeneca.ca/en/sustainability.html","sponsor_type":"Industrial Groups/Organizations","prog_title":"Community Support ","revision_date":"23-Jun-2022","deadline_note":"","sponwebsite":"https://www.astrazeneca.ca/en","deadline_date":null,"contact":null,"contact_tel":"1-800-565-5877","contact_email":null},{"synopsis":"The Pioneer team seeks to anticipate the future, and support unconventional approaches and breakthrough ideas that can help lead the way to a future where everyone in the United States can live their healthiest life possible. The Pioneering Ideas: Exploring the Future to Build a Culture of Health call for proposals (CFP) seeks applications from visionary thinkers across the nation who are doing cutting-edge work to advance health equity.","id":"092814","spon_name":"Johnson (Robert Wood) Foundation","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://www.rwjf.org/en/library/funding-opportunities/2020/pioneering-ideas-2020-exploring-the-future-to-build-a-culture-of-health.html","sponsor_type":"Foundations","prog_title":"Pioneering Ideas: Exploring the Future to Build a Culture of Health","revision_date":"16-Mar-2022","deadline_note":"Submissions are accepted and reviewed on a rolling basis. Applicants must first submit a brief proposal (Phase 1) with a project description and summary and include a preliminary budget. Selected Phase 1 applicants may be invited to submit a full proposal accompanied by a detailed budget, budget narrative, and additional information.","sponwebsite":"https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html","deadline_date":null,"contact":null,"contact_tel":"1-877-843-7953","contact_email":"pioneeringideas@rwjf.org"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.&nbsp; The overarching goal of this&nbsp;R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation&rsquo;s biomedical, behavioral and clinical research needs.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:</span></p><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Courses for Skills Development</em></strong></span></li></ul><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Mentoring Activities</em></strong></span></li></ul><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">NIGMS will support creative educational activities&nbsp;designed to equip a diverse cohort of participants with the technical, operational, and professional skills required for careers in the biomedical research workforce. Funded programs are expected to have robust evaluation, outreach, dissemination, and sustainability plans.</span></p>","id":"103187","spon_name":"National Institute of General Medical Sciences/NIH/DHHS","NextDeadlineDate":"13-Oct-2023","total_funding_limit":500000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-196.html","sponsor_type":"US Federal","prog_title":"Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)","revision_date":"01-Apr-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 14, 2021.. The deadlines for receipt of full applications are: October 14, 2021; October 14, 2022; October 13, 2023, by 5:00 PM local time of applicant organization. This FOA will expire on&nbsp;October 14, 2023.","sponwebsite":null,"deadline_date":["13-Oct-2023"],"contact":"Edgardo FalcÃ³n Ph.D.","contact_tel":null,"contact_email":"edgardo.falcon@nih.gov"},{"synopsis":"<p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Funding Opportunity Announcement (FOA), issued by the National Heart, Lung, and Blood Institute (NHLBI) invites submission of investigator-initiated Program Project (P01) applications.&nbsp;The proposed programs may address scientific areas relevant to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders.&nbsp;Programs may also include implementation science, health disparities, and translation research that addresses the mission of the Institute. Each application submitted in response to this FOA must include at least three related research projects that share a common central theme, focus, and/or overall objective. Higher budgets may be requested for applications that include at least four projects, one of which includes an Early Stage Investigator as Project Leader.</span><span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span></p>","id":"100990","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"25-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-088.html","sponsor_type":"US Federal","prog_title":"NHLBI Program Project Applications (P01 Clinical Trial Optional)","revision_date":"03-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after December 25, 2020. The deadline for receipt of optional letters of intent is 60 days prior to the application due date. The deadlines for receipt of standard applications under this FOA are standard dates of January 25, May 25, and September 25 annually. This program will expire on September 26, 2023. ","sponwebsite":null,"deadline_date":["25-Jan-2023","25-May-2023","25-Sep-2023"],"contact":"Denis Buxton, Ph.D.","contact_tel":"301-435-0515","contact_email":"denis.buxton@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research to improve the oral health of adolescents in the United States, and to reduce observed oral health disparities and inequities in this population. This FOA defines &ldquo;adolescents&rdquo; as those individuals between the ages of 10 and 19.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"087114","spon_name":"National Institute of Dental and Craniofacial Research/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-058.html","sponsor_type":"US Federal","prog_title":"Improving Oral Health and Reducing Disparities in Adolescents (R01 Clinical Trial Not Allowed)","revision_date":"04-Nov-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 5, 2020. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2023. </p>","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Darien Weatherspoon, DDS, MPH","contact_tel":"301-594-5394","contact_email":"darien.weatherspoon@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice is to inform potential applicants to the National Heart, Lung, and Blood Institute (NHLBI) of an area of special interest in supporting analysis of barriers to care and risk of HIV-associated comorbidities among disproportionally vulnerable and affected population groups of people living with or at risk for HIV infection.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108728","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-010.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research on Barriers To Care and Risk of HIV-Associated Comorbidities Among Vulnerable Population Groups","revision_date":"01-Feb-2022","deadline_note":"This notice applies to due dates on or after May 7, 2022 and subsequent receipt dates through May 8, 2025.&nbsp;","sponwebsite":null,"deadline_date":["05-Oct-2024","05-Jun-2024","07-Jan-2023","07-Jan-2025","05-Feb-2025","07-May-2025","07-Sep-2024","05-Feb-2023","07-May-2024","05-Jun-2023","05-Oct-2023","05-Feb-2024","07-May-2023","07-Jan-2024","07-Sep-2023"],"contact":"Sean Altekruse D.V.M., Ph.D.","contact_tel":"301-435-1290","contact_email":"altekrusesf@nhlbi.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) encourages studies that develop and test the effectiveness of strategies for implementation and sustainable delivery of evidence-based mental health treatments and services to improve mental health outcomes for underserved populations in low-resourced settings in the United States. Studies should identify and use innovative approaches to remediate&nbsp;barriers to provision, receipt, and/or benefit from evidence-based practices (EBPs) and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations. Research generating new information about factors causing/reducing disparities are strongly encouraged, including due consideration of the needs of individuals across the life span.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA is published in parallel to a companion R34,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/par-21-283.html\">PAR-21-283</a>,&nbsp;&nbsp;that supports pilot studies in preparation for the larger-scale studies described here.</span></span></p>","id":"105794","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-284.html","sponsor_type":"US Federal","prog_title":"Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional)","revision_date":"30-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 05, 2021. The deadline for receipt of optional letters of intent is September 05, 2021. The deadlines for receipt of full applications are: February 5, June 5, and October 5 annually, by&nbsp;&nbsp;5:00 PM local time of applicant organization. This FOA will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["05-Oct-2023","05-Jun-2023","05-Jun-2024","05-Feb-2023","05-Feb-2024"],"contact":"Denise Pintello, Ph.D.","contact_tel":"301-451-1481","contact_email":"denise.pintello@nih.gov"},{"synopsis":"This NOFO will strengthen the ability of leaders who make decisions in public health to identify, develop, and implement evidence-based policy interventions that can save lives, save money, reduce health disparities, and protect adults and youth from HIV, viral hepatitis, STDs, and TB. Component One will leverage legal epidemiological methods to analyze laws, regulations, and other policies to determine their impact on health and economic outcomes. Component Two will assist leaders with navigating complex legal and policy landscapes including those unique to their jurisdiction. Upon request, recipients of Component Two funding will provide direct legal and policy technical assistance (TA), proactively produce TA tools, and develop a centralized resource center accessible to the public. Applicants may apply to one or both components. Expected outcomes from both components include (1) increased breadth and depth of available evidence demonstrating the impact that laws and policies have on health and economic outcomes and (2) increased application of legal TA tools and resources in advancing evidence-based laws and policies.","id":"113997","spon_name":"National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention/CDC/DHHS","NextDeadlineDate":"01-Feb-2023","total_funding_limit":3750000,"programurl":"https://www.grants.gov/web/grants/view-opportunity.html?oppId=341540","sponsor_type":"US Federal","prog_title":"Advancing Policy as a Public Health Intervention to Reduce Morbidity, Mortality and Disparities in HIV, Viral Hepatitis, STDs, and Tuberculosis","revision_date":"03-Nov-2022","deadline_note":"The deadline for receipt of full applications is February 1, 2023, by 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.&nbsp;","sponwebsite":null,"deadline_date":["01-Feb-2023"],"contact":"Michael Williams, Project Officer","contact_tel":"404-718-4516","contact_email":"xkk3@cdc.gov"},{"synopsis":"There are four (4) awards annually for&nbsp;graduate student research in general health psychology. Each award is $2,000. The awards may cover research related to any topic in health psychology.","id":"074948","spon_name":"American Psychological Association","NextDeadlineDate":"15-Jan-2023","total_funding_limit":2000,"programurl":"https://societyforhealthpsychology.org/councils-committees/student-council/graduate-student-research-awards-general-health-psychology/","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Society for Health Psychology (Division 38) -- Graduate Student Research Awards Program  -- Research in General Health Psychology","revision_date":"28-Nov-2022","deadline_note":"Proposals will be reviewed on an annual basis and must be received by January 15, with notification of award made in late March.","sponwebsite":"https://societyforhealthpsychology.org/councils-committees/health-research-council/graduate-student-awards/","deadline_date":["15-Jan-2023"],"contact":null,"contact_tel":"804-752-4987","contact_email":"apadiv38.studentawards@gmail.com"},{"synopsis":"<p>The American Lung Association Public Policy Research Award is intended to support research on and evaluation of existing public policy and programs, as well as pilot and demonstration projects that inject innovative ideas and provide evidence for the development of new public policies impacting lung health.&nbsp;The award is for a maximum of $50,000 per year for up to two years.&nbsp;</p>","id":"084293","spon_name":"American Lung Association","NextDeadlineDate":"15-Dec-2022","total_funding_limit":100000,"programurl":"https://www.lung.org/research/awards-and-grants-opportunities","sponsor_type":"Voluntary Health Organization","prog_title":"Public Policy Research Award","revision_date":"03-Aug-2022","deadline_note":null,"sponwebsite":"https://www.lung.org/","deadline_date":["15-Dec-2022"],"contact":null,"contact_tel":"1-800-875-2562","contact_email":"research@lung.org"},{"synopsis":"<p>The&nbsp;NYSGE Award for Collaborative Endoscopy Research (ACER) in Honor of Florence Lefcourt&nbsp;provides funding for multi-institutional collaboration focused on translational or clinical research with a strong emphasis on gastrointestinal endoscopy.&nbsp;</p>","id":"043825","spon_name":"New York Society for Gastrointestinal Endoscopy","NextDeadlineDate":"09-Dec-2022","total_funding_limit":50000,"programurl":"https://www.nysge.org/content.asp?contentid=187","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Award For Collaborative Endoscopy Research (ACER) In Honor Of Florence Lefcourt ","revision_date":"12-Sep-2022","deadline_note":"The deadline for applications is&nbsp;December 9, 2022 by 6:00 pm EST.","sponwebsite":"https://www.nysge.org/content.asp?contentid=34","deadline_date":["09-Dec-2022"],"contact":null,"contact_tel":"646-218-0650","contact_email":"info@nysge.org"},{"synopsis":"<p>ASGE Research Awards are offered to investigators (MD, DO, PhD, or equivalent) for projects in basic, translational and clinical research with a relationship to gastrointestinal endoscopy. The ASGE is particularly interested in research pertaining to (in no particular order): colorectal cancer screening, Barrett's esophagus, endoscopy training, health disparities, quality measurement and improvement, endoscope reprocessing and infection control, endoscopic sedation/anesthesia, bowel preparation, novel endoscopic treatments for obesity, endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), and other endoscopically-guided imaging/interventions. The research committee will consider funding pilot projects if there is an explicit outline for subsequent projects, and their funding plan (e.g. NIH, VA Merit), based on the preliminary data generated by the proposed pilot.</p>","id":"026823","spon_name":"American Society for Gastrointestinal Endoscopy","NextDeadlineDate":"09-Dec-2022","total_funding_limit":75000,"programurl":"https://www.asge.org/home/about-asge/grants-awards/asge-grants-awards-and-workshops","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"ASGE Research Award","revision_date":"14-Sep-2022","deadline_note":"<div>&nbsp;</div>","sponwebsite":"https://www.asge.org/home/about-asge/grants-awards","deadline_date":["09-Dec-2022"],"contact":"Marty Roth","contact_tel":"630-570--5652","contact_email":"grants@asge.org"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Though epidemiologic research has helped identify drowning risk factors, little is known about what intervention strategies have the greatest efficacy to prevent drowning and/or improve outcomes after a drowning event. Thus, the goal of this NOSI is to encourage and facilitate scientific discovery for drowning prevention, specifically aimed at reducing drowning risk and improving outcomes in three primary domains.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><em>Domain 1: Understanding drowning disparities and developing drowning interventions to address these disparities.</em></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Rates of drowning vary significantly. Reasons contributing to drowning risks among certain populations are multifaceted and likely related to access and exposure to water, knowledge and skills around water, and behaviors and beliefs. Research evaluating both structural and/or systemic forces which contribute to disparities in drowning risk among children, parents and communities is needed. Development of effective interventions aimed at addressing these factors as they pertain to drowning prevention is critical.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><em>Domain 2: Studying the effects of swim instruction on swim skills to prevent drowning.</em></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Swim skills, which are often obtained through swim instruction, can decrease drowning risk; however tremendous variability among types and techniques of swim instruction exists. Validated measures which consistently assess swim skill efficacy to prevent drowning at differing ages and developmental abilities are lacking. Metrics which help to identify effective, quality swim instruction to prevent drowning are needed. The development of evidence-based best practices as to when and how to instruct populations most at risk for drowning (such as children of young age, of certain races/ethnicities, with intellectual or developmental disabilities, or those with linguistic or cultural differences), is essential.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><em>Domain 3: The adoption, integration and sustainable scale-up of the drowning chain of survival.</em></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The five steps of drowning chain of survival can reduce drowning mortality. These steps include: (1) preventing drowning, (2) recognizing distress, (3) providing flotation, (4) removal from water and (5) providing care as needed. Depending on the water source, interventions which constitute these layers of drowning protection exist. Research to advance the adoption, integration and sustainable scale-up of evidence-based drowning prevention interventions and the drowning chain of survival across families and communities is needed.</span></p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"109066","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-048.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research on Drowning Prevention","revision_date":"16-Feb-2022","deadline_note":"This notice applies to due dates on or after June 5, 2022 and subsequent receipt dates through May 8, 2024.&nbsp;","sponwebsite":null,"deadline_date":["16-Jun-2023","12-Jun-2023","16-Feb-2024","05-Oct-2023","07-Jan-2024","05-Feb-2024","12-Oct-2023","07-Jan-2023","07-May-2023","07-May-2024","05-Jun-2023","05-Feb-2023","07-Sep-2023","12-Feb-2024","12-Feb-2023","16-Feb-2023","16-Oct-2023"],"contact":"Cinnamon A. Dixon, DO, MPH","contact_tel":"301-827-6189","contact_email":"cinnamon.dixon@nih.gov"},{"synopsis":"<p>Pre-existing disparities and apparent challenges in resources for treatment and care of children experiencing abuse call for more data and research resources to identify, substantiate and improve care and ultimately outcomes for vulnerable children and youth during and following the current crisis.&nbsp;It is anticipated that research stemming from this NOSI will help to provide greater recognition of the need for better resources and support for vulnerable children. More touchpoints for communication, identification and screening for risks of child trauma, and injury will help inform processes for screening, identification, treatment and care in new and emerging disaster related contexts in the future.</p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"103810","spon_name":"National Institute of Child Health and Human Development/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-026.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth","revision_date":"28-Apr-2021","deadline_note":"This notice applies to due dates on or after June 5, 2019 and subsequent receipt dates through May 31, 2024.&nbsp;","sponwebsite":null,"deadline_date":["07-Sep-2023","07-Jan-2024","05-Feb-2024","16-Feb-2023","07-Jan-2023","05-Jun-2023","16-Jun-2023","07-May-2023","05-Oct-2023","16-Feb-2024","07-May-2024","16-Oct-2023","05-Feb-2023"],"contact":"Valerie Maholmes, Ph.D., CAS","contact_tel":"301-496-1514","contact_email":"maholmev@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Special Emphasis Notice (SEN) informs the research community that the Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research grant applications to develop models of care that improve access, quality, and outcomes of care related to COVID-19 and post-acute sequalae from COVID-19 (PASC).</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"109186","spon_name":"Agency for Healthcare Research and Quality/DHHS","NextDeadlineDate":"25-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HS-22-010.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Health Services Research on Health System and Healthcare Professional Responsiveness to COVID-19","revision_date":"21-Feb-2022","deadline_note":"Applicants should consider this SEN active until February 14, 2025.","sponwebsite":null,"deadline_date":["16-Jun-2024","25-May-2023","16-Feb-2024","25-Sep-2024","25-Sep-2023","25-Jan-2023","25-May-2024","05-Jun-2024","05-Jun-2023","05-Oct-2023","05-Oct-2024","05-Feb-2025","16-Oct-2024","05-Feb-2023","05-Feb-2024","16-Oct-2023","16-Jun-2023","25-Jan-2024","16-Feb-2023","25-Jan-2025"],"contact":"Leeann Comfort, PhD, MPP","contact_tel":null,"contact_email":"Leeann.Comfort@ahrq.hhs.gov"},{"synopsis":"The Emergency Medicine Foundation invites proposals for an emergency physician investigator-initiated project that improves health care access, delivery, utilization, quality, and outcomes of underserved patients presenting to the emergency department with asthma. Underserved patients include racial and ethnic minority populations; non-English speaking populations; lesbian, gay, bisexual and transgender (LGBT) populations; persons with limited health literacy; socioeconomically disadvantaged populations; and other groups impacted by health disparities.&nbsp;One $125,00 grant will be awarded.","id":"114137","spon_name":"Emergency Medicine Foundation","NextDeadlineDate":"20-Jan-2023","total_funding_limit":125000,"programurl":"https://www.emfoundation.org/grants/apply-for-a-grant/","sponsor_type":"Foundations","prog_title":"Asthma Treatment and Care Grant","revision_date":"11-Nov-2022","deadline_note":"Applications are due&nbsp;January 20, 2023, by 6:00 pm EST.","sponwebsite":"https://www.emfoundation.org/","deadline_date":["20-Jan-2023"],"contact":"Cynthia Singh, MS","contact_tel":"469-499-0297","contact_email":"csingh@acep.org"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of the&nbsp;<em>John Lewis&nbsp;</em>NIMHD Research Endowment Program is to strengthen the research infrastructure and training capacity at eligible institutions of higher education to facilitate minority health and health disparities research and enhance the diversity of the scientific workforce.</span></span>","id":"114049","spon_name":"National Institute on Minority Health and Health Disparities/NIH/DHHS","NextDeadlineDate":"17-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":2000000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-22-010.html","sponsor_type":"US Federal","prog_title":"RFA-MD-22-010 -- John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)","revision_date":"08-Nov-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems Applications may be submitted on or after December 17, 2022. The deadline for receipt of optional letters of intent is December 17, 2022. The deadline for receipt of full applications is January 17, 2023, by 5:00 PM local time of applicant organization.","sponwebsite":null,"deadline_date":["17-Dec-2022 [Optional] [LOI/Pre-App]","17-Jan-2023"],"contact":"Nancy L. Jones, PhD","contact_tel":"301-594-8945","contact_email":"nancy.jones@nih.gov"},{"synopsis":"<span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this funding opportunity announcement (FOA) is to fund COVID research that will strengthen and advance research in minority health and healthy equity, increase understanding of health disparities, and provide future direction for research that will contribute to regulatory decision making.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The FDA Office of Minority Health and Health Equity (OMHHE) is interested in research proposals that will contribute to advancing understanding of COVID and long COVID or post-COVID conditions for racial and ethnic minorities or contribute to informing the continued evaluation of the safety and efficacy of FDA approved products (therapeutics, diagnostics, and vaccines) for the treatment, prevention, or diagnosis of COVID-19. These research proposals should support evaluation of outcomes by demographic data including, but not limited to, ethnicity, race, age, disability and geography.</span></p><br />","id":"114096","spon_name":"Food and Drug Administration/DHHS","NextDeadlineDate":"06-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-23-009.html","sponsor_type":"US Federal","prog_title":"RFA-FD-23-009 -- Innovation Award: COVID-19 and Health Equity (U01)  Clinical Trials Not Allowed","revision_date":"10-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 15, 2022. The deadline for receipt of optional letters of intent is December 6, 2022.&nbsp; The deadline for receipt of full applications is January 16, 2023, by 11:59 PM Eastern Time.</p>","sponwebsite":null,"deadline_date":["06-Dec-2022 [Optional] [LOI/Pre-App]","16-Jan-2023"],"contact":"Christine Lee","contact_tel":"202-402-4228","contact_email":"ChristineS.Lee@fda.hhs.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory or developmental research to improve the oral health of adolescents in the United States, and to reduce observed oral health disparities and inequities in this population. This FOA defines &ldquo;adolescents&rdquo; as those individuals between the ages of 10 and 19.</span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"087115","spon_name":"National Institute of Dental and Craniofacial Research/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-059.html","sponsor_type":"US Federal","prog_title":"Improving Oral Health and Reducing Disparities in Adolescents (R21 Clinical Trial Not Allowed)","revision_date":"05-Nov-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">16</span>, 2020. The deadlines for receipt of standard applications under this announcement are: February <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">16</span>, June <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">16</span>, and October <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">16</span> annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2023. </p>","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Darien Weatherspoon, DDS, MPH","contact_tel":"301-594-5394","contact_email":"darien.weatherspoon@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Eunice Kennedy Shriver National Institute of Child Health and Human Development (<a href=\"https://www.nichd.nih.gov/\" target=\"_blank\" rel=\"noreferrer\">NICHD</a>) invites&nbsp;basic science, clinical researchers, behavioral scientists and implementation science experts either as individual or as multi-disciplinary teams, to submit research projects that will identify risk-reduction strategies that address infant mortality domestically , as well as efforts to understand the root causes of sudden infant death syndrome and sudden unexpected infant death.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"104366","spon_name":"National Institute of Child Health and Human Development/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-032.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Reduction of Sudden Unexpected Infant Death and Sudden Infant Death Syndrome","revision_date":"27-May-2021","deadline_note":"This notice applies to standard due dates starting with cycle III, 2021 (after June 16, 2021) and subsequent receipt dates through May 8, 2023.&nbsp;","sponwebsite":null,"deadline_date":["07-May-2023","16-Feb-2023","05-Feb-2023","07-Jan-2023"],"contact":"Marion Koso-Thomas M.D, MPH","contact_tel":"301-435-6873","contact_email":"kosomari@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This FOA encourages applications from institutions/organizations that propose to conduct vision-related secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects wherein numerous data collection activities are required to meet each project's specific aims. The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a project's originally-intended purpose. Data are not limited to those collected under NEI support, but such data are of the highest programmatic interest. The purpose of this FOA is for secondary data analysis using existing data sets from vision-related clinical trials, epidemiologic, and other clinical research studies. This FOA may be used to develop new statistical methodologies or test hypotheses using existing data, but this FOA must not be used to support the collection of new data.</span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"109824","spon_name":"National Eye Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-141.html","sponsor_type":"US Federal","prog_title":"NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)","revision_date":"17-Mar-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"> Applications may be submitted on or after </span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">May 16, 2022</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, </span>by 5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. The deadlines for receipt of Renewal/Resubmission/Revision (as allowed) applications are: March 16, July 16, and November 16 annually,&nbsp;</span>by 5:00 PM local time of applicant organization.&nbsp;<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, </span>by 5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. This program will expire on </span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">May 08, 2025.</span></p>","sponwebsite":null,"deadline_date":["16-Jun-2024","07-May-2024","16-Feb-2023","16-Jun-2023","07-May-2023","07-Sep-2024","07-Jan-2023","07-Sep-2023","16-Oct-2024","07-Jan-2025","16-Feb-2024","07-Jan-2024","16-Oct-2023","07-May-2025","16-Feb-2025"],"contact":"Donald Everett, M.A.","contact_tel":"301-435-8181","contact_email":"everettd@mail.nih.gov"},{"synopsis":"<p>Janssen Pharmaceuticals, Inc. makes charitable contributions to support therapeutic area initiatives. Applications are evaluated competitively with emphasis given to innovative programs with measurable outcomes that address disparities or unmet needs. The Infectious Disease &amp; Vaccines&nbsp;area of interest supports the following focus areas:&nbsp;</p><ul><li>HIV/AIDS</li><li>Vaccines</li></ul>","id":"081724","spon_name":"Janssen Pharmaceuticals, Inc.","NextDeadlineDate":"31-Jan-2023","total_funding_limit":0,"programurl":"https://www.janssen.com/us/grants-and-giving/charitable-contributions/therapeutic-giving/infectious-disease-vaccines","sponsor_type":"Drug Houses/Laboratories","prog_title":"Therapeutic Area Contributions - Infectious Disease & Vaccines Program","revision_date":"09-Nov-2022","deadline_note":"<p>The submission deadline is:</p><ul><li>January 31 for programs that start on March 1 or later</li><li>March 31 for programs that start on May 1 or later</li><li>May 31 for programs that start on July 1 or later</li><li>July 31 for programs that start on September 1 or later</li><li>September 30 for programs that start on November 1 or later</li><li>October 15 for programs that start on January of the following year or later.<br /></li></ul>","sponwebsite":"https://www.janssen.com/us/grants-and-giving/charitable-contributions/therapeutic-giving","deadline_date":["31-Jan-2023","31-Mar-2023","31-May-2023","31-Jul-2023"],"contact":null,"contact_tel":"908-218-6095","contact_email":null},{"synopsis":"<div data-index=\"14\"><div><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.&nbsp; The overarching goal of this&nbsp;R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation&rsquo;s biomedical, behavioral and clinical research needs.</span></p></div></div><div data-index=\"15\"><div><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:</span></p></div></div><div data-index=\"16\"><div><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Courses for Skills Development</em></strong></span></li></ul><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Mentoring Activities</em></strong></span></li></ul></div></div><div data-index=\"17\"><div><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The Transformative Educational Advancement and Mentoring (TEAM) Network will pilot test the use of training champions (TCs) at minority serving institutions (MSIs) (as defined in Section III), to support the development of educational activities and scientific career development programs and promote the diversity of the cancer research workforce. Examples of underrepresented groups are provided in the Notice of NIH's Interest in Diversity,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html\">NOT-OD-20-031</a>. The career development levels of focus for this FOA will include predoctoral and postdoctoral fellows, and early-stage investigators (ESIs). TCs are defined as personnel located within the MSI who can assist potential scholars with their plans to apply, attain, or transition to an independent grant award. This RFA will leverage TCs to assist scholars in identifying funding opportunities, networking with appropriate NCI/NIH program directors</span></span><span style=\"\">, and locating resources for competitive application preparation. TCs will also provide additional training support, navigation, and resources to enhance the skills required to successfully identify, prepare, submit, and obtain grants and career development opportunities.</span></p></div></div>","id":"114065","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"11-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-013.html","sponsor_type":"US Federal","prog_title":"RFA-CA-23-013 -- Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)","revision_date":"18-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 10, 2023. The deadline for receipt of optional letters of intent is 30 days prior to the Application Due Date. The deadline for receipt of full applications is February 10, 2023, by 5:00 PM local time of applicant organization.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["11-Jan-2023 [Optional] [LOI/Pre-App]","10-Feb-2023"],"contact":"Whitney (Barfield) Steward, Ph.D.","contact_tel":"240-276-5729","contact_email":"whitney.barfield@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this future grant application solicitation is to balance the NIAAA research portfolio by supporting research on alcohol misuse among persons aged 18 to 29 who are not enrolled in four-year colleges or universities. These persons are commonly in the military, workforce, or community college populations, which are understudied relative to their age peers in four-year colleges. Research on epidemiology, prevention, and screening centered on these understudied populations are all encouraged.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"107782","spon_name":"National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AA-22-001.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College","revision_date":"10-Dec-2021","deadline_note":"This notice applies to due dates on or after June 5, 2022 and subsequent receipt dates through September 8, 2025.&nbsp;","sponwebsite":null,"deadline_date":["16-Jun-2023","16-Jun-2024","07-Jan-2023","05-Jan-2023","05-Oct-2023","16-Feb-2024","05-Jan-2024","26-May-2023","05-Sep-2023","05-Oct-2024","16-Oct-2023","07-Sep-2025","16-Jun-2025","07-May-2024","05-Jun-2024","05-Jun-2025","26-Jan-2023","16-Oct-2024","05-Sep-2025","07-May-2025","05-Jun-2023","05-Apr-2025","16-Feb-2023","26-Sep-2023","05-Sep-2024","05-Apr-2024","07-May-2023","07-Jan-2025","07-Sep-2024","07-Jan-2024","05-Jan-2025","07-Sep-2023","16-Feb-2025","05-Feb-2024","05-Apr-2023","05-Feb-2023","05-Feb-2025"],"contact":"Bradley Kerridge, Ph.D.","contact_tel":"301-827-7493","contact_email":"bradley.kerridge@nih.gov"},{"synopsis":"<p>AWHONN&rsquo;s nursing research program is designed primarily for researchers whose efforts are on the beginning stages of a program of research.&nbsp; Awards are granted to researchers whose proposals investigate variables relevant to&nbsp;AWHONN&rsquo;s 2019-2024 Research Priorities.&nbsp; Studies that are clinically focused and outcomes-based are a priority. Projects that focus on the nurse&rsquo;s role in delivering cost-effective care in these subspecialties are encouraged and will also be considered.</p>","id":"086282","spon_name":"Association of Women's Health, Obstetric and Neonatal Nurses","NextDeadlineDate":"27-Jan-2023","total_funding_limit":0,"programurl":"https://awhonn.org/professional-development/research-program/research-grants/","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Research Grants","revision_date":"23-Nov-2022","deadline_note":null,"sponwebsite":"https://www.awhonn.org/professional-development/research-program/","deadline_date":["27-Jan-2023"],"contact":null,"contact_tel":"202-261-2400","contact_email":"researchprograms@awhonn.org"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This NOSI solicits high-priority Alzheimer's disease (AD) and AD-related dementias (ADRD) care partner/caregiver research areas as set forth by the&nbsp;National Institute on Aging&rsquo;s Division of Behavioral and Social Research. Priority areas are guided by the&nbsp;AD/ADRD research implementation milestones&nbsp;and are based on expert discussions from the NIH&nbsp;2020 Dementia Care Summit&nbsp;and recommendations from the&nbsp;NASEM Decadal Survey of Behavioral and Social Science Research on AD/ADRD.</span>","id":"108309","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"10-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-047.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Behavioral and Social Science Priority Areas in Dementia Care Partner/Caregiver Research","revision_date":"10-Jan-2022","deadline_note":"This notice applies to due dates on or after March 11, 2022 and subsequent receipt dates through November 13, 2024.","sponwebsite":null,"deadline_date":["10-Mar-2023","10-Jul-2023","13-Nov-2023","11-Mar-2024","09-Jul-2024","12-Nov-2024"],"contact":"Melissa S. Gerald, Ph.D.","contact_tel":"301-496-3136","contact_email":"melissa.gerald@nih.gov"},{"synopsis":"<span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The<strong>&nbsp;Interventions that Address Structural Racism to Reduce Kidney Health Disparities</strong>&nbsp;Consortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. The Consortium will consist of one Research Coordinating Center and multiple Intervention Sites (see&nbsp;<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-014.html\">RFA-DK-22-014</a>)&nbsp;that will work collaboratively to develop, implement and evaluate meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications for the&nbsp;<strong>Research Coordinating Center&nbsp;</strong>(RCC) that will lead, manage, and harmonize efforts for the Consortium. The specific activities of the RCC will include: 1) providing organization, management, and administrative support of Consortium activities; 2) providing research coordination, data management and data analyses for Consortium studies; and 3) fostering research collaborations and helping to build a community of investigators with skills to develop, implement, and disseminate effective, scalable, and sustainable interventions that address the structural drivers of kidney health disparities.</span></span></p>","id":"114263","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"12-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-23-003.html","sponsor_type":"US Federal","prog_title":"RFA-DK-23-003 -- Interventions that Address Structural Racism to Reduce Kidney Health Disparities â€“ Research Coordinating Center (U24 - Clinical Trial Not Allowed)","revision_date":"21-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after December 12, 2022. The deadline for receipt of optional letters of intent is December 12, 2022.&nbsp; The deadline for receipt of full applications is January 12, 2023,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;</p>","sponwebsite":null,"deadline_date":["12-Dec-2022 [Optional] [LOI/Pre-App]","12-Jan-2023"],"contact":"Raquel C. Greer, M.D., M.H.S. ","contact_tel":"301-402-0306 ","contact_email":"raquel.greer@nih.gov"},{"synopsis":"The purpose of this Notice of Funding Opportunity (NOFO) is to support research to: 1) obtain a better understanding of existing vaccination counseling practices for adults, particularly adults who may experience disproportionate burdens of vaccine-preventable diseases (e.g., pregnant women, racial or ethnic minority groups, those living in rural communities, those with chronic medical conditions); and 2) implement and evaluate interventions, such as a presumptive approach to vaccination counseling and motivational interviewing, to improve adult vaccination counseling practices at all provider levels (e.g., scheduler, medical assistants, nurses, advanced&nbsp;practice clinicians, physicians) in order to decrease misinformation about vaccines, increase vaccine confidence, and ultimately increase adult vaccine uptake.","id":"114378","spon_name":"National Center for Immunization and Respiratory Diseases/CDC/DHHS","NextDeadlineDate":"22-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":1500000,"programurl":"https://www.grants.gov/web/grants/view-opportunity.html?oppId=343401","sponsor_type":"US Federal","prog_title":"Approach to Adult Vaccine Counseling","revision_date":"28-Nov-2022","deadline_note":"The deadline for receipt of optional letters of intent is December 28, 2022. The deadline for receipt of full applications is January 27, 2023, by Grants.gov no later than 11:59 PM U.S. Eastern\nTime.\n","sponwebsite":null,"deadline_date":["22-Dec-2022 [Optional] [LOI/Pre-App]","27-Jan-2023"],"contact":"Amy Yang, Ph.D.","contact_tel":"404-718-8836","contact_email":"AYang@cdc.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA)â€¯is a part ofâ€¯NIDA&rsquo;s Racial Equity Initiative (REI).&nbsp;This FOA invites R01 applications to conduct research that will have a major impact in identifying, developing, implementing, or testing strategies to improve outcomes related to substance misuse, with a goal of preventing, reducing, or eliminating disparities in racial and/or ethnic communities insubstance use, addiction, and related health consequences, including HIV. Community engaged research can facilitate rapid advances in this scientific area by ensuring relevant research questions with immediate applicability. As such, applications must be submitted by collaborative community partnered investigative teams who will conduct research projects that address issues prioritized by the relevant communities. No preliminary data are required. However, projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce desired outcomes. .&nbsp;&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"112854","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"14-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-013.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-013 -- NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)","revision_date":"24-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is October 14, 2022. The deadline for receipt of all types of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["14-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","14-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Kathy Etz, PhD","contact_tel":"301-402-1749","contact_email":"ketz@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice is to announce to potential applicants to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) an interest in research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108115","spon_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AR-22-012.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases","revision_date":"29-Dec-2021","deadline_note":"This notice applies to due dates on or after February 5, 2022 and subsequent receipt dates through January 7, 2023.&nbsp;","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Marie Mancini, Ph.D.","contact_tel":"301-594-5032","contact_email":"mancinim2@mail.nih.gov"},{"synopsis":"<p>The purpose of this announcement is to notify the research community that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (<a href=\"https://www.niams.nih.gov/\" target=\"_blank\">NIAMS</a>) is interested in receiving grant applications focused on pain within the NIAMS mission areas.</p><div>&nbsp;</div><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"106576","spon_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH/DHHS","NextDeadlineDate":"12-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AR-22-007.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas","revision_date":"27-Sep-2021","deadline_note":"This notice applies to due dates on or after November 5, 2021 and subsequent receipt dates through January 10, 2023.&nbsp;","sponwebsite":null,"deadline_date":["22-Jun-2025","12-Dec-2022"],"contact":"Leslie K. Derr, Ph.D.","contact_tel":"301-402-4735","contact_email":"leslie.derr@nih.gov"},{"synopsis":"The goals of research supported by the Autism SDAR Program are to: generate new evidence to address the needs of underserved ASD/DD populations for whom there is limited evidence of the effectiveness of interventions, and limited access to screening, diagnosis, and treatment for ASD/DD; address health inequities facing underserved communities to enhance the evidence and strategies for advancing health equity for children and teenagers with ASD/DD; and, contribute to a broad public health impact by improving patient engagement and care delivery through studies that are generalizable and replicable across underserved children and teenagers with ASD/DD.&nbsp;","id":"114159","spon_name":"Maternal and Child Health Bureau/HRSA/DHHS","NextDeadlineDate":"13-Feb-2023","total_funding_limit":120000,"programurl":null,"sponsor_type":"US Federal","prog_title":"Autism Secondary Data Analysis Research (Autism SDAR)","revision_date":"15-Nov-2022","deadline_note":null,"sponwebsite":"https://www.grants.gov/web/grants/view-opportunity.html?oppId=340374","deadline_date":["13-Feb-2023"],"contact":"Evva Assing-Murray","contact_tel":"301-594-4113","contact_email":"AutismSDAR@hrsa.gov"},{"synopsis":"<p>The Greenwall Foundation is requesting proposals for the Spring 2023 cycle of its bioethics grants program,&nbsp;Making a Difference in Real-World Bioethics Dilemmas. The Making a Difference program supports research to help resolve an important emerging or unanswered bioethics problem in clinical, biomedical, or public health decision-making, policy, or practice.</p><p>The Foundation&rsquo;s vision is&nbsp;to make bioethics integral to decisions in health care, policy, and research. Its mission is&nbsp;to expand bioethics knowledge to improve clinical, biomedical, and public health decision-making, policy, and practice.&nbsp;Projects&nbsp;funded under the Making a Difference&nbsp;program should&nbsp;promote&nbsp;the Foundation&rsquo;s vision&nbsp;and mission&nbsp;through innovative bioethics research that will have a real-world, practical impact.</p>","id":"001746","spon_name":"Greenwall Foundation","NextDeadlineDate":"03-Jan-2023 [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://greenwall.org/making-a-difference-grants/request-for-proposals-MAD-spring-2022","sponsor_type":"Foundations","prog_title":"Bioethics Grants Program - Making a Difference in Real-World Bioethics Dilemmas ","revision_date":"28-Nov-2022","deadline_note":"<p>Letters of intent are due&nbsp;January 3, 2023&nbsp;by 11:59 pm ET, for projects to begin on or after&nbsp;July 1, 2023&nbsp;(not later than October 1, 2023).&nbsp; &nbsp;&nbsp; </p><p>Invited Full Proposals are due by March 13, 2023, 11:59 pm ET. </p>","sponwebsite":"https://greenwall.org/making-a-difference-grants","deadline_date":["03-Jan-2023 [LOI/Pre-App]","13-Mar-2023"],"contact":"Kyle Ruempler","contact_tel":"212-679-7266","contact_email":"kruempler@greenwall.org"},{"synopsis":"<p>The purpose of this announcement is to support research with rigorous study design (i.e., natural experiments, quasi-experimental designs, economic evaluations, and systems simulation modeling) to evaluate the impact of existing programs, policies, or practices that affect social determinants of health (SDOH) and how changes in SDOH impact health disparities related to chronic disease outcomes.</p><p>This announcement has three (3) components:</p><p><strong>Component A: Research Studies to Assess the Impact of Programs, Policies, or Practices that Address SDOH on Chronic Disease-Related Health Disparities</strong> </p><ul><li>The purpose is to identify and evaluate how existing programs, policies, or practices that address SDOH mitigate health disparities related to chronic disease outcomes by using natural experiment or quasi-experimental study designs.</li></ul><p><strong>Component B: SDOH Simulation Model Development</strong></p><ul><li>The purpose is to apply a systems science approach to build a simulation model of the interplay of SDOH and their relationship to chronic disease outcomes and related health disparities and be able to assess the long-term (e.g., 5, 10, 20, 30 years) effectiveness and cost-effectiveness of programs, policies, or practices that address SDOH with a focus on the five priorities areas: Built Environment, Community-Clinical Linkages, Food and Nutrition Security, Social Connectedness, and Tobacco Free Policies.</li></ul><p><strong>Component C: Coordinating Center</strong></p><ul><li>The purpose is to support a coordinating center that provides organizational, logistic, and communication support to enhance the efficiency, productivity, and public health impact of the research centers that are funded under Components A and B. </li></ul>","id":"114345","spon_name":"National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS","NextDeadlineDate":"10-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://www.grants.gov/web/grants/view-opportunity.html?oppId=340501","sponsor_type":"US Federal","prog_title":"Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determinants of Health to Promote Health Equity and Reduce Health Disparities in Chronic Diseases","revision_date":"23-Nov-2022","deadline_note":"The deadline for receipt of optional letters of intent is January 10, 2023. The deadline for receipt of full applications is February 9, 2023, by 11:59 p.m., ET. on www.grants.gov","sponwebsite":null,"deadline_date":["10-Jan-2023 [Optional] [LOI/Pre-App]","09-Feb-2023"],"contact":"Sue Shaw, MPH, Scientific Program Official","contact_tel":"770.488.6142","contact_email":"ResearchNOFO@cdc.gov"},{"synopsis":"<p>AFTD Pilot Grants provide seed funding to advance the careers of early-stage investigators focused on the full spectrum of FTLD disorders (behavioral variant FTD, primary progressive aphasias, progressive supranuclear palsy, corticobasal syndrome, and FTD-ALS). Pilot Grants support recipients in developing an independent research program and generating data that will be the basis for follow-on funding applications to other funders. &nbsp;The award amount is $110,000 (USD).&nbsp;</p>","id":"071367","spon_name":"Association for Frontotemporal Degeneration","NextDeadlineDate":"09-Dec-2022","total_funding_limit":110000,"programurl":"https://www.theaftd.org/for-researchers/funding-opportunities/aftd-pilot-grants/","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Well-Being in FTD Pilot Grant ","revision_date":"30-Sep-2022","deadline_note":"Applications are due&nbsp;Friday, December 9, 2022, 8:00 pm ET.","sponwebsite":"https://www.theaftd.org/for-researchers/funding-opportunities/","deadline_date":["09-Dec-2022"],"contact":"Debra Niehoff","contact_tel":"267-758-8654","contact_email":"dniehoff@theaftd.org"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">There is an urgent need for remotely delivered Substance Use Disorder (SUD) treatments to reduce patient burden and for methods to conduct clinical trials remotely. The purpose of this NOSI is to stimulate research to evaluate the safety and efficacy of telemedicine or remotely provided treatments for SUD, and to develop tools for remote collection of data in clinical trials of treatments for SUD.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"096552","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-058.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders","revision_date":"30-Jun-2020","deadline_note":"<span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through January 8, 2024.</span>","sponwebsite":null,"deadline_date":null,"contact":"Evan S. Hermann, PhD","contact_tel":null,"contact_email":"evan.herrmann@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Special Emphasis Notice (SEN) is to inform the research community that the Agency for Healthcare Research and Quality is interested in receiving health services research grant applications to advance our nation's understanding of the substance use disorder crisis and provide solutions for addressing it.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"102533","spon_name":"Agency for Healthcare Research and Quality/DHHS","NextDeadlineDate":"15-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HS-21-010.html","sponsor_type":"US Federal","prog_title":"Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic","revision_date":"03-Mar-2021","deadline_note":"Applications responding to this SEN should be submitted on regular application receipt dates identified in the respective Funding Opportunity Announcement and will be reviewed by AHRQ standing study sections. Applicants should consider this SEN active until March 15, 2023.&nbsp;","sponwebsite":null,"deadline_date":["15-Mar-2023"],"contact":"Sebastian Tong, MD, MPH","contact_tel":null,"contact_email":"Sebastian.Ton@ahrq.hhs.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Data science is an important cross-cutting research approach in the NIDA Strategic Plan and increasing the capacity of experts in data science for biomedical research of addiction is critical. The purpose of this Notice is to highlight NIDA's high-priority interest in receiving applications that will support training and career development in Big Data and Computational Science (i.e., Data Science) within the overall field of addiction research. Grants supported under this Notice can be from individuals at formative career stages or from established investigators proposing training programs that will support early career scientists. Individuals from diverse backgrounds, including those from groups historically underrepresented in the STEM fields, who wish to pursue further studies or careers in Big Data and Computational Science as it relates to addiction research are highly encouraged to apply.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"101866","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-013.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research","revision_date":"09-Jul-2021","deadline_note":"This notice applies to due dates on or after March 8, 2021 and subsequent receipt dates through&nbsp;<span style=\"text-decoration:underline;\">December 9, 2024.</span>","sponwebsite":null,"deadline_date":null,"contact":"Susan Wright, PhD","contact_tel":"301-402-6683","contact_email":"susan.wright@nih.gov"},{"synopsis":"<div>The Global Team Science Award supports interdisciplinary, collaborative, and highly synergistic projects that push the boundaries of innovation and bridge research and clinical efforts in lupus. The successful Teams will focus on unraveling human lupus heterogeneity by applying cutting-edge technologies to address critical questions that could bring about breakthroughs in lupus care, research or drug development.</div>","id":"089679","spon_name":"Lupus Research Alliance","NextDeadlineDate":"01-Mar-2023","total_funding_limit":0,"programurl":"https://www.lupusresearch.org/research-and-clinical-trials/research/funding-opportunities/","sponsor_type":"Voluntary Health Organization","prog_title":"Global Team Science Awards","revision_date":"23-Jun-2022","deadline_note":"<p>Letters of intent are due by August 1, 2022; full applications, if invited, will be due by March 1, 2023.</p>","sponwebsite":"https://www.lupusresearch.org/","deadline_date":["01-Mar-2023"],"contact":"Diomaris Gonzalez, Director, Grant Programs","contact_tel":"646-884-6056","contact_email":"dgonzalez@lupusresearch.org"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.&nbsp; The overarching goal of this&nbsp;R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:</span></p><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Research Experiences</em></strong></span><strong><em><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span></em></strong></li></ul>","id":"101820","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"25-May-2023","total_funding_limit":1875000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-317.html","sponsor_type":"US Federal","prog_title":"NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)","revision_date":"27-Oct-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 25, 2021.The deadline for receipt of optional letters of intent is August 25, annually. The deadline for receipt of standard applications under this announcement May 25, annually, by 5:00 PM local time of applicant organization. This program will expire on&nbsp;May 26, 2023.</p>","sponwebsite":null,"deadline_date":["25-May-2023"],"contact":"NIA Training Office","contact_tel":null,"contact_email":"NIAtraining@nih.gov"},{"synopsis":"<p>The Commonwealth Fund carries out its&nbsp;<a href=\"https://commonwealthstg.prod.acquia-sites.com/about-us\">mission</a>&nbsp;by supporting independent research on health care issues and making grants to improve health care practice and policy.</p>","id":"000667","spon_name":"Commonwealth Fund","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://www.commonwealthfund.org/sites/default/files/2021-07/GrantProposalGuidelines_July2021_v2.pdf","sponsor_type":"Non-Profit Organizations","prog_title":"Grants Program","revision_date":"04-Apr-2022","deadline_note":"Applicants should submit a letter of inquiry.&nbsp; LOIs are accepted on a rolling basis.&nbsp;Typically, projects recommended for board approval are in development for a few months before a funding decision. The Fund&rsquo;s board meetings are held in April, July, and November. Small and intermediate grants are approved on a monthly basis.<br />","sponwebsite":"https://www.commonwealthfund.org/grants","deadline_date":null,"contact":null,"contact_tel":"212-606-3800","contact_email":"grants@cmwf.org"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in the U.S. Specifically, this FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations. Applicants submitting applications related to health economics are encouraged to consult&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-025.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">NOT-OD-16-025</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">&nbsp;to ensure that the research projects align with NIH mission priorities in health economics research.</span>","id":"099622","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-302.html","sponsor_type":"US Federal","prog_title":"Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)","revision_date":"16-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 12, 2020. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are:&nbsp; November 12, 2020, then standard dates of&nbsp;February 5, June 5, and October 5, by 5:00 PM local time of applicant organization. This FOA will expire on September 08, 2023.","sponwebsite":null,"deadline_date":["05-Jun-2023","05-Feb-2023"],"contact":"Bob Vollinger, DrPH, MSPH","contact_tel":"240-276-6919 ","contact_email":"Bob.Vollinger@nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to inform potential applicants of the special interest of NHLBI in research to understand host resilience as a critical determinant of outcomes in acute respiratory distress syndrome (ARDS) /acute lung injury (ALI).</span></p><div><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></div><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"099859","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-814.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)","revision_date":"16-Sep-2020","deadline_note":"<span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice. This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through July 5, 2024 of reissued FOAs.</span>","sponwebsite":null,"deadline_date":["07-Sep-2023","05-Feb-2023","05-Jun-2023","05-Jun-2024","07-Jan-2024","05-Feb-2024","05-Oct-2023","07-May-2023","07-May-2024","07-Jan-2023"],"contact":"Guofei Zhou, PhD","contact_tel":"301-827-7825","contact_email":"guofei.zhou@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to develop and test the effectiveness and implementation of family navigator models designed to promote early access, engagement, coordination and optimization of mental health treatment and services for children and adolescents who are experiencing early symptoms of mental health problems. For the purposes of this FOA, NIMH defines a family navigator model as a health care professional or paraprofessional whose role is to deploy a set of strategies designed to rapidly engage youth and families in needed treatment and services, work closely with the family and other involved treatment and service providers to optimize care, and through the use of technology &ndash; to monitor the trajectory of mental health symptoms and outcomes over time. Applicants are required to develop and test the navigator model&rsquo;s ability to promote early access, engagement, coordination and optimization of mental health treatment and services for children and adolescents as soon as symptoms are detected. Applicants are also required to identify and test components of navigator models that drive improvements in mental health care; detect and interrogate tailoring variables that optimize the &lsquo;personalized match&rsquo; between the unique mental health needs of youth to the appropriate level of intensity and frequency of mental health services; and utilize emerging novel technologies to track and monitor the trajectory of clinical, functional and behavioral progress toward achieving intended services outcomes.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA is published in parallel to a companion R34 FOA,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/par-21-292.html\">PAR-21-292</a>&nbsp;supporting pilot studies in preparation for the larger-scale studies described here.</span></span></p>","id":"105829","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":2500000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-291.html","sponsor_type":"US Federal","prog_title":"Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required)","revision_date":"05-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 05, 2021. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. This program will expire on September 08, 2024. ","sponwebsite":null,"deadline_date":["05-Jun-2024","05-Oct-2023","05-Feb-2024","05-Jun-2023","05-Feb-2023"],"contact":"Denise Pintello, Ph.D., M.S.W.","contact_tel":"301-451-1481","contact_email":"dpintell@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of the NCI Transition Career Development Award to Promote Diversity (K22) is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a continuation of the NCI Transition Career Development Award to Promote Diversity (K22) to enhance the diversity in the NCI-funded cancer research workforce by supporting eligible individuals from diverse backgrounds, including groups that have been shown to be nationally underrepresented in the biomedical, behavioral, social and clinical sciences. This award will provide \"protected time\" through salary and research support for 3 years beginning at the time when the candidate starts a tenure-track faculty position.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA&nbsp;</span><strong><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">(<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-301.html\">PAR-21-301</a>)</span></span></strong><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">.</span></p><br /><s2s></s2s>","id":"106358","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"12-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-302.html","sponsor_type":"US Federal","prog_title":"NCI Transition Career Development Award to Promote Diversity (K22  Clinical Trial Required)","revision_date":"01-Nov-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 12, 2021. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. This program will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["12-Feb-2023","12-Jun-2023","12-Oct-2023","12-Feb-2024","12-Jun-2024"],"contact":"Mulualem E. Tilahun, D.V.M., Ph.D","contact_tel":"240-276-7360","contact_email":"mulualem.tilahun@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of the NCI Transition Career Development Award to Promote Diversity (K22) is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a continuation of the NCI Transition Career Development Award to Promote Diversity (K22) to enhance the diversity in the NCI-funded cancer research workforce by supporting eligible individuals from diverse backgrounds, including groups that have been shown to be nationally underrepresented in the biomedical, behavioral, social and clinical sciences. This award will provide \"protected time\" through salary and research support for 3 years beginning at the time when the candidate starts a tenure-track faculty position.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial.&nbsp;Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator. Applicants proposing a clinical trial&nbsp;or a separate &nbsp;ancillary clinical trial&nbsp;as lead investigator, should apply to the companion FOA (<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-302.html\">PAR-21-302</a>).</span></span></p><br /><s2s></s2s>","id":"106356","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"12-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-301.html","sponsor_type":"US Federal","prog_title":"NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)","revision_date":"26-Oct-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 12, 2021. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. This program will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["12-Feb-2023","12-Jun-2024","12-Feb-2024","12-Jun-2023","12-Oct-2023"],"contact":"Mulualem E. Tilahun, D.V.M., Ph.D","contact_tel":"240-276-7360","contact_email":"mulualem.tilahun@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of the NCI Mentored Clinical Scientist Career Development Award (K08) program is to prepare individuals for careers that have a significant impact on the health-related research needs of the nation. This program represents the continuation of a long-standing NIH program that provides support and protected time to individuals with a clinical doctoral degree or a health professional doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. This NCI-sponsored K08 award is specifically designed to enhance the diversity in the NCI-funded cancer research workforce by supporting eligible clinical scientists from diverse backgrounds, including groups that have been shown to be nationally underrepresented in health-related sciences and for those who are committed to a career in basic biomedical, behavioral or translational cancer research, including research on cancer health disparities. The expectation is that through this sustained period of research career development and training, awardees will develop enhanced research capabilities for cancer research careers and be better prepared to compete for research project grants (e.g. R03, R21, or R01) funding.&nbsp;</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-300.html\">PAR-21-300</a>).</span></span></p><br /><s2s></s2s>","id":"106354","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"12-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-299.html","sponsor_type":"US Federal","prog_title":"NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)","revision_date":"26-Oct-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 12, 2021. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. This program will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["12-Feb-2023","12-Feb-2024","12-Oct-2023","12-Jun-2024","12-Jun-2023"],"contact":"Mulualem E. Tilahun, D.V.M., Ph.D","contact_tel":"240-276-7360","contact_email":"mulualem.tilahun@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of the NCI Mentored Clinical Scientist Career Development Award (K08) program is to prepare individuals for careers that have a significant impact on the health-related research needs of the nation. This program represents the continuation of a long-standing NIH program that provides support and protected time to individuals with a clinical doctoral degree or a health professional doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. This NCI-sponsored K08 award is specifically designed to enhance the diversity in the NCI-funded cancer research workforce by supporting eligible clinical scientists from diverse backgrounds, including groups that have been shown to be nationally underrepresented in health-related sciences and for those who are committed to a career in basic biomedical, behavioral or translational cancer research, including research on cancer health disparities. The expectation is that through this sustained period of research career development and training, awardees will develop enhanced research capabilities for cancer research careers and be better prepared to compete for research project grants (e.g. R03, R21, or R01) funding.&nbsp;</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial.&nbsp;Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial&nbsp;or a separate ancillary clinical trial&nbsp;as lead investigator, should apply to the companion FOA&nbsp;</span><strong><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">(<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-299.html\">PAR-21-299</a>)</span></span></strong><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">.</span></p><br /><s2s></s2s>","id":"106355","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"12-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-300.html","sponsor_type":"US Federal","prog_title":"NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)","revision_date":"24-Oct-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 12, 2021. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. This program will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["12-Feb-2023","12-Jun-2023","12-Oct-2023","12-Feb-2024","12-Jun-2024"],"contact":"Mulualem E. Tilahun, D.V.M., Ph.D","contact_tel":"240-276-7360","contact_email":"mulualem.tilahun@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research.</span>","id":"105041","spon_name":"National Eye Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-204.html","sponsor_type":"US Federal","prog_title":"NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)","revision_date":"29-Jun-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 25, 2021. The deadlines for receipt of standard applications under this announcement are: January 25, May 25, and September 25 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on September 08, 2024.","sponwebsite":null,"deadline_date":["07-Jan-2023","25-Jan-2023","07-May-2023","25-May-2023","07-Sep-2023","25-Sep-2023","07-Jan-2024","25-Jan-2024","07-May-2024","25-May-2024","07-Sep-2024"],"contact":"Sangeeta Bhargava, PhD,","contact_tel":"301-451-2020 ","contact_email":"bhargavas@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Notice is to invite applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. The recent global outbreak of the novel coronavirus, SARS-CoV-2, is not an anomaly and will most likely not be the last virus occurrence. Today, infectious diseases are emerging and reemerging more quickly than ever before. In the last four-five years alone, two viral infections, one caused by the Zika virus (ZIKV) and the other caused by a SARS-CoV-2 (Covid19), have spread world-wide, resulting in death, severe disease with yet, unknown, long-term morbidities., or severe birth defects to the new-born. Both ZIKV and SARS-CoV-2 infections may affect male and/or female reproductive systems in addition to other non-reproductive sites. Therefore, it becomes essential to investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"099263","spon_name":"National Institute of Child Health and Human Development/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-021.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract","revision_date":"02-Sep-2020","deadline_note":"<span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through July 16, 2023.&nbsp;</span>","sponwebsite":null,"deadline_date":["05-Jun-2023","16-Feb-2023","16-Jun-2023","05-Feb-2023"],"contact":"Stuart B. Moss, PhD","contact_tel":"301-435-6979","contact_email":"mossstua@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Special Emphasis Notice (SEN) informs the research community that the Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research&nbsp;<strong>grant applications to advance the science of primary care</strong>. We will use our standing R01, R18, and R03 mechanism to fund primary care focused health services research.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"109836","spon_name":"Agency for Healthcare Research and Quality/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HS-22-011.html","sponsor_type":"US Federal","prog_title":"Special Emphasis Notice (SEN):  Primary Care Research","revision_date":"17-Mar-2022","deadline_note":"Applicants should consider this SEN active until February 21, 2025.","sponwebsite":null,"deadline_date":["05-Oct-2023","16-Jun-2023","05-Jun-2023","16-Jun-2024","16-Feb-2024","16-Oct-2023","05-Feb-2023","16-Oct-2024","05-Feb-2025","05-Oct-2024","16-Feb-2023","16-Feb-2025","05-Jun-2024","05-Feb-2024"],"contact":"Patrick G. Oâ€™Malley MD, MPH","contact_tel":"301-427-1504","contact_email":"Patrick.O'Malley@ahrq.hhs.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to highlight the interest of the&nbsp;<a href=\"https://cancercontrol.cancer.gov/\">NCI&rsquo;s Division of Cancer Control and Population Sciences</a>&nbsp;in receiving investigator-initiated applications for conducting research on the use of telehealth in cancer-related care. Studies focused on populations that experience inequities in access to care and have worse cancer outcomes compared to the general population are strongly encouraged. This NOSI for R01 and R21 applications is a companion announcement to the RFA titled &ldquo;Centers on Telehealth Research and Cancer-Related Care&rdquo; (<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-029.html\">RFA-CA-21-029</a>).</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"103489","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-043.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Telehealth in Cancer Care","revision_date":"15-Apr-2021","deadline_note":"This notice applies to due dates on or after June 5, 2021, and subsequent receipt dates through March 8, 2024.","sponwebsite":null,"deadline_date":["05-Jun-2023","07-Jan-2024","16-Jun-2023","16-Feb-2023","07-May-2023","05-Oct-2023","07-Sep-2023","07-Jan-2023","16-Oct-2023","05-Feb-2023","05-Feb-2024","16-Feb-2024"],"contact":"Gurvaneet Randhawa, M.D., M.P.H.","contact_tel":"240-276-6940","contact_email":"Gurvaneet.Randhawa@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to develop and pilot test the effectiveness and implementation of existing family navigator models designed to promote early access, engagement, coordination and optimization of mental health treatment and services for children and adolescents who are experiencing early symptoms of mental health problems. For the purposes of this FOA, NIMH defines a family navigator model as a health care professional or paraprofessional whose role is to deploy a set of strategies designed to rapidly engage youth and families in needed treatment and services, work closely with the family and other involved treatment and service providers to optimize care, and through the use of technology &ndash; to monitor the trajectory of mental health symptoms and outcomes over time. Applicants are required to develop and pilot test the navigator model&rsquo;s ability to promote early access, engagement, coordination and optimization of mental health treatment and services for children and adolescents as soon as symptoms are detected. Applicants are also required to identify and pilot test components of navigator models that drive improvements in mental health care; detect and interrogate tailoring variables that optimize the &lsquo;personalized match&rsquo; between the unique mental health needs of youth to the appropriate level of intensity and frequency of mental health services; and utilize emerging novel technologies to track and monitor the trajectory of clinical, functional and behavioral progress toward achieving intended services outcomes.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA is published in parallel to a companion R01 FOA,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-291.html\">PAR-21-291</a>&nbsp;which uses the R01 funding mechanism.</span></span></p>","id":"105830","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-292.html","sponsor_type":"US Federal","prog_title":"Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required)","revision_date":"05-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 16, 2021. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, by 5:00 PM local time of applicant organization. This program will expire on September 08, 2024. ","sponwebsite":null,"deadline_date":["16-Oct-2023","16-Jun-2024","16-Jun-2023","16-Feb-2024","16-Feb-2023"],"contact":"Denise Pintello, Ph.D., M.S.W.","contact_tel":"301-451-1481","contact_email":"dpintell@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in the U.S. Specifically, this FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations. Applicants submitting applications related to health economics are encouraged to consult&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-025.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">NOT-OD-16-025</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">&nbsp;to ensure that the research projects align with NIH mission priorities in health economics research.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"099631","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-303.html","sponsor_type":"US Federal","prog_title":"Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)","revision_date":"09-Jul-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 12, 2020. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are:&nbsp; November 12, 2020, then standard dates of&nbsp;February 16, June 16, and October 16, by 5:00 PM local time of applicant organization. This FOA will expire on September 08, 2023.","sponwebsite":null,"deadline_date":["16-Jun-2023","16-Feb-2023"],"contact":"Bob Vollinger, DrPH, MSPH","contact_tel":"240-276-6919 ","contact_email":"Bob.Vollinger@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institutes of Health seeks research conducted in real-world settings, where a wide range of clinical presentations, psychosocial factors, age-related (e.g., youth; adult; older adult), geographic (rural/remote settings), cultural considerations, and health disparities influence the types of care that are provided. Examples of NIMH and NIDA studies that are encouraged through this Notice address the continuum of crisis service systems. Applications that include crisis services for children and under-resourced populations are encouraged. Topics of research interest span the crisis care continuum, including the effectiveness of these components: call center capabilities to address distress and coordinate care, deployed mobile crisis outreach and support, and crisis services that can diagnose and provide short term stabilization.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108898","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-MH-22-110.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services","revision_date":"09-Feb-2022","deadline_note":"This notice applies to due dates on or after June 5, 2022 and subsequent receipt dates through May 8, 2025.","sponwebsite":null,"deadline_date":["07-Sep-2024","15-Feb-2024","07-May-2023","05-Jun-2024","16-Feb-2025","15-Jun-2023","07-Sep-2023","07-Jan-2025","16-Jun-2024","07-Jan-2024","05-Oct-2024","16-Feb-2024","07-Jan-2023","05-Feb-2025","05-Oct-2023","05-Jun-2023","16-Oct-2023","07-May-2025","15-Feb-2023","17-Oct-2023","05-Feb-2023","16-Feb-2023","07-May-2024","05-Feb-2024","16-Oct-2024","16-Jun-2023"],"contact":"Stephen O'Connor, Ph.D.","contact_tel":"301-480-8366","contact_email":"stephen.o'connor2@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) encourages applications that advance the understanding or reduce the impact of health disparities and inequities in communication disorders among racial/ethnic minority and other underrepresented populations. Applications that address the influence or reduction of racism or discrimination in causing or sustaining health disparities and inequities are also encouraged. The research must address one or more of the NIDCD mission areas of hearing, balance, taste, smell, voice, speech, and language.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"104661","spon_name":"National Institute on Deafness and Other Communication Disorders/NIH/DHHS","NextDeadlineDate":"08-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DC-21-003.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): NIDCD Health Disparities and Inequities Research","revision_date":"14-Jun-2021","deadline_note":"This notice applies to due dates on or after October 5, 2021 and subsequent receipt dates through May 8, 2024.&nbsp;","sponwebsite":null,"deadline_date":["07-Jan-2023","07-May-2023","08-Aug-2023","05-Feb-2023","12-Jun-2023","08-Apr-2023","12-Feb-2023","16-Feb-2024","16-Feb-2023","05-Jun-2023","07-May-2024","05-Feb-2024","07-Jan-2024","08-Dec-2023","12-Feb-2024","16-Jun-2023","08-Dec-2022","12-Oct-2023","05-Oct-2023","16-Oct-2023","07-Sep-2023","08-Apr-2024"],"contact":"Kelly King, Au.D, Ph.D.","contact_tel":"301-402-3458","contact_email":"kingke@nidcd.nih.gov"},{"synopsis":"The Conquer Cancer &ndash; Breast Cancer Research Foundation Advanced Clinical Research Award (ACRA) for Diversity and Inclusion in Breast Cancer Research is designed with the primary goal of increasing diversity in the oncology workforce and cancer research. Awards will be given to mid-career investigators who are members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research, and who wish to conduct original breast cancer research not currently funded. ","id":"098488","spon_name":"Conquer Cancer Foundation of ASCO","NextDeadlineDate":"12-Jan-2023","total_funding_limit":450000,"programurl":"https://www.asco.org/career-development/grants-awards/funding-opportunities/advanced-clinical-research-award","sponsor_type":"Foundations","prog_title":"Career Development Award for Diversity and Inclusion in Breast Cancer Research","revision_date":"25-Sep-2022","deadline_note":"<p>The Letter of Intent deadline is November 14, 2022.</p><p>The application deadline is January 12, 2023.</p><div>&nbsp;</div>","sponwebsite":"https://www.conquer.org","deadline_date":["12-Jan-2023"],"contact":null,"contact_tel":"571-483-1700","contact_email":"grants@conquer.org"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a part of NIDA&rsquo;s Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA&rsquo;s research portfolio.. This announcement invites applications supporting independent, early career or established scholars who self-identify as health equity, health disparities, or social determinants of health experts with the skills to make exceptionally creative contributions to the study of equity for underserved U.S. racial and/or ethnic minority groups that experience poorer outcomes related to substance use and substance use disorders. This award supports transformative, boundary-pushing applications that may be risky or at a stage too early to fare well in the traditional peer review process.</span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span></p>","id":"112858","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":3500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-026 -- NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)","revision_date":"10-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadline for receipt of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["15-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","15-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Aria Davis Crump, Sc.D.","contact_tel":"301-435-0881","contact_email":"aria.crump@nih.gov"},{"synopsis":"<p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The National Institutes of Health (NIH) and the Center for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from underrepresented backgrounds, including those from groups that have been shown to be nationally underrepresented in health-related research.&nbsp;<a name=\"_Hlk29288266\" style=\"box-sizing:border-box;color:black;\">This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.&nbsp;&nbsp;</a>Administrative supplements must support work within the scope of the original project.</span></span></p><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.&nbsp; &nbsp;</span></p><p></p>","id":"093038","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-166.html","sponsor_type":"US Federal","prog_title":"Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)","revision_date":"21-Apr-2020","deadline_note":"<p>Due dates may vary by awarding IC. </p><p>See Table of IC-Specific Information, Requirements and Staff Contacts (https://grants.nih.gov/grants/guide/contacts/Diversity-Supp_contacts.html) for more details. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. </p><p>This FOA will expire on May 22, 2023.</p><p>NOTE: Per NOT-OD-20-098 applications&nbsp;aimed at fostering diversity in the child health research workforce within the ECHO Program are due by June 1, 2020.</p>","sponwebsite":null,"deadline_date":null,"contact":null,"contact_tel":"301-435-0714","contact_email":"GrantsInfo@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The volume, dimension, and complexity of biomedical and behavioral research data are expanding rapidly, requiring bioinformatic, computational, and data science approaches to manage and analyze the data, address new questions, and obtain deeper insight from the data. This Notice of Special Interest (NOSI) calls for research and research training projects that focus on dental, oral, and craniofacial biology and diseases using bioinformatic, computational, and data science approaches.</span>","id":"095672","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"08-Aug-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DE-20-006.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI) of NIDCR in Supporting Dental, Oral, and Craniofacial Research Using Bioinformatic, Computational, and Data Science Approaches","revision_date":"08-Jun-2020","deadline_note":"This notice applies to due dates on or after August 11, 2020 and subsequent receipt dates through August 8, 2023.","sponwebsite":null,"deadline_date":["08-Aug-2023"],"contact":"Jennifer Alvidrez, PhD","contact_tel":"301-594-9567","contact_email":"jennifer.alvidrez@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">Coronavirus Disease 2019 (COVID-19) is a recently emerged human disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is a paucity of data on the impact of SARS-CoV-2 on the sensory and communicative functions within the scientific mission areas of NIDCD. NIDCD invites applications for research on COVID-19 in relation to NIDCD&rsquo;s scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL). Given the early stage of COVID-19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models.</span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"095584","spon_name":"National Institute on Deafness & Other Communication Disorders/NIH/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DC-20-008.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders","revision_date":"08-Jun-2020","deadline_note":"This notice applies to due dates on or after&nbsp;October 5, 2020&nbsp;and subsequent receipt dates through September 8, 2022.","sponwebsite":null,"deadline_date":null,"contact":"Bracie Watson, Jr. Ph.D.","contact_tel":"301-402-3458","contact_email":"watsonb@nidcd.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Funding Opportunity Announcement (FOA) encourages applications that stimulate innovation and advance understanding of when, where, and how best to implement the use of genomic information and technologies in clinical care. Proposed projects should be broadly applicable to genomic medicine as a field, and yield findings of significance beyond a single disease, gene, or setting. Projects are strongly encouraged to include ancestrally diverse and underrepresented participants and populations.</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"095564","spon_name":"National Human Genome Research Institute/NIH/DHHS","NextDeadlineDate":"11-Feb-2023 [Optional] [LOI/Pre-App]","total_funding_limit":3000000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-20-036.html","sponsor_type":"US Federal","prog_title":"RFA-HG-20-036 -- Advancing Genomic Medicine Research (R01 Clinical Trial Optional)","revision_date":"19-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after July 3, 2020. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are:&nbsp;August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; and March 13, 2023, by&nbsp;5:00 PM local time of applicant organization.","sponwebsite":null,"deadline_date":["13-Aug-2023","11-Feb-2023 [Optional] [LOI/Pre-App]"],"contact":"Ms. Christine Chang","contact_tel":"301-480-2255","contact_email":"christine.chang2@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.&nbsp; The overarching goal of this&nbsp;R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation&rsquo;s biomedical, behavioral and clinical research needs.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:</span></p><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Research Experiences</em></strong></span></li></ul><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Mentoring Activities</em></strong></span></li></ul><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Both research experiences and mentoring activities are required. These Research Education Mentoring Programs are expected to enhance the professional development of the mentees and foster career trajectories towards independent research to reduce the incidence of HIV worldwide and to decrease the burden of living with HIV. The terms participant and mentee are used throughout this FOA to refer to individuals who are enrolled in the research education program.</span></p>","id":"104026","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"07-Sep-2023","total_funding_limit":1250000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-228.html","sponsor_type":"US Federal","prog_title":"NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)","revision_date":"10-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 07, 2021. The deadline for receipt of optional letters of intent is 30 days before application due date. The deadline for receipt of full applications is September 7 annually, by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2023.","sponwebsite":null,"deadline_date":["07-Sep-2023"],"contact":"Susannah Allison, PhD","contact_tel":"240-627-3861","contact_email":"allisonsu@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The participating NIH Institutes and Centers are issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see&nbsp;<a href=\"https://www.phe.gov/emergency/news/healthactions/phe/Pages/opioids.aspx\">Determination that a Public Health Emergency Exists Nationwide as the Result of the Opioid Crisis</a>&nbsp;as renewed in&nbsp;<a href=\"https://www.phe.gov/emergency/news/healthactions/phe/Pages/Opioids-6Oct2021.aspx\">Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis</a>.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent&nbsp;<a href=\"https://grants.nih.gov/policy/early-investigators/index.htm\">Early Stage Investigator&nbsp;</a>of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD). Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span></p>","id":"108531","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"22-Apr-2023 [Optional] [LOI/Pre-App]","total_funding_limit":1500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-013.html","sponsor_type":"US Federal","prog_title":"RFA-TR-22-013 -- Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)","revision_date":"21-Jan-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 28, 2022. The deadline for receipt of optional letters of intent is 15 days prior to the application due date. The deadlines for receipt of full applications are: February 28, 2022; August 22, 2022; and May 22, 2023, by 5:00 PM local time of applicant organization.</p>","sponwebsite":null,"deadline_date":["22-Apr-2023 [Optional] [LOI/Pre-App]","22-May-2023"],"contact":"Steven Pittenger, Ph.D","contact_tel":"301-827-5810","contact_email":"steven.pittenger@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Funding Opportunity Announcement (FOA) encourages applications that stimulate innovation and advance understanding of when, where, and how best to implement the use of genomic information and technologies in clinical care. Proposed projects should be broadly applicable to genomic medicine as a field, and yield findings of significance beyond a single disease, gene, or setting. Projects are strongly encouraged to include ancestrally diverse and underrepresented participants and populations.</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"095566","spon_name":"National Human Genome Research Institute/NIH/DHHS","NextDeadlineDate":"11-Feb-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-20-037.html","sponsor_type":"US Federal","prog_title":"RFA-HG-20-037 -- Advancing Genomic Medicine Research (R21 Clinical Trial Optional)","revision_date":"19-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after July 3, 2020. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are:&nbsp;August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; and March 13, 2023, by&nbsp;5:00 PM local time of applicant organization.","sponwebsite":null,"deadline_date":["13-Aug-2023","11-Feb-2023 [Optional] [LOI/Pre-App]"],"contact":"Ms. Christine Chang","contact_tel":"301-480-2255","contact_email":"christine.chang2@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) encourages grant applications to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"107815","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"26-Jan-2023","total_funding_limit":2000000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-21-001.html","sponsor_type":"US Federal","prog_title":"RFA-EB-21-001 -- Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)","revision_date":"13-Dec-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 11, 2021.  The deadlines for receipt of full applications are: February 11, 2022; January 26, 2023; and January 26, 2024, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS and AIDS-related applications are May 2, 2022; May 2, 2023; and May 2, 2024. This FOA will expire on May 3, 2024.</p>","sponwebsite":null,"deadline_date":["26-Jan-2023","02-May-2023","26-Jan-2024","02-May-2024"],"contact":"Zeynep Erim, Ph.D.","contact_tel":"301-451-4797","contact_email":"Zeynep.Erim@nih.gov"},{"synopsis":"<br /><p>Agency for Healthcare Research and Quality (AHRQ) invites applications for discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ. This FOA will use the AHRQ Research Project Grant (R01) award mechanism.</p><p>&nbsp;</p>","id":"074865","spon_name":"Agency for Healthcare Research and Quality/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":2000000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-18-795.html","sponsor_type":"US Federal","prog_title":"AHRQ Health Services Research Projects (R01)","revision_date":"08-Jun-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 5, 2018.The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on July 8, 2023. ","sponwebsite":null,"deadline_date":["05-Feb-2023","05-Jun-2023"],"contact":"Kishena Washwani, Ph.D.","contact_tel":"301-427-1556","contact_email":"Kishena.Wadhwani@ahrq.hhs.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to solicit applications to support multi-disciplinary scientific teams proposing research using systems science approaches to address persistent public health challenges. Systems science refers to multi-level methodologies addressing complex behavioral and social phenomena. This initiative encourages applications for both basic and applied research, including methodological and measurement development, with a focus on human behavioral and/or social science. This initiative also seeks to promote interdisciplinary collaboration among health researchers and experts in mathematical modelling.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"102694","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-032.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health","revision_date":"11-Mar-2021","deadline_note":"This notice applies to due dates on or after June 5, 2021&nbsp;and subsequent receipt dates through May 7, 2024.&nbsp;","sponwebsite":null,"deadline_date":["07-Sep-2023","05-Oct-2023","05-Jun-2023","07-May-2023","07-Jan-2023","05-Feb-2023","07-May-2024","07-Jan-2024","05-Feb-2024"],"contact":"Regina M. Bures, Ph.D.","contact_tel":"301-496-9485","contact_email":"regina.bures@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) encourages applications that investigate the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression and malignancy of bladder cancer. Furthermore, our understanding of the biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and contribute to the future development of new interventions.</span> ","id":"112619","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-218.html","sponsor_type":"US Federal","prog_title":"Biology of Bladder Cancer (R01 Clinical Trial Optional)","revision_date":"27-Jul-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 05, 2022. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadline for receipt of&nbsp;Renewal / Resubmission / Revision (as allowed) applications are March 5, July 5, and November 5&nbsp;annually, by 5:00 PM local time of applicant organization.&nbsp;This program will expire on September 08, 2025. </p>","sponwebsite":null,"deadline_date":["05-Feb-2023","05-Jun-2024","05-Oct-2023","05-Jun-2023","05-Jun-2025","05-Oct-2024","05-Feb-2024","05-Feb-2025"],"contact":"Ron Johnson, Ph. D. ","contact_tel":"240-276-6250 ","contact_email":"rjohnso2@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator should apply to the companion FOA (<a href=\"https://grants.nih.gov/grants/guide/rfa-files/rfa-hl-22-010.html\">RFA-HL-22-010</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span></p>","id":"104360","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":750000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-22-011.html","sponsor_type":"US Federal","prog_title":"RFA-HL-22-011 -- Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)","revision_date":"27-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 14, 2021. NHLBI will not accept letters of intent under this FOA. The deadlines for receipt of full non-AIDS applications are: October 14, 2021, February 11, 2022, October 13, 2022, February 14, 2023, October 13, 2023, February 13, 2024, by 5:00 PM local time of applicant organization. The deadline for receipt of full AIDS-related applications are: January 7, 2022, May 7, 2022, January 7, 2023, May 7, 2023, January 7, 2024, May 7, 2024, by 5:00 PM local time of applicant organization. This FOA will expire on May 08, 2024.","sponwebsite":null,"deadline_date":["07-May-2024","13-Feb-2024","13-Oct-2023","07-Jan-2024","14-Feb-2023","07-Jan-2023","07-May-2023"],"contact":"Jane D. Scott, ScD, MSN, FAHA","contact_tel":"301-435-0535","contact_email":"scottj2@nhlbi.nih.gov"},{"synopsis":"<p>The purpose of this Funding Opportunity Announcement is to support research that investigates the effectiveness of school-based health centers (SBHCs) as a health services care delivery model to address the needs of school-aged children from populations with health disparities (hence, underserved youth).&nbsp;</p><p>The goals of this FOA are to support multidisciplinary research that investigates the effectiveness of SBHCs as a health services care delivery model to detect, manage, and prevent chronic illnesses that disproportionately burden underserved youth. The mechanisms of impact by which SBHCs improve the health of at-risk populations such as sexual and gender minority youth, immigrant youth, and youth who reside in rural areas are also a relevant focus for understanding effective models of SBHCs. Applications are expected to provide a conceptual model that describes hypothesized causal pathways by which SBHCs engage underserved youth to improve health outcomes and how SBHCs may complement (or reduce) the use of other services.</p><p>Lessons learned through this initiative can help determine whether SBHCs can be adopted as a best practice care model to address the health services needs of underserved youth and if so<strong>,</strong> whether SBHCs given their accessibility to students can be an effective site of intervention to address disparities in chronic conditions, and behavioral, oral, and reproductive health of youth from underserved communities who lack access to health care.</p>","id":"105617","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-287.html","sponsor_type":"US Federal","prog_title":"Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)","revision_date":"03-Dec-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 05, 2022. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on January 08, 2025. </p><p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 05, 2022. </p>","sponwebsite":null,"deadline_date":["07-Jan-2023","07-May-2023","07-Jan-2024","05-Feb-2024","07-Sep-2024","05-Jun-2023","07-May-2024","05-Oct-2024","07-Jan-2025","07-Sep-2023","05-Jun-2024","05-Feb-2023"],"contact":null,"contact_tel":null,"contact_email":"GrantsInfo@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) calls for research to understand and promote cardiovascular and cardiometabolic health during transitionary phases across the lifecourse, from pre-adolescence (6-10 years) through adolescence (11-18 years) to young adulthood (19-39 years).</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This initiative would support research to: 1) understand the mechanisms and the pathogenesis of cardiometabolic health and cardiovascular disease (CVD) risk in vulnerable groups throughout transitionary phases from pre-adolescence into adolescence and adolescence into young adulthood, and 2) develop precision prevention interventions (at the individual and populations levels) to address cardiovascular and cardiometabolic risk across these transitionary phases.</span></p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"106202","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-015.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Promoting Cardiovascular and Cardiometabolic Health in Early Stages of the Lifecourse: Pre-adolescence Through Adolescence to Young Adulthood","revision_date":"31-Aug-2021","deadline_note":"This notice applies to due dates on or after October 5, 2021 and subsequent receipt dates through June 5, 2026.&nbsp;","sponwebsite":null,"deadline_date":["05-Jun-2026","05-Jun-2023","05-Oct-2023","07-May-2026","05-Feb-2023","07-Sep-2024","05-Jun-2025","07-May-2025","07-Jan-2023","07-Jan-2025","05-Jun-2024","07-May-2024","07-May-2023","07-Jan-2026","05-Oct-2025","05-Feb-2026","07-Sep-2025","05-Feb-2024","05-Feb-2025","07-Jan-2024","07-Sep-2023","05-Oct-2024"],"contact":"Alison G.M. Brown, PhD, MS, RDN","contact_tel":"301-435-0583","contact_email":"Alison.brown@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this NOSI is to stimulate research focused on the development of transformative diagnostics and disease management tools for heart, lung, blood, or sleep (HLBS) disorders that are designed to meet the needs of the underserved populations. Underserved populations, for the purpose of this NOSI, can include racial and ethnic minorities, immigrants, the homeless, low-income individuals, the uninsured and people who live in communities that are socioeconomically disadvantaged, rural or have few health care resources. Please see&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html\">NOT-OD-20-031</a>&nbsp;for NIH definitions. Special consideration will be given to technology solutions that are accessible and feasible in these communities. Working with community partners is required throughout the project to ensure successful development and implementation.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108068","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-024.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Diagnostics and Disease Management Tools for Use in Underserved Populations","revision_date":"31-May-2022","deadline_note":"This notice applies to due dates on or after February 5, 2022 and subsequent receipt dates through July 6, 2025.","sponwebsite":null,"deadline_date":["05-Feb-2023","07-Jan-2023","05-Jun-2024","05-Oct-2024","07-Sep-2024","05-Oct-2023","07-May-2024","05-Feb-2024","05-Jun-2023","05-Jun-2025","05-Feb-2025","07-May-2023","07-Sep-2023","07-Jan-2024"],"contact":"Bishow Adhikari, Ph.D.","contact_tel":"301-594-2791","contact_email":"adhikarb@nhlbi.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This FOA invites applications from institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Those not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-22-011.html\">RFA-HL-22-011</a>).</span></span></p>","id":"104361","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":750000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-22-010.html","sponsor_type":"US Federal","prog_title":"RFA-HL-22-010 -- Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)","revision_date":"27-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 14, 2021. NHLBI will not accept letters of intent under this FOA. The deadlines for receipt of full non-AIDS applications are: October 14, 2021, February 11, 2022, October 13, 2022, February 14, 2023, October 13, 2023, February 13, 2024, by 5:00 PM local time of applicant organization. The deadline for receipt of full AIDS-related applications are: January 7, 2022, May 7, 2022, January 7, 2023, May 7, 2023, January 7, 2024, May 7, 2024, by 5:00 PM local time of applicant organization. This FOA will expire on May 08, 2024.","sponwebsite":null,"deadline_date":["07-May-2024","14-Feb-2023","07-Jan-2024","13-Oct-2023","13-Feb-2024","07-May-2023","07-Jan-2023"],"contact":"Jane D. Scott, ScD, MSN, FAHA","contact_tel":"301-435-0535","contact_email":"scottj2@nhlbi.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) encourages multidisciplinary projects to investigate the potential health risks of environmental exposures of concern to a community and to develop and implement an environmental public health action plan based on research findings. Projects supported under this program will employ community-engaged research methods to conduct research and to translate research findings into public health action. This announcement reflects NIEHS&rsquo; and NIMHD's commitment to environmental health disparities and environmental justice research. This FOA also advances efforts to nurture and sustain&nbsp;trust and bi-directional communication between academic researchers and affected communities. The Research to Action program is part of the National Institute of Environmental Health Sciences (NIEHS) &ldquo;Partnerships for Environmental Public Health&rdquo; (PEPH) network (<a href=\"https://www.niehs.nih.gov/research/supported/translational/peph/index.cfm\">https://www.niehs.nih.gov/research/supported/translational/peph/index.cfm</a>).</span></span>","id":"112441","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":2500000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-210.html","sponsor_type":"US Federal","prog_title":"Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)","revision_date":"17-Jul-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 05, 2022. The deadlines for receipt of full applications are:&nbsp;February 5, June 5, and October 5, by&nbsp;5:00 PM local time of applicant organization. This FOA will expire on September 8, 2025.","sponwebsite":null,"deadline_date":["05-Feb-2023","05-Jun-2023","05-Feb-2025","05-Jun-2024","05-Oct-2023","05-Oct-2024","05-Feb-2024","05-Jun-2025"],"contact":"Liam Oâ€™Fallon","contact_tel":"984-287-3298","contact_email":"ofallon@niehs.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this NOSI is to encourage research grant applications focused on&nbsp;<strong><em>respiratory complications of the muscular dystrophies</em></strong>. This includes further elucidation of respiratory phenotypes in humans; research to optimize pulmonary function testing and existing respiratory therapies in humans; and mechanistic and translational research, including&nbsp;<em>in vitro</em>&nbsp;and in animal models, that examines respiratory muscle response to gene therapies and other therapeutic strategies in the muscular dystrophies.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"112472","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-025.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Respiratory Complications of the Muscular Dystrophies (R01)","revision_date":"19-Jul-2022","deadline_note":"This notice applies to due dates on or after September 25, 2022 and subsequent receipt dates through January 7, 2025.&nbsp;","sponwebsite":null,"deadline_date":["05-Jun-2024","05-Feb-2023","05-Feb-2024","05-Oct-2023","05-Jun-2023","05-Oct-2024","07-May-2024","07-Sep-2023","07-Jan-2023","07-Jan-2025","07-Jan-2024","07-May-2023","07-Sep-2024"],"contact":"Aruna Natarajan, MD, PhD","contact_tel":"301-827-0180","contact_email":"aruna.natarajan@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Through the HEAL Initiative, NIH requests applications for studies designed to develop and test sustainable, scalable interventions to prevent opioid misuse, opioid use disorder, and co-occurring mental health conditions by intervening directly on social determinants of health (SDOH). This initiative aims to build an evidence base for preventive interventions that address inequities, social risks and/or social disadvantage. Interventions targeting social determinants&nbsp;may be structural (e.g. policy, regulatory, or systemic-wide changes) or designed to alter outcomes of individuals affected by contextual risk factors, and may be implemented in conjunction with psychosocial interventions designed to address behavioral risks.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"112397","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"02-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-051.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-051 -- HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)","revision_date":"02-Aug-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 2, 2023. The deadline for receipt of optional letters of intent is January 2, 2023. The deadline for receipt of full applications is February 02, 2023, by 5:00 PM local time of applicant organization.","sponwebsite":null,"deadline_date":["02-Jan-2023 [Optional] [LOI/Pre-App]","02-Feb-2023"],"contact":"Aria Davis Crump, Sc.D.","contact_tel":"301-435-0881","contact_email":"aria.crump@nih.gov"},{"synopsis":"<span style=\"font-size:small;font-family:Verdana, Geneva, sans-serif;\">This Funding Opportunity Announcement (FOA) encourages applications that investigate the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression and malignancy of bladder cancer. Furthermore, our understanding of the biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and contribute to the future development of new interventions.</span> ","id":"112622","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-219.html","sponsor_type":"US Federal","prog_title":"Biology of Bladder Cancer (R21 Clinical Trial Optional)","revision_date":"14-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 16, 2022. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, by 5:00 PM local time of applicant organization. The deadline for receipt of&nbsp;Renewal / Resubmission / Revision (as allowed) applications are March 16, July 16, and November 16&nbsp;annually, by 5:00 PM local time of applicant organization.&nbsp;This program will expire on September 08, 2025. </p>","sponwebsite":null,"deadline_date":["16-Feb-2023","16-Jun-2023","16-Oct-2023","16-Feb-2024","16-Jun-2024","16-Oct-2024","16-Feb-2025","16-Jun-2025"],"contact":"Ron Johnson, Ph. D. ","contact_tel":"240-276-6250 ","contact_email":"rjohnso2@mail.nih.gov"},{"synopsis":"This Notice of Special Interest (NOSI) invites applications for small research grants that align with the goals of the National Academy of Medicine's Healthy Longevity Grand Challenge, as well as the National Institute on Aging's (NIA) interests in supporting research to promote a long health span and functional independence in both aging and Alzheimer&rsquo;s disease and Alzheimer&rsquo;s disease-related dementias (AD/ADRD).","id":"113278","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-22-030.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Small Research Grants for Innovations in Healthy Longevity Research","revision_date":"13-Sep-2022","deadline_note":"This notice applies to due dates on or after February 16, 2023 and subsequent receipt dates through May 8, 2023.","sponwebsite":null,"deadline_date":["16-Feb-2023","07-May-2023"],"contact":"Francesca Macchiarini, Ph.D., MS","contact_tel":"301-827-4013","contact_email":"francesca.macchiarini@nih.gov"},{"synopsis":"<p><span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research to understand factors uniquely associated with the immigration experience that contribute to health disparities or health advantages among U.S. immigrant populations.</span><span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span></p>","id":"100769","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-080.html","sponsor_type":"US Federal","prog_title":"Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical Trial Not Allowed)","revision_date":"22-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 05, 2021. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2023.","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Deborah Linares, Ph.D.","contact_tel":"301-402-2516","contact_email":"deborah.linares@nih.gov"},{"synopsis":"<span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><div>The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.&nbsp; The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation&rsquo;s biomedical, behavioral and clinical research needs.</div><div>&nbsp;</div><div>To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Courses for Skills Development</div><div>It is essential to expand and diversify the skilled AD/ADRD clinical trial workforce. The intent of this Funding Opportunity Announcement (FOA) is to encourage applications that develop creative and innovative short courses to train the next generation of AD/ADRD clinical trialists in state-of-the-art clinical research skills.</div></span><br />","id":"102562","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"25-May-2023","total_funding_limit":400000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-141.html","sponsor_type":"US Federal","prog_title":"AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)","revision_date":"04-Mar-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 25, 2021. The deadlines for receipt of full applications are: May 25, 2021; 2022 and 2023,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This program will expire on September 8, 2023.","sponwebsite":null,"deadline_date":["25-May-2023"],"contact":"Laurie Ryan","contact_tel":"301-496-9350","contact_email":"ryanl@mail.nih.go"},{"synopsis":"<p></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This notice informs applicants of an expansion to the&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-22-038.html\">NOT-HD-22-038</a>&nbsp;\"Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NICHD Populations of Interest\" to include research priority areas for the National Institute on Drug Abuse (NIDA).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institute on Drug Abuse (NIDA) is issuing this Notice of Special Interest (NOSI) to announce that research on the effects of:</span></p><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">emerging and evolving public health crises; and/or</span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">policy changes on the health, development, and well-being of populations of interest to the NIDA is of high program priority.</span></li></ul><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIDA populations of interest include neonates, infants, children, adolescents, young adults, adults, and older adults, people using or misusing substances, people with substance use disorders, as well as the families of these individuals. The NIDA supports research on the impact of policy in understanding and addressing substance use risk and behavior across the life span. For information on the NIDA Strategic Goals and Mission, see https://nida.nih.gov/about-nida/strategic-plan/nidas-mission.</span></p><ul><li><a href=\"https://www.nichd.nih.gov/about/org/strategicplan\"></a></li></ul><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"113804","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DA-22-084.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NICHD Populations of Interest","revision_date":"21-Oct-2022","deadline_note":"This notice applies to due dates on or after February 5, 2023 and subsequent receipt dates through January 8, 2026.&nbsp;","sponwebsite":null,"deadline_date":["07-May-2024","07-Jan-2024","16-Feb-2024","05-Oct-2023","07-Sep-2025","16-Feb-2023","05-Jun-2025","05-Jun-2023","25-Feb-2024","05-Oct-2025","16-Jun-2025","05-Feb-2023","25-Jun-2023","16-Oct-2023","05-Feb-2024","07-May-2025","16-Oct-2024","05-Jun-2024","25-Oct-2024","25-Feb-2023","07-Jan-2025","16-Feb-2025","16-Jun-2024","05-Oct-2024","05-Feb-2025","25-Oct-2023","16-Oct-2025","25-Jun-2024","07-May-2023","16-Jun-2023","07-Sep-2023","07-Sep-2024","07-Jan-2026"],"contact":"Elyse R. Grossman","contact_tel":"240-551-3628","contact_email":"elyse.grossman@nih.gov"},{"synopsis":"<p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible, domestic institutions to enhance predoctoral and postdoctoral research training, including short-term research training, and help ensure that a diverse and highly trained workforce is available to meet the needs of the Nation&rsquo;s biomedical, behavioral, and clinical research agenda. Research training programs are expected to incorporate didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. Programs proposing only short-term predoctoral research training should not apply to this announcement, but rather to the Kirschstein-NRSA Short-Term Institutional Research Training Grant Program (T35) exclusively reserved for predoctoral, short-term research training.</span></p><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.</span></p>","id":"090787","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-142.html","sponsor_type":"US Federal","prog_title":"Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)","revision_date":"07-Feb-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 25, 2020. The deadline for receipt of standard applications under this announcement are: January 25, May 25, and September 25 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2023.</p><p>NOTE: Per NOT-DA-21-088 NIDA&nbsp;will accept T32 applications for two cycles per year:</p><p>January 25 for non-AIDS applications and May 7 for AIDS applications; and May 25 for non-AIDS applications and September 7 for AIDS applications.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["07-Jan-2023","25-Jan-2023","07-May-2023"],"contact":null,"contact_tel":null,"contact_email":"GrantsInfo@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This FOA provides resources for assessing the feasibility, acceptability, and utility of these approaches, in addition to usual trial preparation activities.</span>","id":"104076","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-21-180.html","sponsor_type":"US Federal","prog_title":"Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)","revision_date":"12-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 16, 2021. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2024.","sponwebsite":null,"deadline_date":["16-Oct-2023","07-May-2023","16-Jun-2023","16-Feb-2024","07-Jan-2024","16-Feb-2023","07-Sep-2023","07-May-2024","07-Jan-2023"],"contact":"Keisher Highsmith, DrPH","contact_tel":null,"contact_email":"duffys@nida.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This announcement encourages applications to conduct research on the effects of public policies on health-related behaviors and outcomes associated with alcohol, cannabis, tobacco, prescription drugs, and other substances. The purpose of the Notice is to advance understanding of how public policy may serve as a tool for improving public health and welfare through its effects on behaviors and outcomes pertaining to alcohol and other drugs. This Notice is intended to support innovative research to examine policy effects that have the potential to lead to meaningful changes in public health. Research projects that may be supported include, but are not necessarily limited to: causal analyses of the effects of one or multiple public policies; evaluations of the effectiveness of specific public policies as tools for improving public health through their effects on alcohol-, cannabis-, tobacco-, and other substance-related behaviors and outcomes; studies of disparities in policy effects and the role of policy in exacerbating or potentially reducing health disparities; and research to advance methods and measurement used in studying relationships between public policies and alcohol-, cannabis-, tobacco-, and other substance-related behaviors and outcomes.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"103983","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-028.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes","revision_date":"06-May-2021","deadline_note":"This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through September 8, 2024.&nbsp;","sponwebsite":null,"deadline_date":["07-Jan-2024","05-Feb-2024","07-Jan-2023","07-Sep-2023","16-Jun-2023","16-Feb-2023","16-Jun-2024","05-Jun-2024","07-May-2024","07-Sep-2024","16-Feb-2024","05-Feb-2023","16-Oct-2023","07-May-2023","05-Jun-2023","05-Oct-2023"],"contact":"Gregory Bloss, M.A., M.P.P.","contact_tel":null,"contact_email":"Gregory.Bloss@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This NOSI is intended to support projects that will employ existing and new clinical trial cohorts/observational cohorts to screen for co-infection, phenotype and collect biospecimens to answer some of these questions and to encourage investigator-initiated applications for basic, translational and human subject research (not clinical trials) in this space.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108065","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-004.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Pediatric COVID-19 and Respiratory Viral Co-infection","revision_date":"27-Dec-2021","deadline_note":"This notice applies to due dates on or after February 5, 2022 and subsequent receipt dates through September 8, 2025.&nbsp;","sponwebsite":null,"deadline_date":["07-May-2025","16-Feb-2024","05-Jun-2023","05-Feb-2023","07-Jan-2025","05-Feb-2025","16-Jun-2024","16-Jun-2024","05-Feb-2024","07-Sep-2025","07-Sep-2023","05-Oct-2023","16-Feb-2024","05-Oct-2024","07-May-2024","07-May-2023","16-Jun-2023","16-Oct-2024","05-Jun-2024","07-Jan-2023","07-Sep-2024","16-Oct-2023","05-Jun-2025","16-Feb-2023","07-Jan-2024"],"contact":null,"contact_tel":null,"contact_email":null},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Notice of Special Interest (NOSI) is to solicit applications to support the secondary analyses of existing data sets with the goal of enhancing our understanding of the following: 1) the patterns and trajectories of alcohol consumption, 2) the epidemiology and etiology, including genetics, of alcohol-related problems and disorders, and 3) alcohol-related health services and health systems, including access, quality, and efficiency. This Notice encourages applications proposing innovative analyses of existing alcohol research data, answering novel research hypotheses and questions, and developing and testing advanced analytical methodologies applicable to alcohol related epidemiological, behavioral and genetics research.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"097916","spon_name":"National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AA-20-018.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Secondary Analyses of Existing Alcohol Research Data","revision_date":"18-Jul-2022","deadline_note":"This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 5, 2023.&nbsp;","sponwebsite":null,"deadline_date":["16-Jun-2023","07-Jan-2023","16-Feb-2023","07-May-2023","05-Feb-2023"],"contact":"Wenxing Zha, Ph.D. ","contact_tel":"301-443-0633","contact_email":"zhaw@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Special Emphasis Notice (SEN) is to inform the research community of the Agency for Healthcare Research and Quality&rsquo;s (AHRQ) interest in receiving health services research grant applications that propose innovative and evidence-based interventions that advance the nation&rsquo;s goal of achieving equity in the delivery of healthcare services including reducing disparities in quality of care, patient safety, healthcare utilization and access, and ultimately, health outcomes.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"103873","spon_name":"Agency for Healthcare Research and Quality/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":null,"sponsor_type":"US Federal","prog_title":"Special Empahsis Notice (SEN): Health Services Research to Advance Health Equity","revision_date":"02-May-2021","deadline_note":"Applications responding to this SEN should be submitted on regular application receipt dates identified in the respective Funding Opportunity Announcement and will be reviewed by AHRQ standing study sections. Applicants should consider this SEN active until April 27, 2023.","sponwebsite":null,"deadline_date":["16-Feb-2023","01-Feb-2023","25-Jan-2023","12-Feb-2023","05-Feb-2023","07-Jan-2023"],"contact":"William Freeman, DrPH, MPH","contact_tel":"William.Freeman@ahrq.hhs.gov","contact_email":null},{"synopsis":"<br /><p>The sponsor encourages Small Research Grant (R03) applications, and expresses AHRQ portfolio priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and, development of new research technology. </p>","id":"074880","spon_name":"Agency for Healthcare Research and Quality/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":100000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-18-794.html","sponsor_type":"US Federal","prog_title":"AHRQ Small Research Grant Program (R03)","revision_date":"08-Jun-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 17, 2018.The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on July 8, 2023.","sponwebsite":null,"deadline_date":["16-Feb-2023","16-Jun-2023"],"contact":"Kishena Wadhwani, Ph.D.","contact_tel":"301-427-1556","contact_email":"Kishena.Wadhwani@ahrq.hhs.gov"},{"synopsis":"<br /><p>Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes.</p><s2s></s2s>","id":"106282","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":2500000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-331.html","sponsor_type":"US Federal","prog_title":"Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)","revision_date":"03-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 12, 2021. Optional letters of intent are due 30 days prior to the application due date. The deadlines for receipt of full applications are: November 12, 2021, and October 5, February 5, and June 5 annually, by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["05-Mar-2023","05-Feb-2023","05-Jul-2023","05-Mar-2024","05-Jun-2023","05-Nov-2023","05-Jun-2024","05-Feb-2024","05-Oct-2023","05-Jul-2024"],"contact":"Edward R. Sauter, M.D., Ph.D.","contact_tel":"240-276-7657","contact_email":"edward.sauter@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice is to encourage the submission of research project applications that enhance our understanding of the nature, extent, distribution, etiology, comorbidities, and consequences of drug use, misuse, and&nbsp;addiction&nbsp;across individuals, families, communities, and diverse population groups.&nbsp;Of interest are&nbsp;applications that address multiple levels of risk, resilience, and causation across scientific disciplines, and that apply novel methods to advance knowledge of the interplay among genetic, environmental, neurobiological, and developmental factors and associated health and disease outcomes.&nbsp;Priority will be given to&nbsp;research&nbsp;with&nbsp;a&nbsp;well described&nbsp;path&nbsp;towards&nbsp;translation and/or&nbsp;public health impact.&nbsp;In addition to&nbsp;novel data collection, approaches are encouraged&nbsp;that build on the research investments&nbsp;of NIH and sister HHS agencies to harness existing data on the epidemiology and etiology of drug misuse to improve public health prevention and treatment programs. The research areas noted below should be considered in the context of topics&nbsp;such as&nbsp;health disparities&nbsp;or inequities, familial/genetic liability, and physical, psychiatric, and polysubstance comorbidities and interactions.&nbsp;&nbsp;</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"109268","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DA-22-004.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Epidemiology of Drug Abuse","revision_date":"23-Feb-2022","deadline_note":"This notice applies to due dates on or after June 5 2022 and subsequent receipt dates through September 8, 2025&nbsp;.&nbsp;","sponwebsite":null,"deadline_date":["05-Feb-2025","07-May-2024","16-Jun-2025","05-Feb-2023","05-Jun-2023","07-Jan-2025","05-Oct-2024","16-Jun-2023","05-Jun-2024","07-May-2025","16-Jun-2024","07-Sep-2023","07-Sep-2025","16-Feb-2025","16-Feb-2023","07-Jan-2023","07-Jan-2024","07-May-2023","16-Oct-2023","05-Jun-2025","05-Feb-2024","16-Feb-2024","05-Oct-2023","07-Sep-2024","16-Oct-2024"],"contact":"Marsha Lopez, PhD, MHS","contact_tel":"301-443-6504","contact_email":"Marsha.Lopez@nih.gov"},{"synopsis":"<p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This funding opportunity announcement (FOA) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.</span> </p><s2s></s2s>","id":"086964","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":100000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-052.html","sponsor_type":"US Federal","prog_title":"NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)","revision_date":"24-Mar-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after December 7&nbsp;, 2019.&nbsp;The deadlines for receipt of standard applications under this announcement are: June 24, 2020; October 20, 2020; February 24, 2021; June 24, 2021; October 20, 2021; February 24, 2022; June 24, 2022; and October 20, 2022, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: May 7, 2020; September 7, 2020; January 7, 2021; May 7, 2021; September 7, 2021; January 7, 2022; May 7, 2022; September 7, 2022; January 7, 2023, by 5:00 PM local time of applicant organization. This FOA will expire on January 08, 2023.","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":null,"contact_tel":null,"contact_email":null},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The National Cancer Institute (NCI) is issuing this Notice of Special Interest (NOSI) to encourage applications that efficiently use the existing cancer registry infrastructure by augmenting existing data with additional information not routinely collected by registries to study observed health disparities such as those that exist by race, ethnicity, socioeconomic status, income, insurance status, age, education level, or geographic area. The&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://seer.cancer.gov/about/\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">Surveillance, Epidemiology, and End Results</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">&nbsp;(SEER) Program and the&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://www.cdc.gov/cancer/npcr/\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">National Program of Cancer Registries</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">&nbsp;(NPCR) are uniquely positioned to support research to assess health disparities in the United States (US) population because they contain information on all cases diagnosed within geographically defined areas. The goal of these hypothesis-driven studies should be to understand why disparities in cancer treatment and outcomes persist by identifying factors contributing to disparities and their relative importance.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"101459","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-020.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Leveraging Population-based Cancer Registry Data to Study Health Disparities","revision_date":"05-Jan-2021","deadline_note":"This NOSI applies to Application Due Dates on or after February 5, 2021 and subsequent receipt dates through May 7, 2023.","sponwebsite":null,"deadline_date":["16-Feb-2023","07-Jan-2023","07-May-2023","05-Feb-2023"],"contact":"Kathy Cronin, Ph.D.","contact_tel":"240-276-6836","contact_email":"cronink@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to promote research in understanding the mechanisms by which cannabis and cannabinoids affect cancer biology, cancer interception, cancer treatment and resistance, and management of cancer symptoms.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"110931","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"28-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-CA-22-085.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer","revision_date":"06-May-2022","deadline_note":"This notice applies to due dates on or after June 5, 2022 and subsequent receipt dates through May 8, 2027.","sponwebsite":null,"deadline_date":["16-Jun-2026","12-Feb-2024","07-Sep-2024","16-Jun-2023","05-Feb-2025","26-Aug-2023","16-Oct-2025","28-Dec-2023","16-Feb-2023","05-Jun-2023","05-Jun-2026","16-Oct-2023","05-Oct-2024","05-Oct-2024","07-Jan-2027","12-Jun-2023","07-Sep-2023","07-May-2025","07-Jan-2026","26-Jan-2023","12-Oct-2024","28-Dec-2022","16-Jun-2024","05-Oct-2023","26-May-2023","05-Jun-2024","07-May-2026","12-Feb-2027","05-Oct-2025","16-Feb-2027","12-Oct-2025","05-Feb-2027","16-Jun-2025","05-Feb-2024","26-Sep-2023","05-Jun-2025","07-Jan-2024","16-Oct-2026","12-Oct-2023","16-Feb-2025","26-Apr-2023","07-Jan-2023","05-Feb-2026","12-Feb-2023","16-Feb-2024","05-Feb-2023","16-Oct-2024","07-Sep-2025","12-Oct-2026","12-Jun-2024","16-Feb-2026","07-May-2027","12-Feb-2026","07-Sep-2026","05-Jun-2024","07-May-2023","12-Jun-2026","07-Jan-2025","07-May-2024","12-Feb-2025","05-Oct-2026","12-Jun-2025"],"contact":"Ron Johnson, Ph.D.","contact_tel":"240-276-6250","contact_email":"rjohnso2@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The proposed initiative seeks to test innovative models of service delivery to improve substance use and mental health outcomes for individuals who have actionable needs following exposure to violence.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"112749","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"12-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DA-23-007.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence","revision_date":"03-Aug-2022","deadline_note":"his notice applies to due dates on or after October 12, 2022 and subsequent receipt dates through July 13, 2025.&nbsp;","sponwebsite":null,"deadline_date":["12-Feb-2023","20-Mar-2023","12-Jun-2023","12-Oct-2023","15-Nov-2023","12-Feb-2024","20-Mar-2024","12-Jun-2024","12-Oct-2024","12-Feb-2025","12-Jun-2025"],"contact":"Carrie Mulford","contact_tel":"301-827-6473","contact_email":"Carrie.Mulford@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) encourages research on the use of digital technology for early detection and monitoring of cognitive and functional decline in persons with Alzheimer&rsquo;s disease (AD) and AD-related dementias (ADRD).</span>","id":"108313","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"10-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-048.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimerâ€™s Disease and Related Dementias","revision_date":"10-Jan-2022","deadline_note":"This notice applies to due dates on or after March 11, 2022 and subsequent receipt dates through November 13, 2024.","sponwebsite":null,"deadline_date":["10-Mar-2023","10-Jul-2023","13-Nov-2023","11-Mar-2024","09-Jul-2024","12-Nov-2024"],"contact":"Yuan Luo, Ph.D.","contact_tel":"301-496-9350","contact_email":"yuan.luo@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) encourages primary care practice-based research focused on rigorous evaluations of factors that impact or account for the effectiveness of existing suicide prevention practices and/or pilot clinical trials aimed at optimizing and pilot testing patient-, provider-, or systems-level suicide prevention strategies. Applications of interest include those that refine and test scalable strategies for use in primary care across different intercepts in the chain-of-care, including strategies for identifying individuals at risk, assessing and stratifying risk, providing brief interventions, promoting initial and ongoing engagement in indicated services, continued outcome monitoring and follow-up, and tracking patient outcomes. For purposes of this FOA, primary care is defined as pediatric practice, family practice, obstetrics/gynecology, internal medicine, and geriatric practice. Primary care practices range in size, resources and patient health needs; proposed strategies should meet the practice needs to be feasible, scalable, sustainable, and practice-ready. NIMH encourages prevention approaches that incorporate the use of mHealth (the use of mobile and wireless devices [cell phones, tablets, etc.]) and other design features that can facilitate scalability and sustainability, and deployment-focused research approaches that take into account the perspectives of key stakeholders (e.g., patients, providers, administrators) and system-level factors such as setting resources, workforce capacity, and training needs. This FOA also encourages studies that examine suicide prevention strategies that have broad reach, including potential for addressing risk among individuals who experience mental health service disparities (e.g., racial/ethnic minority groups; sexual and gender minorities, individuals living in rural areas, socioeconomically disadvantaged persons), and studies that explore how the proposed strategies can reduce health disparities and promote health equity.</span>","id":"106865","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"22-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-120.html","sponsor_type":"US Federal","prog_title":"RFA-MH-22-120 -- Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)","revision_date":"26-Jan-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 20, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date.. The deadlines for receipt of full applications are: June 21, 2022; and February 21, 2023, by 5:00 PM local time of applicant organization.</p>","sponwebsite":null,"deadline_date":["22-Jan-2023 [Optional] [LOI/Pre-App]","21-Feb-2023"],"contact":"Stephen O'Connor, Ph.D.","contact_tel":"301-480-8366","contact_email":"stephen.o'connor2@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component and possible inclusion of international comparator cohorts. A trans NCI effort, the concept reissuance of the Collaborative Program is supported by NCI&rsquo;s Division of Cancer Biology (DCB), Division of Cancer Treatment and Diagnosis (DCTD), Division of Cancer Prevention (DCP), Division of Cancer Control and Population Sciences (DCCPS), Center to Reduce Cancer Health Disparities (CRCHD) and now, also included Center for Global Health.</span><p>&nbsp;</p>","id":"109396","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"23-Jan-2023","total_funding_limit":150000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-114.html","sponsor_type":"US Federal","prog_title":"Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)","revision_date":"24-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after&nbsp;August 06, 2022; December 23, 2022; August 06, 2023; December 23, 2023; August 6, 2023; and December 23, 2024.&nbsp;The deadlines for receipt of full applications are:&nbsp;September 23, 2022; January 23, 2023; September 06, 2023; January 23, 2024; September 06, 2024; and January 23, 2025 by 5:00 PM local time of applicant organization.. This program will expire on January 24, 2025.</p>","sponwebsite":null,"deadline_date":["23-Jan-2023","06-Sep-2023","23-Jan-2024","06-Sep-2024","23-Jan-2025"],"contact":"Maria Jamela R. Revilleza, PhD, MS","contact_tel":"240-620-0616","contact_email":"mariajamela.revilleza@nih.gov"},{"synopsis":"<span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement invites multiple Program Director/Principal Investigator (multi-PD/PI) applications to conduct a study to establish a longitudinal cohort of individuals who developed diabetes following SARS-CoV-2 infection to understand the pathophysiology and clinical course post-COVID-19 diabetes. The cohort must include children and adults and reflect the geography and demographics of COVID-19 in the U.S. There must be an appropriate comparator population recruited and followed. The goals are to determine the contribution of: 1) specific pathophysiologic pathways; 2) overall health impact of the pandemic; 3) COVID-19 severity, and 4) COVID-19 treatment upon excess new onset diabetes from SARS-CoV-2 infection and response to diabetes therapy.&nbsp;</span><br />","id":"112409","spon_name":"National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS","NextDeadlineDate":"20-Dec-2022","total_funding_limit":17500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-016.html","sponsor_type":"US Federal","prog_title":"RFA-DK-22-016 -- Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)","revision_date":"14-Jul-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 20, 2022. The deadline for receipt of optional letters of intent is November 20, 2022.&nbsp; The deadline for receipt of full applications is December 20, 2022,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;</p>","sponwebsite":null,"deadline_date":["20-Dec-2022"],"contact":"Saul Malozowski, M.D.","contact_tel":"301-451-4683","contact_email":"malozowskis@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) highlights interest in mental health services and implementation science research to support the adoption and sustainability of evidence-based practices (EBPs) in community-based settings that deliver care to people with mental illness. These settings could include, but are not limited to, Certified Community Behavioral Health Clinics (CCBHCs) funded through the Substance Abuse and Mental Health Services Administration (SAMHSA) Certified Community Behavioral Health Clinic-Expansion (CCBHC-E) grant program.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"110034","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-MH-22-170.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research Using Implementation Science To Support the Delivery of Evidence-Based Practices in Community-Based Mental or General Medical Healthcare Settings","revision_date":"28-Mar-2022","deadline_note":"This notice applies to due dates on or after May 7, 2022 and subsequent receipt dates through May 8, 2025.&nbsp;","sponwebsite":null,"deadline_date":["11-Aug-2023","15-Feb-2024","05-Feb-2023","16-Oct-2023","05-Jun-2024","07-May-2023","16-Oct-2024","05-Oct-2024","16-Jun-2023","05-Feb-2024","07-Jan-2025","16-Jun-2024","15-Feb-2023","17-Oct-2023","16-Feb-2025","16-Feb-2023","05-Oct-2023","15-Jun-2023","16-Feb-2024","07-May-2024","05-Jun-2023","07-Jan-2024","07-Sep-2023","07-Jan-2023","07-Sep-2024","07-May-2025","05-Feb-2025"],"contact":null,"contact_tel":null,"contact_email":null},{"synopsis":"<p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.&nbsp; Administrative supplements must support work within the scope of the original project.</span></p><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.&nbsp; &nbsp;</span></p><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><br /></p><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">&nbsp;</span></p><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"100761","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-21-071.html","sponsor_type":"US Federal","prog_title":"Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)","revision_date":"30-Aug-2022","deadline_note":"Submission dates vary by awarding IC.&nbsp; See&nbsp;Table of IC-Specific Information, Requirements and Staff Contacts&nbsp;for more details.&nbsp; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. This FOA will expire on&nbsp;May 8, 2023.","sponwebsite":null,"deadline_date":null,"contact":null,"contact_tel":"301-435-0714","contact_email":"GrantsInfo@nih.gov"},{"synopsis":"This funding opportunity announcement is designed to support biomedical knowledgebases. Biomedical knowledgebases under this announcement should have the primary function to extract, accumulate, organize, annotate, and link growing bodies of information related to core datasets. Support for data curation should include efficient and effective methods of curation that scale to the needs of the community and include semi-automated methods. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the knowledgebase.<br /><br />Applications that have a significant focus on software or tool development are not appropriate for this activity.","id":"088347","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"06-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-097.html","sponsor_type":"US Federal","prog_title":"Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)","revision_date":"16-Feb-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 25, 2020. The deadlines for receipt of standard applications under this announcement are: September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023, by&nbsp;5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, 2021; May 7, 2021; January 7, 2022; May 6, 2022; January 6, 2023; May 8, 2023, by&nbsp;5:00 PM local time of applicant organization. This program will expire on May 9, 2023.&nbsp;","sponwebsite":null,"deadline_date":["06-Jan-2023","25-Jan-2023","08-May-2023"],"contact":"Veerasamy Ravichandran, Ph.D.","contact_tel":null,"contact_email":"veerasamy.ravichandra@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This funding opportunity announcement is designed to support biomedical data repositories. Biomedical data repositories under this announcement should have the primary function to ingest, archive, preserve, manage, distribute, and make accessible the data related to a particular system or systems. Support for data curation must be limited to that which improves the efficiency and accessibility of data ingestion, management, and use and reuse by the user communities. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the repository. Applications that have a significant focus on software and tool development are not appropriate for this activity.</span>","id":"088346","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"06-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-089.html","sponsor_type":"US Federal","prog_title":"Biomedical Data Repository (U24 - Clinical Trials Not Allowed)","revision_date":"11-Feb-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 25, 2020. The deadlines for receipt of standard applications under this announcement are: September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023, by&nbsp;5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, 2021; May 7, 2021; January 7, 2022; May 6, 2022; January 6, 2023; May 8, 2023, by&nbsp;5:00 PM local time of applicant organization. This program will expire on May 9, 2023.&nbsp;","sponwebsite":null,"deadline_date":["06-Jan-2023","25-Jan-2023","08-May-2023"],"contact":"Veerasamy Ravichandran, Ph.D.","contact_tel":null,"contact_email":"veerasamy.ravichandra@nih.gov"},{"synopsis":"<br /><p>Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes.</p><s2s></s2s>","id":"106283","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":550000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-332.html","sponsor_type":"US Federal","prog_title":"Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)","revision_date":"03-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 18, 2021. Optional letters of intent are due 30 days prior to the application due date. The deadlines for receipt of full applications are: November 18, 2021, and October 16, February 16, and June 16 annually, by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["16-Feb-2024","16-Jul-2023","16-Nov-2023","16-Mar-2024","16-Oct-2023","16-Jul-2024","16-Feb-2023","16-Jun-2024","16-Jun-2023","16-Mar-2023"],"contact":"Edward R. Sauter, M.D., Ph.D.","contact_tel":"240-276-7657","contact_email":"edward.sauter@nih.gov"},{"synopsis":"PCORI is pleased to announce the simplification and expansion of two longstanding funding opportunities known as the Broad PCORI Funding Announcement (PFA) and Pragmatic Clinical Studies (PCS) PFA. Starting in Cycle 1 2022, PCORI combined these two PFAs into a single PFA entitled the Broad Pragmatic Studies (BPS) PFA. This new PFA covers the following four priority areas: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options;â€¯Communication and Dissemination Research;â€¯and Improving Healthcareâ€¯Systems.â€¯These broad areas encompass the patient-centered comparative clinical effectiveness research (CER) that PCORI has long funded.&nbsp; ","id":"038162","spon_name":"Patient-Centered Outcomes Research Institute (PCORI)","NextDeadlineDate":"23-Jan-2023","total_funding_limit":10000000,"programurl":"https://www.pcori.org/funding-opportunities/announcement/broad-pragmatic-studies-funding-announcement-2022-standing-pfa","sponsor_type":"Professional/Academic Assoc &amp; Soc.","prog_title":"Broad Pragmatic Studies Funding","revision_date":"12-Sep-2022","deadline_note":"Letters of Intent are due October 4, 2022; if invited, full applications are due January 23, 2023.","sponwebsite":"https://www.pcori.org","deadline_date":["23-Jan-2023"],"contact":null,"contact_tel":"202-827-7700","contact_email":"info@pcori.org"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, or epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality. Projects proposing the application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This funding opportunity is part of a broader NCI-sponsored&nbsp;<a href=\"https://imat.cancer.gov/\" target=\"_blank\">Innovative Molecular Analysis Technologies</a>&nbsp;(IMAT) Program.</span></span></p>","id":"114496","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"30-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-004.html","sponsor_type":"US Federal","prog_title":"RFA-CA-23-004 -- Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)","revision_date":"05-Dec-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 01, 2023. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: March 1, 2023, and September 1, 2023, by 5:00 PM local time of applicant organization.</p>","sponwebsite":null,"deadline_date":["30-Jan-2023 [Optional] [LOI/Pre-App]","01-Mar-2023","02-Aug-2023 [Optional] [LOI/Pre-App]","01-Sep-2023"],"contact":"Kelly Crotty Ph.D.","contact_tel":"240-760-7997","contact_email":"kelly.crotty@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous validation to encourage adoption by the research community. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, or epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality. Projects proposing to use existing technologies where the novelty resides in the application of the technology or the biological or clinical question being pursued, and not the technical capabilities being developed, are not appropriate for this FOA and will not be reviewed.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This funding opportunity is part of a broader NCI-sponsored&nbsp;<a href=\"https://imat.cancer.gov/\" target=\"_blank\">Innovative Molecular Analysis Technologies (IMAT) Program</a>.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span></p>","id":"114497","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"30-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":900000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-005.html","sponsor_type":"US Federal","prog_title":"RFA-CA-23-005 -- Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)","revision_date":"05-Dec-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 01, 2023. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: March 1, 2023, and September 1, 2023, by 5:00 PM local time of applicant organization.</p>","sponwebsite":null,"deadline_date":["30-Jan-2023 [Optional] [LOI/Pre-App]","01-Mar-2023","02-Aug-2023 [Optional] [LOI/Pre-App]","01-Sep-2023"],"contact":"Kelly Crotty Ph.D.","contact_tel":"240-760-7997","contact_email":"kelly.crotty@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies. It also encourages biobehavioral and behavioral/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women.</span>","id":"106233","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"09-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-297.html","sponsor_type":"US Federal","prog_title":"Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)","revision_date":"01-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 09, 2021. The deadline for receipt of optional letters of intent is 30 days prior to application receipt date. The deadline for receipt of full applications is December 9 annually, by 5:00 PM local time of applicant organization. This FOA will expire on December 10, 2023.","sponwebsite":null,"deadline_date":["09-Dec-2023","09-Dec-2022"],"contact":"Nahida Chakhtoura, MD MsGH ","contact_tel":"301-435-6872 ","contact_email":"nahida.chakhtoura@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies. It also encourages biobehavioral and behavioral/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women.</span>","id":"106235","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"09-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-298.html","sponsor_type":"US Federal","prog_title":"Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)","revision_date":"01-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 09, 2021. The deadline for receipt of optional letters of intent is 30 days prior to application receipt date. The deadline for receipt of full applications is December 9 annually, by 5:00 PM local time of applicant organization. This FOA will expire on December 10, 2023.","sponwebsite":null,"deadline_date":["09-Dec-2023","09-Dec-2022"],"contact":"Nahida Chakhtoura, MD MsGH ","contact_tel":"301-435-6872 ","contact_email":"nahida.chakhtoura@mail.nih.gov"},{"synopsis":"<br /><p>The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.</p>","id":"106312","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html","sponsor_type":"US Federal","prog_title":"RFA-DA-22-040 -- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)","revision_date":"08-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 15, 2022. The deadlines for receipt of AIDS-related applications are: February 15 and August 15 annually. This program will expire on February 16, 2024. ","sponwebsite":null,"deadline_date":["15-Feb-2023","15-Aug-2023","15-Feb-2024"],"contact":"Richard A. Jenkins, Ph.D.","contact_tel":"301-443-1923 ","contact_email":"jenkinsri@nida.nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) seeks innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Division&rsquo;s research priorities.</span></p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://grants.nih.gov/grants/guide/pa-files/pa-20-144.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">PA-20-144</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">&nbsp;uses the R01 grant mechanism while this&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://grants.nih.gov/grants/guide/pa-files/pa-20-145.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">PA-20-145</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">&nbsp;uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data and/or including longitudinal analysis may apply using the R01 mechanism.</span><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">&nbsp;</span></span></p>","id":"090889","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-145.html","sponsor_type":"US Federal","prog_title":"Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)","revision_date":"22-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">April 07, 2020</span>. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2023. ","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Christopher Gordon, Ph.D.","contact_tel":"240-627-3867","contact_email":"cgordon1@mail.nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This FOA seeks innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches, and intervention efficacy or effectiveness trials. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Division&rsquo;s research priorities.</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"><a href=\"https://grants.nih.gov/grants/guide/pa-files/PA-20-145.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\"><span style=\"text-decoration:underline;box-sizing:border-box;\">PA-20-145</span></a>&nbsp;uses the R21 grant mechanism while this&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PA-20-144.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">PA-20-144</a>uses the R01 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applications with preliminary data and/or including longitudinal analysis may be more appropriate for the R01 mechanism.</span></span></p>","id":"090888","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-144.html","sponsor_type":"US Federal","prog_title":"Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01 Clinical Trial Optional)","revision_date":"21-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">April 07, 2020</span>. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2023. ","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Christopher Gordon, Ph.D.","contact_tel":"240-627-3867","contact_email":"cgordon1@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment. For the purposes of this FOA, &ldquo;intervention&rdquo; is defined to include behavioral, social, or structural approaches, as well as combination biomedical and behavioral, social, or structural approaches that prevent acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected, or both.</span>","id":"090786","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-141.html","sponsor_type":"US Federal","prog_title":"Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)","revision_date":"09-Apr-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 7, 2020. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2023.","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Christopher Gordon ","contact_tel":"240 -627-3867 ","contact_email":"cgordon1@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities for Resident-Investigators and foster their ability to transition to individual career development research awards. The program will support institutions to provide support for up to 2 years of research conducted by Resident-Investigators in structured programs for clinician-investigators with defined program milestones.</span>","id":"108508","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"15-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-006.html","sponsor_type":"US Federal","prog_title":"RFA-HL-23-006 -- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)","revision_date":"17-Mar-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 15, 2022. NIH will not accept optional letters of intent under this FOA . The deadline for receipt of full applications is March 15 annually, by by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is May 16 annually,&nbsp;by by 5:00 PM local time of applicant organization. This FOA will expire on May 17, 2024. ","sponwebsite":null,"deadline_date":["15-Mar-2024","16-May-2023","16-May-2024","15-Mar-2023"],"contact":"David Schopfer","contact_tel":"301-402-3833","contact_email":"david.schopfer@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The Outstanding New Environmental Scientist (ONES) Award is intended to identify the most talented Early Stage Investigators (ESIs) who intend to make a long-term commitment to research in the Environmental Health Sciences and assist them in launching an innovative research program focused on understanding the effects of environmental exposure on people&rsquo;s health.</span>","id":"100822","spon_name":"National Institute of Environmental Health Sciences/NIH/DHHS","NextDeadlineDate":"25-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":2375000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-21-001.html","sponsor_type":"US Federal","prog_title":"RFA-ES-21-001 -- Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional)","revision_date":"17-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 26, 2021. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: February 26, 2021; February 24, 2022; and February 24, 2023, by 5:00 PM local time of applicant organization. This FOA will expire on February 25, 2023.","sponwebsite":null,"deadline_date":["25-Jan-2023 [Optional] [LOI/Pre-App]","24-Feb-2023"],"contact":"Carol Shreffler, PhD","contact_tel":"948-287-3322 ","contact_email":"shreffl1@niehs.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">NIMH seeks applications for research projects to evaluate the effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health conditions affecting youth, adults, and older adults. This Funding Opportunity Announcement (FOA) encourages clinical trials to establish the effectiveness and test hypotheses regarding moderators, mediators, and mechanisms of action of post-acute phase therapeutic and services interventions that are matched to the stage of illness in terms of both their focus (e.g., consolidating and maintaining gains from initial treatment, managing residual symptoms/impairment, preventing relapse, promoting adherence and appropriate service use) and intensity/burden for promoting optimal longer-term outcomes.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA is intended to support trials that are statistically powered to provide a definitive answer regarding the effectiveness of the post-acute phase intervention. Support for pilot effectiveness trials designed to evaluate the initial feasibility, tolerability, acceptability, safety and preliminary indications of post-acute phase intervention approaches is provided via the R34,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/par-21-211.html\">PAR-21-211</a>.</span></span></p>","id":"103213","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-210.html","sponsor_type":"US Federal","prog_title":"Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)","revision_date":"30-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 05, 2021. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on March 6, 2024. ","sponwebsite":null,"deadline_date":["05-Feb-2024","05-Jun-2023","05-Oct-2023","05-Feb-2023"],"contact":"Adam Haim, Ph.D.","contact_tel":"301-435-3593","contact_email":"haima@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this initiative is to support research to design and implement effective interventions to enhance health advantages and reduce the health disparities among US immigrant populations.</span><span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span></p>","id":"100780","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-081.html","sponsor_type":"US Federal","prog_title":"Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)","revision_date":"28-Jan-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 05, 2021. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2023.","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Deborah Linares, Ph.D.","contact_tel":"301-402-2516","contact_email":"deborah.linares@nih.gov"},{"synopsis":"<span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><div data-index=\"15\"><div><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of the Stimulating Access to Research in Residency Transition Scholar (StARRTS) K38 Career Development program is to retain and support clinician investigators who have successfully completed the&nbsp;<a href=\"https://grants.nih.gov/grants/guide/rfa-files/rfa-hl-18-023.html\">Stimulating Access to Research in Residency (StARR) R38 Program</a>&nbsp;(<a href=\"https://grants.nih.gov/grants/guide/rfa-files/rfa-hl-18-023.html\">RFA-HL-18-023</a>&nbsp;or&nbsp;<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-006.html\">RFA-HL-23-006)</a>&nbsp;as resident-investigators. Individuals who are awarded K38 grants described in this FOA will be referred to as Transition Scholars. The intent of this FOA is to provide Transition Scholars with opportunities for additional research and career development during subsequent clinical fellowship or early career faculty appointments (as defined in&nbsp;<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-006.html#_3._Additional_Information\">Section III. 3. Additional Information on Eligibility</a>). It is anticipated that the StARRTS K38 program will provide a pathway to retain the newly-created pool of clinician-investigators generated through the StARR R38 program. Transition Scholar grantees will receive support for continued research and career development opportunities in basic, clinical and/or translational research thereby providing enhanced potential to accelerate the transition to independent research careers.</span></span></p></div></div><div data-index=\"16\"><div tabindex=\"0\" data-element-id=\"91741\" data-element-required=\"false\" data-element-has-value=\"true\" data-section-code=\"OI\" data-element-type=\"TEXT\"></div><div><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.</span></p></div></div>","id":"109762","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"10-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-007.html","sponsor_type":"US Federal","prog_title":"RFA-HL-23-007 -- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)","revision_date":"15-Mar-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 12, 2022. NIH will not accept optional letters of intent under this FOA . The deadlines for receipt of full applications are: October 13, 2022; October 13, 2023; and October 11, 2024, by&nbsp;5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: January 10, 2023; January 10, 2024; and January 10, 2025, by 5:00 PM local time of applicant organization. This FOA will expire on January 11, 2025.</p>","sponwebsite":null,"deadline_date":["10-Jan-2025","13-Oct-2023","11-Oct-2024","10-Jan-2023","10-Jan-2024"],"contact":"David Schopfer, M.D.","contact_tel":"301-402-3833","contact_email":"david.schopfer@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The Adolescent Brain Cognitive Development (ABCD) Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function from youth starting when they are 9-10 years-old and following them longitudinally to early adulthood.&nbsp; These data will be made available to the scientific community through the NIMH Data Archive. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. More information about the ABCD Study may be found on the ABCD Study web page (<a href=\"http://www.abcdstudy.org/\" title=\"Link to Non-U.S. Government Site\">www.abcdstudy.org</a>).&nbsp;&nbsp;This FOA uses the R01 grant mechanism, whereas its companion FOA,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-22-138.html\">PAR-22-138</a>, seeks shorter, higher-risk R21 grant applications.&nbsp;&nbsp;</span></span> ","id":"109791","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":1250000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-137.html","sponsor_type":"US Federal","prog_title":"Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)","revision_date":"06-Apr-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 05, 2022. The deadline for receipt of optional letters of intent is&nbsp;30 days prior to the application due date.&nbsp;The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for&nbsp;Renewal / Resubmission / Revision (as allowed) applications are: March 5, July 5, and November 5,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on May 08, 2025.</p>","sponwebsite":null,"deadline_date":["05-Feb-2023","07-Jan-2025","07-Jan-2023","07-Sep-2024","05-Jun-2024","05-Feb-2024","05-Jun-2023","05-Oct-2023","07-May-2023","05-Oct-2024","05-Feb-2025","07-Sep-2023","07-May-2025","07-May-2024","07-Jan-2024"],"contact":"Julia Zehr, Ph.D.","contact_tel":"301-443-1617","contact_email":"Zehrj@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This initiative will support innovative research to develop, test and evaluate multi-level/multi-component strategies (including models of health care) to effectively adapt and implement comprehensive clinical care for individuals with Type 2 diabetes mellitus from populations with health disparities concordant with recommended and evidence-based guidelines.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"104359","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":2500000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-21-232.html","sponsor_type":"US Federal","prog_title":"Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)","revision_date":"27-May-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 06, 2021. Optional letters of intent may be submitted thirty (30) days before the application deadline.&nbsp;The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2024. </p>","sponwebsite":null,"deadline_date":["05-Feb-2023","07-Sep-2024","05-Jun-2024","07-May-2023","07-May-2024","05-Feb-2024","07-Sep-2023","05-Jun-2023","07-Jan-2024","07-Jan-2023"],"contact":"Larissa Aviles-Santa, MD, MPH","contact_tel":"301-827-6924","contact_email":"avilessantal@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This FOA will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"110333","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-156.html","sponsor_type":"US Federal","prog_title":"Alcohol Health Services Research (R01 Clinical Trial Optional)","revision_date":"08-Apr-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 05, 2022. The deadline for receipt of optional letters of intent is 30 days before application due date. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for Renewal/Resubmission/Revision applications (as allowed) are: March 5, July 5, and November 5 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on May 08, 2023. </p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["05-Feb-2023"],"contact":"Laura E. Kwako, Ph.D.","contact_tel":"301-451-8507","contact_email":"laura.kwako@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to promote and support innovative methods in Big Data Science (BDS) to identify unappreciated biomedical, behavioral, social patterns and other social determinants that shed light on HIV acquisition, transmission, the development of comorbidities, and long-term viral control as in the HIV treatment continuum. BDS approaches can bring together data to evaluate the complex interplay between individual, contextual, and structural factors influencing the epidemiology of risk and care. Further, because this field can reveal unexpected associations through analysis of diverse data, BDS approaches may reveal events that are unseen or transient in traditional analysis of datasets. Discovery of these events will considerably advance research on HIV networks of transmission and the care continuum. This NOSI will support the establishment of BDS standards, bioinformatics data tools, machine-learning algorithms, mathematical modeling, advanced epidemiology and statistical analytic methods, and consideration and application of privacy and ethical issues in the use of public and personal data in the context of HIV research.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"104854","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-054.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV","revision_date":"23-Jun-2021","deadline_note":"This notice applies to due dates on or after<strong>&nbsp;<strong>September 7, 2021</strong>&nbsp;</strong>and subsequent receipt dates through<strong>&nbsp;<strong>May 7, 2024</strong>.</strong>","sponwebsite":null,"deadline_date":["07-May-2023","05-Oct-2023","05-Feb-2024","07-Sep-2023","05-Feb-2023","07-Jan-2023","07-Jan-2024","07-May-2024","05-Jun-2023"],"contact":"Rosemary McKaig, M.P.H, Ph.D.","contact_tel":"240-627-3214","contact_email":"rm434n@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative research that will inform and support the delivery of high-quality, continuously improving mental health services to benefit the greatest number of individuals with, or at risk for developing, a mental illness. This announcement invites applications for non-clinical trial R01-level projects that address NIMH strategic priorities that strengthen the public health impact of NIMH-supported research as described in&nbsp;<a href=\"https://www.nimh.nih.gov/about/strategic-planning-reports/goal-4-strengthen-the-public-health-impact-of-nimh-supported-research\">Goal 4 of the NIMH Strategic Plan</a>.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Proposed research should seek to:</span></p><ol><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Identify mutable factors that impact access, continuity, utilization, quality, value, and outcomes, including disparities in outcomes, or scalability of mental health services, which may serve as targets in future service delivery intervention development;</span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Develop and test new research tools, technologies, measures, or methods and statistical approaches to study these issues;</span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Integrate and analyze large data sets to understand factors affecting mental health services outcomes using advanced computational and predictive analytic approaches;</span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Wherever possible, leverage existing infrastructure and partnerships to accomplish these goals.</span></li></ol>","id":"106066","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-316.html","sponsor_type":"US Federal","prog_title":"Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)","revision_date":"18-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems Applications may be submitted on or after September 5, 2021. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. This program will now expire on September 08, 2024.<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-MH-20-063.html\"></a>","sponwebsite":null,"deadline_date":["05-Jun-2023","05-Jun-2024","05-Feb-2024","05-Oct-2023","05-Feb-2023"],"contact":"Michael C. Freed, Ph.D., EMT","contact_tel":"301-443-3747 ","contact_email":"michael.freed@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this funding opportunity announcement (FOA) is to support innovative research that will inform our understanding of the mechanisms underlying the formation of structural birth defects using animal models in conjunction with human translational/clinical approaches. Applicants are encouraged to take advantage of advances in genetics, &lsquo;omics methods (genomics, proteomics, metabolomics, etc.), and synthetic biology, biochemical and other approaches to developmental biology research to identify specific genetic, epigenetic, environmental, or gene/environment interactions associated with the formation of, susceptibility to, and variability of structural birth defects in human populations.</span>","id":"112833","spon_name":"National Institute of Child Health and Human Development/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":2499995,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-215.html","sponsor_type":"US Federal","prog_title":"Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)","revision_date":"10-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after&nbsp;September 05, 2022.&nbsp;The deadlines for receipt of new standard applications under this announcement are: June 5, and October 5 annually, by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of Renewal / Resubmission / Revision (as allowed) applications under this announcement are: March 5, July 5, and November 5 annually, by 5:00 PM local time of applicant organization.&nbsp;This program will expire on September 08, 2025.</p>","sponwebsite":null,"deadline_date":["05-Feb-2023","05-Feb-2025","05-Feb-2024","05-Oct-2024","05-Jun-2023","05-Oct-2023","05-Jun-2024","05-Jun-2025"],"contact":"Reiko Toyama, Ph.D.","contact_tel":"301-435-2723","contact_email":"toyamar@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnerships between institutions serving health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major goal of the NCI P20 partnership programs is to provide support for investigators at ISUPSs and Cancer Centers to conduct cancer research pilot projects and cancer research education programs. The purpose of the pilot projects and education programs is to allow awardees to obtain preliminary data that will lead to competitive grant applications for funding by the NIH/NCI and/or other Federal/Non-Federal agencies.</span>","id":"113878","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"07-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":1500000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-239.html","sponsor_type":"US Federal","prog_title":"Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)","revision_date":"27-Oct-2022","deadline_note":"Applications must be submitted through NIH's Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications will be accepted on or after December 06, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadline for receipt of full applications is January 06, 2023, by 5:00 PM local time of applicant organization. This FOA will expire on January 07, 2023. ","sponwebsite":null,"deadline_date":["07-Dec-2022 [Optional] [LOI/Pre-App]","06-Jan-2023"],"contact":"Behrous Davani, Ph.D.","contact_tel":"240-276-6170","contact_email":"behrous.davani@nih.gov"},{"synopsis":"<p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Small Research Grant Program (R03) will support important and innovative system biology projects in which more scientific insight is needed to improve the prevention, diagnosis, treatment, and care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The overall goal of this R03 program is (i) to facilitate the next generation of researchers in the United States to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies toward developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise. Individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities, are always encouraged to apply for NIH support.</span></p><span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span>","id":"086252","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":200000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAS-19-393.html","sponsor_type":"US Federal","prog_title":"Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed)","revision_date":"17-Oct-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 16, 2020. The deadlines for receipt of full applications are: February 16, June 16, and October 16, annually, by 5:00 PM local time of applicant organization.&nbsp; This FOA will expire on March 17, 2023.","sponwebsite":null,"deadline_date":["16-Feb-2023"],"contact":"Alison Yao, Ph.D.","contact_tel":"301-496-9350","contact_email":"alison.yao@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to support innovative population-based research that can contribute to identifying and characterizing pathways and mechanisms through which work or occupation influences health outcomes and health status among populations with health and/or health care disparities, and how work functions as a social determinant of health.&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"105002","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-275.html","sponsor_type":"US Federal","prog_title":"The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)","revision_date":"14-Oct-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 05, 2021. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on September 08, 2024. </p>","sponwebsite":null,"deadline_date":["07-Jan-2023","05-Feb-2023","07-May-2023","05-Jun-2023","07-Sep-2023","07-Jan-2024","05-Feb-2024","07-May-2024","05-Jun-2024","07-Sep-2024"],"contact":"Rada K. Dagher, PhD, MPH","contact_tel":"301-451-2187","contact_email":"rada.dagher@nih.gov"},{"synopsis":"<p>&nbsp;</p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Small Research Grant (R03) will support important and innovative projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Specifically, this FOA will support archiving and leveraging existing data sets for analyses of projects covering a wide array of topics relating to AD/ADRD. The overall goal of this FOA is (i) to encourage the next generation of U.S. researchers to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise. Individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities, are always encouraged to apply for NIH support.</span><span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span>","id":"086244","spon_name":"National Institute on Aging/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":200000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAS-19-391.html","sponsor_type":"US Federal","prog_title":" Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed)","revision_date":"17-Oct-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 16, 2020. The deadlines for receipt of full applications are: February 16, June 16, and October 16, annually, by 5:00 PM local time of applicant organization.&nbsp; This FOA will expire on March 17, 2023.","sponwebsite":null,"deadline_date":["16-Feb-2023"],"contact":"Partha Bhattacharyya, Ph.D.","contact_tel":"301-496-3136","contact_email":"bhattacharyyap@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Library of Medicine (NLM) supports innovative research and development in biomedical informatics and data science. This funding opportunity focuses on biomedical discovery and data-powered health, integrating streams of complex and interconnected research outputs that can be translated into scientific insights, clinical care, public health practices, and personal wellness. The scope of NLM's interest in these research domains is broad, with emphasis on new and innovative methods and approaches to foster data driven discovery in the biomedical and clinical health sciences as well as domain-independent, scalable, and reusable/reproducible approaches to discovery, curation, analysis, organization, and management of health-related digital objects.</span></p>","id":"113609","spon_name":"National Library of Medicine/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":1000000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-23-034.html","sponsor_type":"US Federal","prog_title":"NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)","revision_date":"07-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 05, 2023. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of&nbsp;Renewal / Resubmission / Revision (as allowed) applications are March 5, July 5, and November 5 annually,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on January 08, 2026.</p>","sponwebsite":null,"deadline_date":["07-Jan-2026","05-Feb-2025","05-Oct-2023","07-May-2023","07-May-2025","07-Jan-2024","05-Feb-2023","05-Jun-2024","07-Sep-2024","07-May-2024","05-Jun-2025","05-Feb-2024","07-Sep-2023","05-Jun-2023","07-Sep-2025","05-Oct-2024","07-Jan-2025","05-Oct-2025"],"contact":"Meryl Sufian, PhD","contact_tel":"301-496-4671","contact_email":"sufianm@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Arial, Helvetica, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 &ndash; 10 years.</span><br />","id":"109673","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"09-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-123.html","sponsor_type":"US Federal","prog_title":"Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)","revision_date":"09-Mar-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 26, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: May 26, 2022; September 26, 2022; May 26, 2023; September 26, 2023; May 24, 2024; and September 26, 2024, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: September 7, 2022; January 9, 2023; September 7, 2023; January 8, 2024; September 6, 2024; and January 7, 2025, by 5:00 PM local time of applicant organization. The deadlines for Renewal/Resubmission/Revision applications (as allowed) are: March 5, July 5, and November 5 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on January 08, 2025. </p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["09-Jan-2023","26-May-2023","07-Sep-2023","26-Sep-2023","08-Jan-2024","24-May-2024","06-Sep-2024","26-Sep-2024","07-Jan-2025"],"contact":"I. George Zubal, Ph.D.","contact_tel":"301-827-5168","contact_email":"igeorge.zubal@nih.gov"},{"synopsis":"The National Institute of Dental and Craniofacial Research (NIDCR) is issuing this Notice of Special Interest (NOSI) to encourage research studies designed to identify and understand the mechanisms by which biologic factors (microbial, immune, genetic) contribute to disparities in dental, oral, and craniofacial disease onset, progression, and persistence.<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"106848","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DE-21-013.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities","revision_date":"08-Oct-2021","deadline_note":"This notice applies to due dates on or after Fenruary 5, 2022 and subsequent receipt dates through January 8, 2025.&nbsp;","sponwebsite":null,"deadline_date":["07-May-2024","16-Oct-2024","07-Jan-2023","05-Jun-2024","16-Jun-2023","07-Sep-2024","16-Feb-2024","05-Oct-2023","16-Jun-2024","07-Sep-2023","07-Jan-2024","16-Oct-2023","07-May-2023","05-Feb-2023","05-Feb-2024","05-Jun-2023","07-Jan-2025","16-Feb-2023","05-Oct-2024"],"contact":"Hiroko Iida, DDS, MPH","contact_tel":"301-594-7404","contact_email":"hiroko.iida@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This FOA will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"110344","spon_name":"National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-157.html","sponsor_type":"US Federal","prog_title":"Alcohol Health Services Research (R34 Clinical Trial Optional)","revision_date":"08-Apr-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 15, 2022. The deadline for receipt of optional letters of intent is 30 days before application due date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, by 5:00 PM local time of applicant organization. The deadlines for Renewal/Resubmission/Revision applications (as allowed) are: March 5, July 5, and November 5 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on May 08, 2023. </p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["16-Feb-2023"],"contact":"Laura E. Kwako, Ph.D.","contact_tel":"301-451-8507","contact_email":"laura.kwako@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) highlights the need for research on strategies, and interventions to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities in the US and its territories. Research is needed to understand and address misinformation, distrust, and hesitancy regarding uptake of vaccines (e.g., SARS-CoV-2, pneumococcal, influenza, hepatitis B, human papilloma virus (HPV)) among adults in the United States and territories, especially in populations at increased risk for morbidity and mortality due to long-standing systemic health and social inequities and chronic medical conditions. This NOSI is focused on adults 18 years and older except for SARS-CoV-2 and HPV-related vaccine topics, which may include eligible children and adolescents. The purpose of this NOSI is to solicit research to: 1) evaluate community-engaged interventions (e.g., expand reach, increase access, address psychosocial barriers) to facilitate vaccination uptake in clinical and community contexts; 2) evaluate organizational, local, state, and federal policies and initiatives that mitigate or exacerbate disparities in vaccine access, uptake, and series completion, and 3) understand and address barriers to increasing reach, access, and uptake of vaccinations among populations who experience health disparities.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108008","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-MD-22-006.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities","revision_date":"15-Feb-2022","deadline_note":"This NOSI will expire on January 8, 2023.","sponwebsite":null,"deadline_date":["07-Jan-2023"],"contact":"Deborah E. Linares, Ph.D., M.A.","contact_tel":"301-402-2516","contact_email":"deborah.linares@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">NIMH seeks applications for pilot projects to evaluate the preliminary effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health conditions that are matched to the stage of illness in terms of both their focus (e.g., consolidating and maintaining gains from initial treatment, managing residual symptoms/impairment, preventing relapse, promoting adherence and appropriate service use) and intensity/burden. In this pilot phase of effectiveness research, the trial should be designed to evaluate the feasibility, tolerability, acceptability, safety, and potential effectiveness of the approach; to address whether the intervention engages the target(s)/mechanisms(s) that is/are presumed to underlie the intervention effects; and to obtain preliminary data needed as a pre-requisite to a larger-scale effectiveness trial (e.g., comparative effectiveness study, practical trial) designed to definitely test the effectiveness of interventions to improve post-acute outcomes.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA supports pilot research to evaluate the feasibility, tolerability, acceptability, safety and preliminary indications of effectiveness of post-acute phase intervention approaches and inform the design of definitive effectiveness trials. Support for fully-powered, definitive effectiveness studies focused on post-acute phase interventions is provided via the R01,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-210.html\" target=\"_blank\">PAR-21-210</a></span></span><span style=\"text-decoration:underline;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">&nbsp;</span></span></p>","id":"103214","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-211.html","sponsor_type":"US Federal","prog_title":"Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)","revision_date":"30-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 16, 2021. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on March 17, 2024. ","sponwebsite":null,"deadline_date":["16-Jun-2023","16-Oct-2023","16-Feb-2024","16-Feb-2023"],"contact":"Adam Haim, Ph.D.","contact_tel":"301-435-3593","contact_email":"haima@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative pilot research that will inform and support the delivery of high-quality, continuously improving mental health services to benefit the greatest number of individuals with, or at risk for developing, a mental illness. This announcement invites applications for non-clinical trial pilot projects that address NIMH strategic priorities to strengthen the public health impact of NIMH-supported research as described in&nbsp;<a href=\"https://www.nimh.nih.gov/about/strategic-planning-reports\">Goal 4 of the NIMH Strategic Plan</a>.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Proposed research should seek to:</span></p><ol><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Identify mutable factors that impact access, continuity, utilization, quality, value, and outcomes, including disparities in outcomes, or scalability of mental health services, which may serve as targets in future service delivery intervention development;</span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Develop and test new research tools, technologies, measures, or methods and statistical approaches to study these issues;</span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Test the feasibility of integrating&nbsp;and analyzing large data sets to understand factors affecting mental health services outcomes using advanced computational and predictive analytic approaches;</span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Wherever possible, leverage existing infrastructure and partnerships to accomplish these goals.</span></li></ol>","id":"108811","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-082.html","sponsor_type":"US Federal","prog_title":"Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)","revision_date":"04-Feb-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 16, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadlines for receipt of standard applications under this announcement are: March 28, 2019, then standard receipt dates February 16, June 16, and October 16 annually, by&nbsp;5:00 PM local time of applicant organization. The deadlines for receipt of Renewal/Resubmission/Revision (as allowed) applications are: March 16, July 16, and November 16 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on May 08, 2025.</p>","sponwebsite":null,"deadline_date":["16-Feb-2024","16-Feb-2025","16-Feb-2023","16-Oct-2024","16-Oct-2023","16-Jun-2023","16-Jun-2024"],"contact":"Christine M. Ulbricht, Ph.D.","contact_tel":"301-480-6928","contact_email":"christine.ulbricht@nih.gov"},{"synopsis":"<p><span style=\"box-sizing:border-box;color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">NIMHD invites applications to support short-term exploratory or developmental research projects&nbsp;</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">that&nbsp;</span><span style=\"box-sizing:border-box;color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">have the potential to break new ground in the fields of minority health and/or health disparities or extend previous discoveries toward new directions or applications</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">&nbsp;that can directly contribute to improving minority health and/or reducing health disparities in the U.S</span><span style=\"box-sizing:border-box;color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">.</span><br /></p>","id":"091370","spon_name":"National Institute on Minority Health and Health Disparities/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-150.html","sponsor_type":"US Federal","prog_title":"NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)","revision_date":"29-Apr-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, or through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST). Applications may be submitted on or after May 16, 2020. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2023. ","sponwebsite":null,"deadline_date":["16-Feb-2023","07-May-2023","07-Jan-2023"],"contact":null,"contact_tel":"301-402-1366","contact_email":"GrantsInfo@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This NOSI encourages applications that address dimensions of access, acceptance and uptake of CDC-recommended vaccines among infants, children, adolescents, pregnant and lactating women, and persons with disabilities, especially among populations who are underserved or experience health disparities.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"105045","spon_name":"National Institute of Child Health and Human Development/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-038.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities","revision_date":"29-Jun-2021","deadline_note":"This notice applies to due dates on or after September 8, 2021 and subsequent receipt dates through September 8, 2024.&nbsp;","sponwebsite":null,"deadline_date":["07-May-2024","16-Oct-2023","07-Sep-2023","16-Jun-2023","07-Jan-2023","16-Jun-2024","16-Feb-2024","07-Sep-2024","07-May-2023","07-Jan-2024","16-Feb-2023"],"contact":"Regina M. Bures, Ph.D.","contact_tel":"301-496-9485","contact_email":"regina.bures@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institute of Mental Health is issuing this Notice to highlight interest in research applications to optimize health communication strategies that advance HIV prevention, treatment and cure.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"102539","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"08-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-105.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment and Cure","revision_date":"17-Feb-2022","deadline_note":"his notice applies to due dates on or after&nbsp;<strong><em>April 8, 2021</em></strong>&nbsp;and subsequent receipt dates through&nbsp;<strong><em>May 8, 2024</em></strong>.","sponwebsite":null,"deadline_date":["25-Feb-2024","12-Feb-2024","12-Jun-2023","16-Feb-2023","16-Jun-2023","16-Oct-2023","07-Sep-2023","07-May-2023","25-Oct-2023","08-Apr-2023","25-Jun-2023","08-Aug-2023","08-Dec-2023","08-Dec-2022","08-Apr-2024","25-Feb-2023","12-Feb-2023","07-Jan-2023","25-Jan-2024","12-Oct-2023","05-Feb-2024","07-Jan-2024","25-Jan-2023","16-Feb-2024","05-Oct-2023","05-Feb-2023","25-Sep-2023","05-Jun-2023","25-May-2023"],"contact":"Collene Lawhorn, Ph.D.","contact_tel":"301-828-7186","contact_email":"collene.lawhorn@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The Adolescent Brain Cognitive Development (ABCD) Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function from youth starting when they are 9-10 years-old and following them longitudinally to early adulthood.&nbsp; These data will be made available to the scientific community through the NIMH Data Archive. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. More information about the ABCD Study may be found on the ABCD Study web page (<a href=\"http://www.abcdstudy.org/\" title=\"Link to Non-U.S. Government Site\">www.abcdstudy.org</a>).&nbsp;&nbsp;This FOA seeks shorter, higher-risk</span></span> ","id":"109792","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-138.html","sponsor_type":"US Federal","prog_title":"Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)","revision_date":"23-May-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 05, 2022. The deadline for receipt of optional letters of intent is&nbsp;30 days prior to the application due date.&nbsp;The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, by 5:00 PM local time of applicant organization. The deadlines for&nbsp;Renewal / Resubmission / Revision (as allowed) applications are: March 16, July 16, and November 16,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on May 08, 2025.</p>","sponwebsite":null,"deadline_date":["07-May-2025","16-Jun-2024","16-Oct-2023","07-Sep-2024","07-Sep-2023","16-Feb-2024","16-Feb-2023","07-May-2023","16-Oct-2024","07-Jan-2025","16-Feb-2025","07-Jan-2024","07-May-2024","16-Jun-2023","07-Jan-2023"],"contact":"Julia Zehr, Ph.D.","contact_tel":"301-443-1617","contact_email":"Zehrj@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to encourage applications for research on hearing health care in adults in support of improving access and affordability. Further research is needed to strengthen the evidence base with a goal of delivering better hearing health care outcomes in adults.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"102240","spon_name":"National Institute on Deafness and Other Communication Disorders/NIH/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-DC-21-001.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Hearing Healthcare for Adults: Improving Access and Affordability","revision_date":"17-Feb-2021","deadline_note":"This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through January 7, 2024&nbsp;","sponwebsite":null,"deadline_date":["05-Sep-2023","05-Jun-2023","16-Feb-2024","16-Oct-2023","07-Jan-2024","05-Feb-2024","16-Jun-2023","05-Jan-2024","05-Jan-2023","16-Jun-2024","07-Sep-2024","05-Feb-2023","07-May-2024","07-Jan-2023","07-Sep-2023","05-Jun-2024","05-Apr-2023","07-May-2023","05-Oct-2023","16-Feb-2023"],"contact":"Kelly King, Au.D, Ph.D.","contact_tel":"301-402-3458","contact_email":"kingke@nidcd.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The overall goal of this Notice of Special Interest (NOSI) is to promote mechanistic research aimed at better understanding the pathophysiology of immune-related adverse events (irAEs). It is anticipated that the mechanistic research supported through this NOSI will build the foundational knowledge which will ultimately lead to better strategies to predict, prevent and/or ameliorate toxicities that can arise as a consequence of current immunotherapeutic regimens, and improve treatment outcomes. The proposed research can be basic or translational but should be focused on revealing the mechanisms underlying irAEs. Single investigators and/or multidisciplinary teams with relevant expertise in the research area proposed and/or patient characterization and selection are encouraged to apply.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"110865","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"28-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-CA-22-063.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy","revision_date":"04-May-2022","deadline_note":"This notice applies to due dates on or after&nbsp;June 5, 2022&nbsp;and subsequent receipt dates through&nbsp;July 5, 2024.","sponwebsite":null,"deadline_date":["07-Jan-2023","07-Sep-2023","16-Jun-2024","12-Oct-2023","05-Jun-2023","26-Jan-2023","16-Oct-2023","28-Dec-2022","05-Oct-2023","05-Feb-2023","05-Feb-2024","16-Feb-2023","25-Feb-2024","25-Feb-2023","26-Sep-2023","25-Oct-2023","07-May-2024","28-Dec-2023","12-Feb-2023","26-Aug-2023","05-Jun-2024","07-Jan-2024","25-Jun-2023","07-May-2023","16-Feb-2024","26-May-2023","12-Feb-2024","12-Jun-2024","12-Jun-2023","26-Apr-2023","16-Jun-2023"],"contact":"Yin Liu, Ph.D.","contact_tel":"240-276-6251","contact_email":"liuy@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research priority. Applications submitted under this FOA are expected to propose a multi-site feasibility clinical trial to assess whether the intervention can be delivered with fidelity across sites; demonstrate feasibility of recruitment, accrual, and randomization of participants across sites; demonstrate participant adherence to the intervention, as well as retention of participants throughout the study across sites; and/or demonstrate feasibility of data collection across sites in preparation for a future fully powered, multi-site efficacy/ effectiveness trial. The need for multi-site feasibility trials is expected to be justified by sufficient preliminary data from previous single site feasibility or acceptability trial(s) or the published literature. This FOA will not support clinical trials that determine efficacy or effectiveness. The data collected should be used to fill gaps in scientific knowledge and be necessary to develop a competitive fully powered multi-site clinical trial that has the potential to make a significant impact on public health</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Prior to submitting to this FOA, applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact person for the science area of the planned application.</span></p>","id":"104709","spon_name":"National Center for Complementary and Integrative Health/NIH/DHHS","NextDeadlineDate":"21-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-241.html","sponsor_type":"US Federal","prog_title":"NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)","revision_date":"18-May-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after June 21, 2021. The deadlines for receipt of standard applications under this announcement are: July 20, 2021; October 20, 2021; February 18, 2022; June 20, 2022; October 19, 2022; February 21, 2023; June 20, 2023; October 20, 2023; and February 20, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: July 6, 2021; November 15, 2021; March 11, 2022; July 22, 2022; November 14, 2022; March 10, 2023; July 22, 2023; November 14, 2023; and March 11, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This program will expire on March 12, 2024. </p>","sponwebsite":null,"deadline_date":["21-Feb-2023","10-Mar-2023","20-Jun-2023","22-Jul-2023","20-Oct-2023","14-Nov-2023","20-Feb-2024","11-Mar-2024"],"contact":"Della White, Ph.D.","contact_tel":"301-827-6538","contact_email":"della.white@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The goal of this funding opportunity is to support early phase clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high priority research topics. This funding opportunity is intended to support feasibility clinical trials, which will provide data that are critical for the planning and design of a subsequent clinical efficacy or effectiveness study, or a pragmatic trial. The data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial, including, but not limited to the following: examining feasibility and acceptability of interventions lacking published data; adapting an intervention to a specific population; refining the intervention to determine the most appropriate frequency or duration; determining feasibility of recruitment, retention and data collection procedures; refining and assessing the feasibility of protocolized multimodal interventions; or examining acceptability and adherence of control conditions. This FOA will not support randomized clinical trials that test or determine efficacy or effectiveness; nor will this FOA support repetition of feasibility or acceptability research that has been previously conducted in the same or similar patient population with the same or similar intervention. Applications that propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial are not appropriate for this announcement. Applications must propose to conduct a feasibility clinical trial. The subsequent larger trial should have the potential to make a significant impact on public health.</span>","id":"104706","spon_name":"National Center for Complementary and Integrative Health/NIH/DHHS","NextDeadlineDate":"21-Feb-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-240.html","sponsor_type":"US Federal","prog_title":"Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)","revision_date":"15-Jun-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after June 21, 2021. The deadlines for receipt of standard applications under this announcement are: July 20, 2021; October 20, 2021; February 18, 2022; June 20, 2022; October 19, 2022; February 21, 2023; June 20, 2023; October 20, 2023; and February 20, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: July 6, 2021; November 15, 2021; March 11, 2022; July 22, 2022; November 14, 2022; March 10, 2023; July 22, 2023; November 14, 2023; and March 11, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This program will expire on March 12, 2024. </p>","sponwebsite":null,"deadline_date":["21-Feb-2023","10-Mar-2023","20-Jun-2023","22-Jul-2023","20-Oct-2023","14-Nov-2023","20-Feb-2024","11-Mar-2024"],"contact":"Peter Murray, Ph.D.","contact_tel":"301-496-4054","contact_email":"peter.murray@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses using existing human datasets in areas relevant to the National Heart, Lung, Blood Diseases and Sleep Disorders Institute (NHLBI) scientific mission. The FOA aims to stimulate the use of existing human datasets to investigate novel scientific ideas, and/or generate new models, systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. Generation of new primary data is not allowed.</span></p><s2s></s2s>","id":"114386","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"28-Feb-2023","total_funding_limit":150000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-23-036.html","sponsor_type":"US Federal","prog_title":"Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)","revision_date":"29-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 28, 2023. The deadlines for receipt of standard applications under this announcement are: February 28, 20223; October 28, 2023; February 28, 2024; October 28, 2024; February 28, 2025; and October 28, 2025, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications under this announcements are: May 8, 2023; January 8, 2024; May 7, 2024; January 7, 2025; May 7, 2025; and January 7, 2026, by 5:00 PM local time of applicant organization. This program will expire on January 8, 2026.</p>","sponwebsite":null,"deadline_date":["28-Oct-2025","28-Feb-2024","08-Jan-2024","28-Feb-2025","07-May-2025","28-Oct-2024","28-Oct-2023","28-Feb-2023","07-Jan-2026","07-May-2024","07-Jan-2025","08-May-2023"],"contact":"Ruth Kirby, RN, BS","contact_tel":"301-435-0401","contact_email":"kirbyr@nhlbi.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a part of NIDA&rsquo;s Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA&rsquo;s research portfolio. The purpose of this FOA is to support pilot or feasibility research on structural factors, organizational practices, policies, and other social, cultural, and contextual influences that lead to inequities at the intersection of HIV and substance use among underserved racial and/or ethnic minority populations affected by persistent HIV disparities. Research that addresses the multiple dimensions of individuals&rsquo; identity (e.g., race, ethnicity, gender, sexual orientation, gender identity) and social systems as they intersect with one another is encouraged.</span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"113590","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-062.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-062 --NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)","revision_date":"06-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadline for receipt of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["15-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","15-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Sheba K. Dunston, EdD","contact_tel":"301-402-1526","contact_email":"Sheba.Dunston@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA)â€¯is a part ofâ€¯NIDA&rsquo;s Racial Equity Initiative (REI).This FOA invites R01 applications to conduct research that will have a major impact in identifying, developing, implementing, or testing strategies to improve outcomes related to substance misuse, with a goal of preventing, reducing, or eliminating disparities in racial and ethnic minority populations in substance use, addiction, and related health consequences, including HIV. Community engaged research can facilitate rapid advances in this scientific area by ensuring relevant research questions with immediate applicability. As such, applications must be submitted by collaborative community partnered investigative teams who will conduct research projects that address issues prioritized by the relevant communities. No preliminary data are required. However, projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce desired outcomes.&nbsp;This FOA solicits applications from minority serving institutions (see Section III. Eligibility).</span>","id":"112875","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-032.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-032 -- NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)","revision_date":"24-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadline for receipt of all types of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["15-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","15-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Kathy Etz, PhD","contact_tel":"301-402-1749","contact_email":"ketz@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a part of NIDA&rsquo;s Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA&rsquo;s research portfolio. The purpose of this FOA is to stimulate new observational and intervention research on structural factors, organizational practices, policies, and other social, cultural, and contextual influences that lead to inequities at the intersection of HIV and substance use among underserved racial and/or ethnic minority populations affected by persistent HIV disparities. Research that addresses the multiple dimensions of individuals&rsquo; identity (e.g., race, ethnicity, gender, sexual orientation, gender identity) and social systems as they intersect with one another is encouraged.</span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span></p>","id":"112855","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-061.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-061 -- NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)","revision_date":"06-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadline for receipt of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["15-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","15-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Sheba K. Dunston, EdD","contact_tel":"301-402-1526","contact_email":"Sheba.Dunston@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a part of NIDA&rsquo;s Racial Equity Initiative (REI) and invites clinical research applications that are exploratory/developmental in nature and seek to parse the complex effects of structural racism and investigate their impact on neurocognition, with an emphasis on reducing SUD risk and informing preventative interventions.</span></p><p><strong><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This FOA solicits applications from minority serving institutions (see Section III. Eligibility).</span></strong></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span></p>","id":"112861","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":2000000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-029.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-029 -- NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)","revision_date":"10-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadline for receipt of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["15-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","15-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Vani Pariyadath, Ph.D.","contact_tel":"301-443-3209","contact_email":"vani.pariyadath@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a part of NIDA&rsquo;s Racial Equity Initiative (REI) and invites&nbsp;clinical research applications that are exploratory/developmental in nature and seek to parse the complex effects of structural racism and investigate their impact on neurocognition, with an emphasis on reducing SUD risk and informing preventative interventions.</span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"112859","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":2000000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-028.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-028 -- NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)","revision_date":"10-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadline for receipt of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["15-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","15-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Vani Pariyadath, Ph.D.","contact_tel":"301-443-3209","contact_email":"vani.pariyadath@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a part of NIDA&rsquo;s Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA&rsquo;s research portfolio. This announcement invites applications supporting independent, early career or established scholars who self-identify as health equity, health disparities, or social determinants of health experts&nbsp;with the skills to make exceptionally creative contributions to the study of equity for underserved U.S. racial and/or ethnic minority groups that experience poorer outcomes related to substance use and substance use disorders.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This award supports transformative, boundary-pushing applications that may be risky or at a stage too early to fare well in the traditional peer review process. This FOA is a limited-competition annoucement, open to institutions meeting the eligibility criteria in Section III (below). All institutions are eligible to submit applications for the companion FOA,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html\">RFA-DA-23-026</a>.</span></span></p>","id":"112862","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"15-Oct-2023 [Optional] [LOI/Pre-App]","total_funding_limit":3500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-031.html","sponsor_type":"US Federal","prog_title":"RFA-DA-23-031 -- NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional)","revision_date":"10-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 14, 2022. The deadline for receipt of optional letters of intent is 30 days prior to application due date. The deadline for receipt of full applications is November 14 annually, by 5:00 PM local time of applicant organization. This FOA will expire on November 15, 2024.</p>","sponwebsite":null,"deadline_date":["15-Oct-2023 [Optional] [LOI/Pre-App]","14-Nov-2023","15-Oct-2024 [Optional] [LOI/Pre-App]","14-Nov-2024"],"contact":"Vani Pariyadath, Ph.D.","contact_tel":"301-443-3209","contact_email":"vani.pariyadath@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) encourages applications for investigator-initiated multi-site clinical trials (e.g. efficacy, effectiveness or pragmatic trials) to study the effects of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH designated areas of high research priority. Clinical Coordinating Centers should develop and implement the proposed fully powered multi-site clinical trial. The objective of a Clinical Coordinating Center application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. Clinical Coordinating Center applications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. Clinical Coordinating Center applications submitted under this FOA will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">In addition, an accompanying Data Coordinating Center application (U24), submitted under&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-242.html\" rel=\"noreferrer\" target=\"_blank\">PAR-21-242</a>&nbsp;proposing a data analysis and data management plan for the clinical project is required. Both a Clinical Coordinating Center application and a corresponding Data Coordinating Center (DCC) application need to be submitted simultaneously for consideration by NCCIH. For additional information about the mission, strategic vision, and research priorities of the NCCIH, applicants are encouraged to consult the NCCIH website: (<a href=\"https://nccih.nih.gov/about/plans\">https://nccih.nih.gov/about/plans</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applicants are encouraged to contact the appropriate the Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this FOA.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"104713","spon_name":"National Center for Complementary and Integrative Health/NIH/DHHS","NextDeadlineDate":"21-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-243.html","sponsor_type":"US Federal","prog_title":"Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)","revision_date":"15-Jun-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after June 21, 2021. The deadlines for receipt of standard applications under this announcement are: July 20, 2021; October 20, 2021; February 18, 2022; June 20, 2022; October 19, 2022; February 21, 2023; June 20, 2023; October 20, 2023; and February 20, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: July 6, 2021; November 15, 2021; March 11, 2022; July 22, 2022; November 14, 2022; March 10, 2023; July 22, 2023; November 14, 2023; and March 11, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This program will expire on March 12, 2024. </p>","sponwebsite":null,"deadline_date":["21-Feb-2023","10-Mar-2023","20-Jun-2023","22-Jul-2023","20-Oct-2023","14-Nov-2023","20-Feb-2024","11-Mar-2024"],"contact":"Lanay Mudd, Ph.D.","contact_tel":"301-594-9346","contact_email":"lanay.mudd@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase III and beyond) application submitted under&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/par-21-243.html\">PAR-21-243</a>. The DCC application must be specific to the companion Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Trials for which this FOA applies must be relevant to the research mission of NCCIH and considered a high priority by the Center. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult NCCIH website: (<a href=\"http://www.nccih.nih.gov/\">http://www.nccih.nih.gov</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applicants are encouraged to contact the appropriate the Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this FOA</span></p>","id":"104712","spon_name":"National Center for Complementary and Integrative Health/NIH/DHHS","NextDeadlineDate":"21-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-242.html","sponsor_type":"US Federal","prog_title":"Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)","revision_date":"15-Jun-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after June 21, 2021. The deadlines for receipt of standard applications under this announcement are: July 20, 2021; October 20, 2021; February 18, 2022; June 20, 2022; October 19, 2022; February 21, 2023; June 20, 2023; October 20, 2023; and February 20, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: July 6, 2021; November 15, 2021; March 11, 2022; July 22, 2022; November 14, 2022; March 10, 2023; July 22, 2023; November 14, 2023; and March 11, 2024,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This program will expire on March 12, 2024. </p>","sponwebsite":null,"deadline_date":["21-Feb-2023","10-Mar-2023","20-Jun-2023","22-Jul-2023","20-Oct-2023","14-Nov-2023","20-Feb-2024","11-Mar-2024"],"contact":"Lanay Mudd, Ph.D.","contact_tel":"301-594-9346","contact_email":"lanay.mudd@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) encourages applications that examine mediators and moderators of disparities in AD/ADRD, using diverse cohorts of subjects.&nbsp;</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108113","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"10-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-033.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Health Disparities and Alzheimer's Disease","revision_date":"29-Dec-2021","deadline_note":"This notice applies to due dates on or after March 11, 2022 and subsequent receipt dates through November 13, 2024.","sponwebsite":null,"deadline_date":["10-Mar-2023","10-Jul-2023","13-Nov-2023","11-Mar-2024","09-Jul-2024","12-Nov-2024"],"contact":"Damali Martin, Ph.D.","contact_tel":"301-402-8310","contact_email":"martinda@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this&nbsp;Notice of Special Interest (NOSI)&nbsp;is&nbsp;toâ€¯highlight interest inâ€¯supportingâ€¯research thatâ€¯aims to promoteâ€¯health equityâ€¯in the prevention, treatment, and management ofâ€¯eye and visionâ€¯conditions. Applications that target reduction of health disparities experienced by people who areâ€¯visually&nbsp;impairedâ€¯or blindâ€¯are encouraged, as well as applications thatâ€¯investigateâ€¯the impact of bias,â€¯structural racism, andâ€¯discriminationâ€¯in causing or sustaining eye or vision health inequities.â€¯&nbsp;</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"109009","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"08-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-EY-22-004.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research Addressing Eye and Vision Health Equity/Health Disparities","revision_date":"15-Feb-2022","deadline_note":"This notice applies to due dates on or after May 25,&nbsp;2022&nbsp;and subsequent receipt dates through January 25, 2025.&nbsp;","sponwebsite":null,"deadline_date":["08-Dec-2022","05-Jan-2023","07-Jan-2023","25-Jan-2023","05-Feb-2023","16-Feb-2023","17-Feb-2023","05-Apr-2023","08-Apr-2023","07-May-2023","25-May-2023","05-Jun-2023","16-Jun-2023","08-Aug-2023","05-Sep-2023","07-Sep-2023","25-Sep-2023","05-Oct-2023","16-Oct-2023","08-Dec-2023","05-Jan-2024","07-Jan-2024","25-Jan-2024","05-Feb-2024","16-Feb-2024","05-Apr-2024","08-Apr-2024","07-May-2024","25-May-2024","05-Jun-2024","16-Jun-2024","08-Aug-2024","05-Sep-2024","07-Sep-2024","25-Sep-2024","08-Dec-2024","05-Jan-2025","07-Jan-2025","25-Jan-2025"],"contact":"Jimmy Le, Sc.D.","contact_tel":"301-435-8160","contact_email":"Jimmy.Le@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is a continuation of an NCI program to enhance the diversity of the pool of the cancer research workforce by recruiting and supporting eligible New Investigators and Early Stage Investigators from diverse backgrounds, including from groups that have been shown to be nationally underrepresented in the biomedical, behavioral, clinical and social sciences. This FOA will fund investigators to develop a larger research project grant application.</span>","id":"102905","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"14-Jun-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-061.html","sponsor_type":"US Federal","prog_title":"Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)","revision_date":"25-Feb-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 15, 2021. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: June 15, 2021; November 17, 2021; June 14, 2022; November 17, 2022; June 14, 2023; and November 17, 2023, by 5:00 PM local time of applicant organization. This program will expire on November 18, 2023.","sponwebsite":null,"deadline_date":["14-Jun-2023","17-Nov-2023"],"contact":"Mauricio Rangel-Gomez, Ph.D.","contact_tel":"240-620-0534","contact_email":"Mauricio.Rangel-Gomez@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"113621","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"15-Dec-2022","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-057.html","sponsor_type":"US Federal","prog_title":"RFA-CA-22-057 -- Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)","revision_date":"07-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 15, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date.. The deadline for receipt of full applications is December 15 annually, by 5:00 PM local time of applicant organization. This FOA will expire on December 16, 2023.</p>","sponwebsite":null,"deadline_date":["15-Dec-2022","15-Nov-2023 [Optional] [LOI/Pre-App]","15-Dec-2023"],"contact":"Elizabeth L. Read-Connole, Ph.D.","contact_tel":"240-276-6190","contact_email":"bconnole@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"113620","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"15-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-056.html","sponsor_type":"US Federal","prog_title":"RFA-CA-22-056 -- Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed)","revision_date":"07-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 15, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date.. The deadline for receipt of full applications is December 15 annually, by 5:00 PM local time of applicant organization. This FOA will expire on December 16, 2023.</p>","sponwebsite":null,"deadline_date":["15-Dec-2022","15-Nov-2023 [Optional] [LOI/Pre-App]","15-Dec-2023"],"contact":"Elizabeth L. Read-Connole, Ph.D.","contact_tel":"240-276-6190","contact_email":"bconnole@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This FOA is intended to: (1) increase our understanding of how music affects the brain when it is used therapeutically and/or (2) use that knowledge to better develop evidence-based music interventions to enhance health or treat specific diseases and disorders.</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"101369","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-100.html","sponsor_type":"US Federal","prog_title":"Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)","revision_date":"30-Nov-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">January 5, 2021</span>. The deadlines for receipt of standard applications under this announcement is February 5 annually, by 5:00 PM local time of applicant organization. This program will expire on February 6, 2023. </p>","sponwebsite":null,"deadline_date":["05-Feb-2023"],"contact":"Robert Riddle, PhD","contact_tel":"301-496-5745","contact_email":"riddler@ninds.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of the ViCTER program is to use the R01 mechanism to foster and promote early-stage transdisciplinary collaborations and/or translational research efforts to address fundamental research among basic (technology and mechanism oriented), clinical (patient-oriented) and population-based researchers in the environmental health field. The newly established collaborative teams will come together in common interest to investigate potential linkages between human health and one or more environmental stressor(s). The ViCTER program is intended to support innovative high-risk, high-reward transdisciplinary/translational research projects that are more difficult to achieve in a typical R01 application. Collaboration among investigators at different institutions through a virtual consortium arrangement is encouraged.</span>","id":"106814","spon_name":"National Institute of Environmental Health Sciences/NIH/DHHS","NextDeadlineDate":"02-Jan-2023 [Optional] [LOI/Pre-App]","total_funding_limit":1425000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-21-007.html","sponsor_type":"US Federal","prog_title":"RFA-ES-21-007 -- Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)","revision_date":"26-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 01, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadline for receipt of full applications is February 1 annually, by 5:00 PM local time of applicant organization. This FOA will expire on February 2, 2024.","sponwebsite":null,"deadline_date":["02-Jan-2023 [Optional] [LOI/Pre-App]","01-Feb-2023","02-Jan-2024 [Optional] [LOI/Pre-App]","01-Feb-2024"],"contact":"Heather Henry, Ph.D.","contact_tel":"984-287-3268","contact_email":"heather.henry@nih.gov/"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">NIMH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). See \"<a href=\"https://www.phe.gov/emergency/news/healthactions/phe/Pages/2019-nCoV.aspx\">Determination that a Public Health Emergency Exists Nationwide as the Result of the 2019 Novel Coronavirus</a>\" as renewed in \"<a href=\"https://aspr.hhs.gov/legal/PHE/Pages/COVID19-14Jan2022.aspx\">Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of Coronavirus Disease 2019 (COVID-19) Pandemic</a>\". This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through rapid acceleration of research to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions to respond to new and worsening mental illness and HIV-related outcomes among those who experience COVID-19 as well as the broader population impacted by the pandemic. All research is anticipated to focus on particularly vulnerable populations based on existing evidence of increased mental health symptoms and illness and preexisting health disparities.</span></span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"108717","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"23-Dec-2022","total_funding_limit":2250000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-112.html","sponsor_type":"US Federal","prog_title":"Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)","revision_date":"01-Feb-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after March 25, 2022. The deadlines for receipt of standard applications under this announcement are: April 25, 2022; August 25, 2022; and December 23, 2022, by 5:00 PM local time of applicant organization. This program will expire on December 24, 2022. </p>","sponwebsite":null,"deadline_date":["23-Dec-2022"],"contact":"Pim Brouwers, Ph.D.","contact_tel":"240-627-3863","contact_email":"ebrouwer@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">NIMH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). See \"<a href=\"https://www.phe.gov/emergency/news/healthactions/phe/Pages/2019-nCoV.aspx\">Determination that a Public Health Emergency Exists Nationwide as the Result of the 2019 Novel Coronavirus</a>\" as renewed in \"<a href=\"https://aspr.hhs.gov/legal/PHE/Pages/COVID19-14Jan2022.aspx\">Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of Coronavirus Disease 2019 (COVID-19) Pandemic</a>\". This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through 1) understanding mechanisms by which mental illness impacts SARS-CoV-2 morbidity and mortality, 2) exploring how COVID-19 contributes to incident mental illness or HIV-outcomes, 3) identifying modifiable targets uniquely or robustly implicated in the pandemic that are relevant to new and worsening mental illness, and 4) conducting mechanistic trials probing biological or behavioral processes of those targets that may be pursued in future mental health therapeutic development. Research is anticipated to be informed by and directed towards vulnerable populations based on evidence of preexisting and worsened health disparities.</span></span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"108721","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"23-Dec-2022","total_funding_limit":2250000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-113.html","sponsor_type":"US Federal","prog_title":"Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional)","revision_date":"01-Feb-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after March 25, 2022. The deadlines for receipt of standard applications under this announcement are: April 25, 2022; August 25, 2022; and December 23, 2022, by 5:00 PM local time of applicant organization. This program will expire on December 24, 2022. </p>","sponwebsite":null,"deadline_date":["23-Dec-2022"],"contact":"Pim Brouwers, Ph.D.","contact_tel":"240-627-3863","contact_email":"ebrouwer@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This FOA is intended to: (1) increase our understanding of how music affects the brain when it is used therapeutically and/or (2) use that knowledge to better develop evidence-based music interventions to enhance health or treat specific diseases and disorders.</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"101370","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/par-21-099.html","sponsor_type":"US Federal","prog_title":"Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional)","revision_date":"30-Nov-2021","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">January 16, 2021</span>. The deadlines for receipt of standard applications under this announcement is February 16 annually, by 5:00 PM local time of applicant organization. This program will expire on February 6, 2023. </p>","sponwebsite":null,"deadline_date":["16-Feb-2023"],"contact":"Robert Riddle, PhD","contact_tel":"301-496-5745","contact_email":"riddler@ninds.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.</span>","id":"113337","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"04-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-006.html","sponsor_type":"US Federal","prog_title":"RFA-NS-23-006 -- HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)","revision_date":"03-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after . The deadlines for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: January 4, 2023, April 4, 2023, September 4, 2023, January 4, 2024, April 4, 2024, September 4, 2024, January 3, 2025, and April 4, 2025. This program will expire on April 05, 2025.&nbsp; </p>","sponwebsite":null,"deadline_date":["04-Jan-2023","04-Apr-2023","04-Sep-2023","04-Jan-2024","04-Apr-2024","04-Sep-2024","03-Jan-2025","04-Apr-2025"],"contact":"Emily Caporello, Ph.D.","contact_tel":"301-496-1778","contact_email":"emily.caporello@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"093035","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-172.html","sponsor_type":"US Federal","prog_title":"Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)","revision_date":"09-Jul-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 4, 2020. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2023","sponwebsite":null,"deadline_date":["05-Jun-2023","05-Feb-2023","07-May-2023","07-Sep-2023","07-Jan-2023"],"contact":"Larissa AvilÃ©s-Santa, MD, MPH","contact_tel":"301-827-6924","contact_email":"avilessantal@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The goal of this funding opportunity announcement is to support a Human Pain-associated Genes &amp; Cells Data Coordination and Integration Center as part of the NIH HEAL Initiative&rsquo;s Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins, and the Nature of Human Pain (PRECISION Human Pain).The Data Coordination and Integration Center will curate, harmonize, and integrate comprehensive -omics and cellular function datasets generated by companion U19 Centers for Discovery and Functional Evaluation of Human Pain-associated Genes &amp; Cells, which include the characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain signal transduction, transmission and processing.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The Human Pain-associated Genes &amp; Cells Data Coordination and Integration Center will lead efforts to establish spatial and semantic standards for managing heterogeneous human pain-associated data types and information, collect and register multimodal human pain-associated data to common neural tissue coordinate systems, and establish a web-accessible information system that can be widely used throughout the research community. A central goal of the PRECISION Human Pain network is to generate comprehensive, integrated datasets, maps, and other resources on human genes and cellular function phenotypes underlying the heterogeneity, pathogenesis and susceptibility to specific pain conditions.</span></p>","id":"108853","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Feb-2023 [Optional] [LOI/Pre-App]","total_funding_limit":5000000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-021.html","sponsor_type":"US Federal","prog_title":"RFA-NS-22-021 -- HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)","revision_date":"13-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 17, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: March 17, 2022;  October 11, 2022; and March 9, 2023, by 5:00 PM local time of applicant organization. This FOA will expire on&nbsp;March 10, 2023.</p>","sponwebsite":null,"deadline_date":["07-Feb-2023 [Optional] [LOI/Pre-App]","09-Mar-2023"],"contact":"D.P. Mohapatra, PhD","contact_tel":"301-496-9964","contact_email":"dp.mohapatra@ni.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Notice of Special Interest is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"098071","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-MD-20-025.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities","revision_date":"25-Sep-2020","deadline_note":"<span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">This notice applies to due dates on or after October 5, 2020&nbsp;and subsequent receipt dates through May 8, 2023.&nbsp;</span>","sponwebsite":null,"deadline_date":["05-Feb-2023"],"contact":"Rada Dagher, Ph.D., M.P.H.","contact_tel":"301-451-2187","contact_email":"rada.dagher@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to support innovative multi-disciplinary and multi-level (e.g., patient, clinician, interpersonal, health care system, community) research designed to understand how optimizing patient-clinician communication and relationship affects health care outcomes in patients from populations with health care disparities. In addition, this initiative will support research to (1) gain an understanding of how the Patient-Clinician Relationship (PCR) in the primary care and chronic disease care settings affects clinical and non-clinical health outcomes in populations that experience health disparities, and (2) identify best practices and interventions that build and improve PCR leading to better health outcomes and increased health equity.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"107429","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-064.html","sponsor_type":"US Federal","prog_title":"Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)","revision_date":"07-Feb-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 05, 2022. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of Renewal / Resubmission / Revision (as allowed) applications are: March 5, July 5, and November 5 annually, by 5:00 PM local time of applicant organization. This program will expire on January 08, 2025. ","sponwebsite":null,"deadline_date":["05-Jun-2023","05-Jun-2024","05-Feb-2023","05-Feb-2024","05-Oct-2024"],"contact":"Larissa Aviles-Santa, MD, MPH","contact_tel":"301-827-6924","contact_email":"avilessantal@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This FOA will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"110336","spon_name":"National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-158.html","sponsor_type":"US Federal","prog_title":"Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)","revision_date":"08-Apr-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 05, 2022. The deadline for receipt of optional letters of intent is 30 days before application due date. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for Renewal/Resubmission/Revision applications (as allowed) are: March 5, July 5, and November 5 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on May 08, 2023. </p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["05-Feb-2023"],"contact":"Laura E. Kwako, Ph.D.","contact_tel":"301-451-8507","contact_email":"laura.kwako@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this funding opportunity announcement is to support research that uses human tissue or cells to generate comprehensive datasets for the discovery and characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain transduction, transmission, and processing. This FOA will support concerted multidisciplinary team science efforts that apply large-scale high-throughput approaches on tissues involved in human pain processing as part of the NIH HEAL Initiative&rsquo;s Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins, and the Nature of Human Pain (PRECISION Human Pain). U19 Centers will operate as a cooperative network to promote collaboration and coordination of research activities. U19 Centers will also coordinate with the U24 HEAL Initiative: Human Pain-associated Genes &amp; Cells Data Coordination and Integration Center that will curate, harmonize, and integrate datasets generated by this U19 research program.</span>","id":"108852","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Feb-2023 [Optional] [LOI/Pre-App]","total_funding_limit":7500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-018.html","sponsor_type":"US Federal","prog_title":"RFA-NS-22-018 -- HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed)","revision_date":"07-Feb-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 17, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: March 17, 2022; July 7, 2022; October 11, 1011; and March 8, 2023, by 5:00 PM local time of applicant organization.</p>","sponwebsite":null,"deadline_date":["07-Feb-2023 [Optional] [LOI/Pre-App]","09-Mar-2023"],"contact":"D.P. Mohapatra, PhD","contact_tel":"301-496-9964","contact_email":"dp.mohapatra@ni.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to stimulate novel epidemiological research to address key knowledge gaps within and between subpopulations of Asian Americans, Native Hawaiians, and Pacific Islanders. These populations are frequently aggregated in research, potentially masking important social and health differences. Given clear heterogeneity in ancestry, culture, immigration patterns among Asian Americans, socioeconomic position, and acculturation into American life, a critical need exists for epidemiological research to enhance our understanding of the interplay of environmental exposures, lifestyle, behavioral, genomics, social, neighborhood, and biological factors that impact the health of Asian American, Native Hawaiian, and Pacific Islander subpopulations.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"108001","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HL-23-001.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)","revision_date":"21-Dec-2021","deadline_note":null,"sponwebsite":null,"deadline_date":["05-Oct-2024","07-May-2024","05-Oct-2023","07-May-2023","05-Feb-2024","05-Jun-2023","07-Sep-2023","07-Jan-2024","05-Jun-2024","05-Feb-2023","07-Jan-2023","07-Sep-2024"],"contact":"Robb Rowley, MD","contact_tel":"301-827-9126","contact_email":"Robb.Rowley@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R&amp;D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see&nbsp;<a href=\"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf\">PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed.&nbsp; The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"111679","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf","sponsor_type":"US Federal","prog_title":"PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)","revision_date":"02-Nov-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. A Applications may be submitted on or after August 06, 2021. The deadlines for receipt of standard applications under this announcement are: January 5,&nbsp; April 5, and September 5 annually. by 5:00 PM local time of applicant organization. This program will expire on April 6, 2022.&nbsp;","sponwebsite":"https://grants.nih.gov/grants/guide/pa-files/PA-22-179.html","deadline_date":["05-Jan-2023","05-Apr-2023"],"contact":null,"contact_tel":"301-435-2688","contact_email":"sbir@od.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to support research that will advance the measurement and methodology of complex constructs relevant to minority health and health disparities.&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"107524","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-072.html","sponsor_type":"US Federal","prog_title":"Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)","revision_date":"14-Mar-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 05, 2022.&nbsp; The deadline for receipt of full applications is February 5 annually, by 5:00 PM local time of applicant organization.&nbsp;The deadline for receipt of Renewal / Resubmission / Revision (as allowed) applications are: March 5 annually, by 5:00 PM local time of applicant organization. This FOA will expire on May 8, 2024.","sponwebsite":null,"deadline_date":["05-Feb-2023","05-Feb-2024"],"contact":"Nancy L. Jones, PhD, MS","contact_tel":"301-594-8945","contact_email":"nancy.jones@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the participating NIH Institutes or Centers. This program is intended to support&nbsp;<a href=\"https://grants.nih.gov/policy/early-investigators/index.htm\">New Investigators</a>&nbsp;and&nbsp;<a href=\"https://nexus.od.nih.gov/all/2020/02/07/whats-happening-with-at-risk-investigators/\">At-Risk&nbsp;</a><a href=\"https://nexus.od.nih.gov/all/2020/02/07/whats-happening-with-at-risk-investigators/\">Investigators</a>&nbsp;from diverse backgrounds, including those from groups underrepresented in the health-related sciences.&nbsp;Investigators from diverse backgrounds, including those from underrepresented groups (e.g., see&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html\">NOT-OD-20-031</a>, Notice of NIH&rsquo;s Interest in Diversity), are encouraged to work with their institutions to apply for support under this program. Investigators from categories A and B are particularly encouraged to work with their institutions to apply.</span></span></p><p><br /></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><br /></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"111805","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"06-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-181.html","sponsor_type":"US Federal","prog_title":"NIDA, NIMH, NINR, and NINDS Research Opportunities for New and \"At-Risk\" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)","revision_date":"17-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 08, 2022. The deadlines for receipt of standard applications under this announcement are: September 8, 2022; January 6, 2023; May 5, 2023; September 6, 2023; January 9, 2024; May 6, 2024; September 6, 2024; January 8, 2025; and May 5, 2025, by 5:00 PM local time of applicant organization. The deadlines for Renewal/Resubmission/Revision applications (as allowed) are: October 6, 2022; February 7, 2023; June 6, 2023; October 6, 2023; February 6, 2024; June 6, 2024; October 8, 2024; February 6, 2025; and June 6, 2025, by&nbsp;5:00 PM local time of applicant organization. The AIDS application deadlines are January 7, 2023; May 7, 2023; September 7, 2023; January 7, 2024; May 7, 2024; September 7, 2024; January 7, 2025; May 7, 2025; and September 7, 2025. This program will expire on September 8, 2025. </p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["06-Jan-2023","07-Jan-2023","07-Feb-2023","05-May-2023","07-May-2023","06-Jun-2023","06-Sep-2023","07-Sep-2023","06-Oct-2023","07-Jan-2024","09-Jan-2024","06-Feb-2024","06-May-2024","07-May-2024","06-Jun-2024","06-Sep-2024","07-Sep-2024","08-Oct-2024","07-Jan-2025","08-Jan-2025","06-Feb-2025","05-May-2025","07-May-2025","06-Jun-2025","07-Sep-2025"],"contact":"Albert Avila, Ph.D.","contact_tel":"301-496-8804","contact_email":"aavila@nida.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.</span>","id":"113338","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"04-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-007.html","sponsor_type":"US Federal","prog_title":"RFA-NS-23-007 -- HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)","revision_date":"29-Sep-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after . The deadlines for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: January 4, 2023, April 4, 2023, September 4, 2023, January 4, 2024, April 4, 2024, September 4, 2024, January 3, 2025, and April 4, 2025. This program will expire on April 05, 2025.&nbsp; </p>","sponwebsite":null,"deadline_date":["04-Jan-2023","04-Apr-2023","04-Sep-2023","04-Jan-2024","04-Apr-2024","04-Sep-2024","03-Jan-2025","04-Apr-2025"],"contact":"Emily Caporello, Ph.D.","contact_tel":"301-496-1778","contact_email":"emily.caporello@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIMH Exploratory/Developmental Grant program supports exploratory and high-risk research projects that fall within the NIMH mission by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough or to the development of novel techniques, agents, methods, measures, models, or strategies, or to the generation of pilot or feasibility data. The preliminary work from these studies could lead to a major impact on biomedical, behavioral, or clinical mental health research, or on the delivery of mental health care.</span>","id":"104058","spon_name":"National Institute of Mental Health/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-21-235.html","sponsor_type":"US Federal","prog_title":"NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)","revision_date":"18-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems Applications may be submitted on or after May 16, 2021. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2024. ","sponwebsite":null,"deadline_date":["07-May-2024","07-Jan-2023","07-May-2023","16-Feb-2024","16-Feb-2023","07-Jan-2024","07-Sep-2023","16-Oct-2023","16-Jun-2023"],"contact":"Susan Koester, Ph.D.","contact_tel":"301-443-3563","contact_email":"koesters@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This FOA will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"110346","spon_name":"National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-159.html","sponsor_type":"US Federal","prog_title":"Alcohol Treatment and Recovery Research (R34 Clinical Trial Required)","revision_date":"08-Apr-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 15, 2022. The deadline for receipt of optional letters of intent is 30 days before application due date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, by 5:00 PM local time of applicant organization. The deadlines for Renewal/Resubmission/Revision applications (as allowed) are: March 5, July 5, and November 5 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on May 08, 2023. </p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["16-Feb-2023"],"contact":"Laura E. Kwako, Ph.D.","contact_tel":"301-451-8507","contact_email":"laura.kwako@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Notice of Special Interest (NOSI) is to advance research on various topics that fall within NIAAA&rsquo;s Division of Treatment and Recovery Research (DTRR). DTRR&rsquo;s research interests are wide-ranging and encompass broad categories such as health services, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for alcohol use disorder (AUD) treatment and sustaining recovery. Other areas of interest include topics focusing on special-emphasis and underserved populations, including NIH-designated U.S. health disparity populations, as well as those with co-occurring disorders; and fetal alcohol spectrum disorders (FASD). In all studies, at all levels from FASD to elderly, efforts will be made to include participants that reflect the diversity of the population at large.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"100945","spon_name":"National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AA-20-022.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Advances in Research for the Treatment, Services, and Recovery of Alcohol Use Disorder","revision_date":"30-Nov-2020","deadline_note":"This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2023.&nbsp;","sponwebsite":null,"deadline_date":["07-May-2023","07-Jan-2023","16-Feb-2023","05-Feb-2023","16-Jun-2023","07-Sep-2023","05-Jun-2023"],"contact":"Brett T. Hagman, Ph.D.","contact_tel":"301-443-0638","contact_email":"brett.hagman@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Notice is to inform potential applicants of the NIAAA&rsquo;s special interest in research project applications studying the harmful effects of alcohol on the body&rsquo;s tissues, organs, and systems in diverse populations across the lifespan.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"101458","spon_name":"National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AA-20-024.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Alcohol-induced Tissue-specific and Organ System Diseases (R01/R21/R03)","revision_date":"05-Jan-2021","deadline_note":"This notice applies to due dates on or after February 5, 2021 and subsequent receipt dates through May 8, 2023.&nbsp;","sponwebsite":null,"deadline_date":["16-Oct-2023","07-May-2024","05-Oct-2023","16-Feb-2023","05-Feb-2024","16-Jun-2023","07-Jan-2024","16-Feb-2024","07-May-2023","05-Jun-2023","07-Jan-2023","07-Sep-2023","05-Feb-2023"],"contact":"Li Lin","contact_tel":"301-827-7749","contact_email":"linli@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The Office of Disease Prevention and participating ICOs are issuing this Notice to highlight our interest in encouraging highly innovative and promising translational research to improve our understanding of how to increase and maintain health-enhancing physical activity using multi-level interventions in a wide range of population groups across the lifespan (e.g., including racial and ethnic minorities, children, older adults, persons with medical/behavioral health conditions, and persons with disabilities). This includes efficacy, effectiveness and dissemination and implementation studies. It also includes support for pilot, exploratory, or developmental work in preparation for full-scale, fully powered efficacy studies, preliminary feasibility studies, as well as expanded feasibility work for a discrete, specified, circumscribed project that is based on well-established theory, existing data and evidence-based interventions.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"103312","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-087.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being","revision_date":"07-May-2021","deadline_note":"This notice applies to due dates on or after June 5, 2021&nbsp;and subsequent receipt dates through February 16, 2024.&nbsp;","sponwebsite":null,"deadline_date":["05-Feb-2024","07-Jan-2024","05-Feb-2023","05-Jun-2023","07-Sep-2023","16-Feb-2024","07-Jan-2023","07-May-2023","16-Jun-2023","05-Oct-2023","16-Oct-2023","16-Feb-2023"],"contact":"Bramaramba Kowtha MS, RDN, LDN","contact_tel":"301-435-8052","contact_email":"bramaramba.kowtha@nih.gov"},{"synopsis":"<br /><p>National Cancer Institute (NCI) invites applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities. This FOA will use the NIH Research Project (R01) award mechanism.</p><s2s></s2s>","id":"106261","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-322.html","sponsor_type":"US Federal","prog_title":"Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) ","revision_date":"02-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 5, 2021. The sponsor will not accept letters of intent under this FOA. The deadlines for receipt of full applications are: October 5, February 5, and June 5 annually, by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["05-Feb-2023","05-Jul-2024","05-Jun-2023","05-Mar-2023","05-Mar-2024","05-Jul-2023","05-Feb-2024","05-Nov-2023","05-Jun-2024","05-Oct-2023"],"contact":"Anu Sharman, Ph.D.","contact_tel":"240-276-6250","contact_email":"sharmananu@nih.gov"},{"synopsis":"<p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">&nbsp;</span></span></p>NIOSH supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty with respect to individuals receiving monitoring and/or treatment under subtitle B, of the James Zadroga 9/11 Health and Compensation Act of 2010 (<a href=\"https://www.congress.gov/111/plaws/publ347/PLAW-111publ347.pdf\">Public Law 111&ndash;347</a>, as amended by Public Laws&nbsp;<a href=\"https://www.congress.gov/114/plaws/publ113/PLAW-114publ113.pdf\">114&ndash;113</a>&nbsp;and&nbsp;<a href=\"https://www.congress.gov/116/plaws/publ59/PLAW-116publ59.pdf\">116&ndash;59</a>). Enrolled WTC responders and certified-eligible WTC survivors will be included in the research project.<p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"113105","spon_name":"National Institute for Occupational Safety & Health/CDC/DHHS","NextDeadlineDate":"06-Dec-2022","total_funding_limit":500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-OH-23-001.html","sponsor_type":"US Federal","prog_title":"RFA-OH-23-001 -- Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) ","revision_date":"29-Aug-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 1, 2022. The deadline for receipt of optional letters of intent is November 1, 2022. The deadline for receipt of full applications is December 6, 2022,by 5:00 PM Eastern Time.","sponwebsite":null,"deadline_date":["06-Dec-2022"],"contact":"James Yiin, PhD, Scientific Program Official","contact_tel":"513-841-4271","contact_email":"JCY5@cdc.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications to participate as a Research Center as part of the&nbsp;<em>Maternal Health Research Centers of Excellence&nbsp;</em>initiative. The purpose of this initiative is to generate innovative approaches to address preventable maternal mortality, decrease severe maternal morbidity, and promote maternal health equity in partnership with one or more populations that experience maternal health disparities, including but not limited to, Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations (e.g., living in maternity care deserts), or sexual and gender minority (SGM) populations. Persons with disabilities are also a priority population.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This initiative will use an integrated multi-level approach encompassing structural, social, and biobehavioral research strategies to address the multiple contributing factors that lead to adverse maternal health outcomes and health disparities..Significant contributing factors include comorbid conditions (e.g., hypertension, diabetes, cerebrovascular disease, chronic stress, immune-mediated diseases, sleep disorders, organ-specific diseases, mental illness, and substance use disorders) and structural and social determinants of health, which include but not limited to structural racism and health care system factors.</span></p>","id":"112896","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Dec-2022","total_funding_limit":12250000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-035.html","sponsor_type":"US Federal","prog_title":"RFA-HD-23-035 -- Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional)","revision_date":"12-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 2, 2022. The deadline for receipt of optional letters of intent is November 2, 2022. The deadline for receipt of full applications is December 5, 2022, by 5:00 PM local time of applicant organization.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["05-Dec-2022"],"contact":"Nahida Chakhtoura, M.D","contact_tel":"301-435-6872","contact_email":"nahida.chakhtoura@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA) seeks applications for the Implementation Science Hub/Resource Center for the Maternal Health Research Centers of Excellence initiative. This FOA runs in parallel with companion FOAs that seek applications for Research Centers of Excellence (<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-035.html\">RFA-HD-23-035</a>) and a Data Innovation and Coordinating Hub/Resource Center (<a href=\"https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-036.html\">RFA-HD-23-036</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">It is expected that the Implementation Science Hub will serve as a resource to Research Centers, with a particular emphasis on assisting in implementing evidence-informed programs, practices and policies to improve maternal health outcomes. The Implementation Science Hub will help bridge the evidence-to-practice gap to support the development and implementation of strategies to inform integrated efforts involving policy and practice changes to improve pregnancy, perinatal, and postpartum care and advance maternal health and maternal health equity. It is also expected that the Implementation Science/Resource Hub work collaboratively with the Data Innovation and Coordination Hub/Resource Center.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"112902","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-036.html","sponsor_type":"US Federal","prog_title":"RFA-HD-23-036 -- Maternal Health Research Centers of Excellence Data Innovation and Coordinating Hub/Resource Center (U24 Clinical Trial Not Allowed)","revision_date":"12-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 2, 2022. The deadline for receipt of optional letters of intent is November 2, 2022. The deadline for receipt of full applications is December 5, 2022, by 5:00 PM local time of applicant organization.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["05-Dec-2022"],"contact":"Nahida Chakhtoura, M.D","contact_tel":"301-435-6872","contact_email":"nahida.chakhtoura@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) seeks applications for the Data Innovation and Coordinating Hub/Resource Center (hereafter referred to as &ldquo;the Innovation Hub&rdquo;) for the Maternal Health Research Centers of Excellence initiative. This FOA runs in parallel with companion FOAs that seek applications for Research Centers of Excellence (RFA-HD-23-035) and an Implementation Science Hub/Resource Center (RFA-HD-23-037).</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">It is expected that the Data Innovation Hub will provide 1) a coordination infrastructure to foster communication and collaboration for participating Research Centers and the Implementation Science Hub under the Maternal Health Centers of Excellence initiative, 2) Support data collection, facilitate data curation, and ensure high-quality data is shared with Centers of Excellence researchers and submitted to public repositories when appropriate, and 3) provide cutting edge biomedical research informatics and data science expertise to maximize data comparability and facilitate data harmonization. The Data Innovation Hub itself will not generate new experimental data, but rather will serve as a resource, analysis tools, and portal for available analytical and data tools.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"112900","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-036.html","sponsor_type":"US Federal","prog_title":"RFA-HD-23-036 -- Maternal Health Research Centers of Excellence Data Innovation and Coordinating Hub/Resource Center (U24 Clinical Trial Not Allowed)","revision_date":"12-Aug-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 2, 2022. The deadline for receipt of optional letters of intent is November 2, 2022. The deadline for receipt of full applications is December 5, 2022, by 5:00 PM local time of applicant organization.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["05-Dec-2022"],"contact":"Nahida Chakhtoura, M.D","contact_tel":"301-435-6872","contact_email":"nahida.chakhtoura@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The Clinical and Translational Science Award (CTSA) Program Collaborative and Innovative Acceleration Award (CCIA) supports synergistic activities that accelerate the translational research process through collaboration and innovation. This funding opportunity announcement (FOA) invites applications to develop, demonstrate and disseminate innovative solutions to transform the field of translational science by addressing the inefficiencies that are common across diseases and bringing more interventions to all people more quickly through collaborative science among the CTSA Program hubs, NIH Institutes, Centers, Offices (ICOs), and/or external stakeholders.</span>","id":"110997","spon_name":"National Center for Advancing Translational Sciences/NIH/DHHS","NextDeadlineDate":"15-Feb-2023","total_funding_limit":3250000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-167.html","sponsor_type":"US Federal","prog_title":"Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)","revision_date":"09-May-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after June 15, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: July 15, 2022; October 17, 2022; February 15, 2023; June 15, 2023; October 17, 2023; February 15, 2024; June 18, 2024; and October 17, 2024,&nbsp;by 5:00 PM local time of applicant organization. The program will expire on October 18, 2024.</p>","sponwebsite":null,"deadline_date":["15-Feb-2023","15-Feb-2024","15-Jun-2023","17-Oct-2023","17-Oct-2024","18-Jun-2024"],"contact":"Soju Chang, M.D., M.P.H.","contact_tel":"301-827-9206","contact_email":"soju.chang@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">NIH Institutes, Centers, and Offices participating in the&nbsp;<a href=\"https://covid19.nih.gov/news-and-stories/covid19-ripple-effects\">Social, Behavioral, and Economic Impacts of COVID-19 in Vulnerable and Health Disparity Populations initiative</a>&nbsp;are issuing this Notice of Special Interest (NOSI) to highlight interest in research to strengthen the understanding and response to the Coronavirus Disease 2019 (COVID-19) pandemic and help us prepare more effectively for future public health emergencies. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, there are additional urgent public health needs, particularly in populations who experience health disparities and in vulnerable populations. The purpose of this Notice is to 1) emphasize the roles and impacts of interventions, particularly those under the umbrella of digital health, as well as community-engaged and multi-level interventions in healthcare settings to address access, reach, delivery, engagement, effectiveness, scalability, and sustainability of services that are utilized during and following the pandemic, and 2) encourage the leveraging of existing large-scale data sources with broad population coverage to improve prediction of various mitigation efforts (including vaccinations, masking, and physical distancing to inform the public health response) on transmission reduction and on social and economic impacts, and assess the downstream health and healthcare access effects, with an emphasis on underserved and vulnerable populations. Additionally, the use of large-scale data sources to study the indirect health impacts of the pandemic and subsequent social and economic changes is needed to understand the costs and benefits of various COVID-19 mitigation strategies.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"106126","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-330.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations","revision_date":"23-Aug-2021","deadline_note":"This notice applies to due dates on or after October 5, 2021 and subsequent receipt dates through September 8, 2024.&nbsp;","sponwebsite":null,"deadline_date":["06-Feb-2024","05-Oct-2023","16-Oct-2023","15-Feb-2023","07-Sep-2023","05-Jun-2023","07-Feb-2023","05-Feb-2024","15-Feb-2024","05-Jun-2024","16-Jun-2023","07-Jan-2024","05-Feb-2023","07-May-2024","03-Oct-2023","07-May-2023","16-Feb-2024","15-Jun-2023","16-Jun-2024","06-Jun-2023","16-Feb-2023","17-Oct-2023","07-Sep-2024","07-Jan-2023"],"contact":"Adam Haim, Ph.D.","contact_tel":null,"contact_email":"haima@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The goal of this Notice of Special Interest (NOSI) is to encourage the use of existing cohorts and datasets for well-focused secondary analyses to investigate novel scientific ideas and/or address clinically related issues on: (1) aging changes&nbsp;influencing health across the lifespan (e.g., Alzheimer&rsquo;s disease and Alzheimer's disease-related dementias (AD/ADRD)), (2) diseases and disabilities in older persons, and/or (3) the changes in basic biology of aging that underlie these impacts on health (the hallmarks of aging). Activities of high priority include those addressing specific hypotheses in basic biological research, clinical aging research, behavioral or social research, and/or translational geroscience to inform: the design and implementation of future epidemiologic or human intervention studies; interventions in animal models of aging; research on behavioral and social factors over the life course that influence health (e.g., early life adversity); current geriatric practice in maintenance of health, disease management, and prevention of disability; or research testing of possible causal relationships between rates of aging and findings extracted by secondary analysis of the existing data. Existing datasets may also be used to develop and test new mathematical modeling and statistical analytical approaches. Analyses of sex and/or gender differences across health disparity groups (e.g., racial and ethnic groups, socioeconomic status, and sexual and gender minorities) are of high relevance. Use of cohorts that are linked to electronic health record systems and/or Centers for Medicare and Medicaid Services (CMS) administrative data are especially welcome.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Applicants responding to this NOSI are strongly encouraged to describe plans for rapid sharing of data and results as well as innovative data analytics approaches (see Goal 3,&nbsp;<a href=\"http://datascience.nih.gov/strategicplan\" target=\"_blank\"><em>NIH Strategic Plan For Data Science</em></a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Please note that applications proposing exploratory or developmental projects should consider using&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/pa-20-195.html\">PA-20-195</a>, whereas projects that already have sufficient preliminary data or a very strong and well-developed scientific premise should use&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PA-20-185.html\">PA-20-185</a>.</span></span></p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"106131","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-020.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research","revision_date":"30-Nov-2021","deadline_note":"This Notice applies to due dates on or after October 5, 2021 and subsequent receipt dates through May 08, 2023.","sponwebsite":null,"deadline_date":["07-Jan-2023","16-Feb-2023","05-Feb-2023","07-May-2023"],"contact":"Rosaly Correa-de-Araujo, MD, MSc, Ph.D.","contact_tel":"301-496-6762","contact_email":"rosaly.correa-de-Araujo@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.&nbsp; The overarching goal of this ORWH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation&rsquo;s diverse biomedical, behavioral and clinical research needs.&nbsp;&nbsp;&nbsp;&nbsp;</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"><strong><em>Courses for Skills Development</em></strong>&nbsp;and&nbsp;</span></span></li><li><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"><strong><em>Curriculum or Methods Development</em></strong>.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></span></li></ul>","id":"112451","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"28-Dec-2022 [Optional] [LOI/Pre-App]","total_funding_limit":600000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-015.html","sponsor_type":"US Federal","prog_title":"RFA-OD-22-015 -- Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)","revision_date":"24-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 27, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full non-AIDS applications are: October 27, 2022; and June 27, 2023, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS and AIDS-related applications are: January 7, 2023; and September 7, 2023,&nbsp;by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2023.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["27-Jun-2023","07-Sep-2023","28-Dec-2022 [Optional] [LOI/Pre-App]","07-Jan-2023","08-Aug-2023 [Optional] [LOI/Pre-App]","28-May-2023 [Optional] [LOI/Pre-App]"],"contact":"Elizabeth Barr, Ph.D.","contact_tel":"301-402-7895","contact_email":"elizabeth.barr@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV. Primary data collection is not allowed for applications in response to this FOA.</span>","id":"108341","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"07-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-038.html","sponsor_type":"US Federal","prog_title":"Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)","revision_date":"11-Jan-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 04, 2022. The deadlines for receipt of standard applications under this announcement are: March 4, 2022; August 5, 2022; November 15, 2022; March 7, 2023; August 9, 2023; November 15, 2023; March 4, 2024; August 5, 2024; and November 15, 2024, by 5:00 PM local time of applicant organization.&nbsp; This program will expire on November 16, 2024.</p>","sponwebsite":null,"deadline_date":["07-Mar-2023","09-Aug-2023","15-Nov-2023","04-Mar-2024","05-Aug-2024","15-Nov-2024"],"contact":"Marsha F. Lopez, Ph.D., M.H.S.","contact_tel":"301-443-6504","contact_email":"marsha.lopez@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV.&nbsp;Primary data collection is not allowed for applications in response to this FOA.</span>","id":"108340","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"07-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-037.html","sponsor_type":"US Federal","prog_title":"RFA-DA-22-037 -- Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)","revision_date":"11-Jan-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 04, 2022. The deadlines for receipt of standard applications under this announcement are: March 4, 2022; August 5, 2022; November 15, 2022; March 7, 2023; August 9, 2023; November 15, 2023; March 4, 2024; August 5, 2024; and November 15, 2024, by 5:00 PM local time of applicant organization.&nbsp; This program will expire on November 16, 2024.</p>","sponwebsite":null,"deadline_date":["07-Mar-2023","09-Aug-2023","15-Nov-2023","04-Mar-2024","05-Aug-2024","15-Nov-2024"],"contact":"Marsha F. Lopez, Ph.D., M.H.S.","contact_tel":"301-443-6504","contact_email":"marsha.lopez@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This FOA utilizes NIH&rsquo;s R61/R33 Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Through this award, investigators will endeavor to develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.</span></p><p><span style=\"font-size:small;font-family:Verdana, Geneva, sans-serif;\"></span></p><span style=\"font-size:small;font-family:Arial, Helvetica, sans-serif;\"></span><br /><span style=\"color:#333333;font-family:Arial, Helvetica, sans-serif;font-size:medium;line-height:19.4286px;background-color:#ffffff;\"></span>","id":"114327","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"03-Jul-2023","total_funding_limit":2499995,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-23-053.html","sponsor_type":"US Federal","prog_title":"Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)","revision_date":"22-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after June 02, 2023. The deadlines for receipt of standard applications under this announcement are: July 3, 2023; November 2, 2023; July 2, 2024; November 4, 2024; July 2, 2025; and November 3, 2025, by 5:00 PM local time of applicant organization. The deadlines for receipt of&nbsp;Renewal / Resubmission / Revision (as allowed) applications are: August 2, 2023; December 4, 2023; August 2, 2024; December 2, 2024; August 4, 2025; and December 2, 2025,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This program will expire on December 03, 2025.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["03-Jul-2023","02-Nov-2023","02-Jul-2024","04-Nov-2024","02-Jul-2025","03-Nov-2025"],"contact":"Dr. Sanoj Suneja","contact_tel":"301-402-7710","contact_email":"sunejas@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications that propose to support advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA utilizes NIH&rsquo;s&nbsp;<a href=\"https://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr=r33&amp;Search.x=0&amp;Search.y=0&amp;Search_Type=Activity\">R33</a>&nbsp;Exploratory/Developmental Grants Phase II activity code to provide support for expanded activities. Applicants are expected to&nbsp;have an existing research infrastructure developed with other NIH or non-NIH support.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Through this award, investigators will endeavor to develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.</span></p><p><span style=\"font-size:small;font-family:Verdana, Geneva, sans-serif;\">&nbsp;</span></p><span style=\"font-size:small;font-family:Arial, Helvetica, sans-serif;\"></span><br /><span style=\"color:#333333;font-family:Arial, Helvetica, sans-serif;font-size:medium;line-height:19.4286px;background-color:#ffffff;\"></span>","id":"114328","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"03-Jul-2023","total_funding_limit":2499995,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html","sponsor_type":"US Federal","prog_title":"Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)","revision_date":"22-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after June 02, 2023. The deadlines for receipt of standard applications under this announcement are: July 3, 2023; November 2, 2023; July 2, 2024; November 4, 2024; July 2, 2025; and November 3, 2025, by 5:00 PM local time of applicant organization. The deadlines for receipt of&nbsp;Renewal / Resubmission / Revision (as allowed) applications are: August 2, 2023; December 4, 2023; August 2, 2024; December 2, 2024; August 4, 2025; and December 2, 2025,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This program will expire on December 03, 2025.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":["03-Jul-2023","02-Nov-2023","02-Jul-2024","04-Nov-2024","02-Jul-2025","03-Nov-2025"],"contact":"Dr. Sanoj Suneja","contact_tel":"301-402-7710","contact_email":"sunejas@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this Notice of Special Interest (NOSI) to encourage applications proposing to test multilevel strategies and interventions to improve the uptake of evidence-based screening services across the lifespan and in populations including, but not limited to, those experiencing health disparities and those that are underserved. Studies addressing efficacy, effectiveness, dissemination and implementation research, as well as studies seeking to understand and address barriers to screening are encouraged.&nbsp;</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"112420","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-178.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan","revision_date":"15-Jul-2022","deadline_note":"This NOSI applies to due dates on or after October 4, 2022, and subsequent receipt dates through May 8, 2025.","sponwebsite":null,"deadline_date":["07-Jan-2023","05-Feb-2023","07-Feb-2023","15-Feb-2023","16-Feb-2023","17-Feb-2023","07-Mar-2023","07-May-2023","05-Jun-2023","06-Jun-2023","07-Jun-2023","15-Jun-2023","16-Jun-2023","19-Jun-2023","07-Sep-2023","03-Oct-2023","05-Oct-2023","09-Oct-2023","16-Oct-2023","17-Oct-2023","05-Nov-2023","07-Jan-2024","05-Feb-2024","06-Feb-2024","15-Feb-2024","16-Feb-2024","07-Mar-2024","07-May-2024","05-Jun-2024","07-Jun-2024","16-Jun-2024","07-Sep-2024","05-Oct-2024","08-Oct-2024","16-Oct-2024","07-Jan-2025","05-Feb-2025","16-Feb-2025","07-May-2025"],"contact":"Melissa C. Green Parker, PhD","contact_tel":"301-480-1161","contact_email":"melissa.greenparker@nih.gov"},{"synopsis":"<span style=\"color:#333333;background-color:#ffffff;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) solicits grant applications to further develop enabling technologies and transformative platforms to catalyze next-generation predictive, diagnostic and therapeutic products to address heart, lung, blood, and sleep (HLBS)-related disorders and diseases. This FOA solicits R33 applications where major feasibility gaps for the enabling technology or transformative platform have already been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage downstream demonstration, utilization and adoption. Well-suited applications must offer the potential to accelerate and/or transform the areas of early detection and screening, model development, clinical diagnosis, treatment, control, prevention or epidemiology, while addressing issues associated with HLBS-related diseases and disorders. Projects proposing application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not appropriate for this solicitation. Applications considered nonresponsive to the FOA will not be reviewed.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This FOA is part of a suite of&nbsp;<a href=\"https://nhlbicatalyze.org/about\" title=\"Link to Non-U.S. Government Site\">Catalyze</a>&nbsp;innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Product Definition or Preclinical FOAs.</span></span></p>","id":"108574","spon_name":"National Heart, Lung, and Blood Institute/NIH/DHHS","NextDeadlineDate":"21-Dec-2022","total_funding_limit":600000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-010.html","sponsor_type":"US Federal","prog_title":"RFA-HL-23-010 -- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)","revision_date":"25-Mar-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 21, 2022. The deadline for receipt of optional letters of intent is <span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">30 days prior to the application due date</span>. The deadlines for receipt of full applications are: March 21, 2022; July 21, 2022; November 21, 2022; February 2, 2023; July 21, 2023; November 21, 2023; February 21, 2024; July 22, 2024; and November 21, 2024, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS application are: April 18, 2022; August 18, 2022; December 21, 2022; April 18, 2023; August 18, 2023; December 21, 2023; April 18, 2024; August 19, 2024; and December 20, 2024, by 5:00 PM local time of applicant organization. This program expires December 21, 2024.</p>","sponwebsite":null,"deadline_date":["21-Nov-2024","21-Dec-2022","18-Apr-2024","21-Feb-2023","21-Dec-2023","19-Aug-2024","21-Feb-2024","18-Apr-2023","20-Dec-2024","18-Aug-2023","21-Jul-2023","22-Jul-2024","21-Nov-2023"],"contact":"Mike Pieck, Ph.D.","contact_tel":"301-827-7986","contact_email":"nhlbi_catalyze@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to encourage applications in high-priority research areas related to pediatric health care transition for youth with chronic physical/medical conditions or intellectual/developmental disabilities. Research applications that will advance our understanding of promising practices designed to facilitate successful health care transitions (HCT) from pediatric to adult care settings as well as barriers and facilitators to such transition are encouraged. The ultimate goal is to improve care quality and patient and family outcomes during and after HCT.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"104865","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-027.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition","revision_date":"14-Jul-2021","deadline_note":"This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through January 8, 2024.&nbsp;","sponwebsite":null,"deadline_date":["07-Sep-2023","16-Jun-2023","07-May-2023","07-Jan-2023","07-Mar-2023","05-Oct-2023","07-Jan-2024","05-Feb-2023","05-Jun-2023","16-Feb-2023","05-Nov-2023","16-Oct-2023"],"contact":"Sonia Lee, PhD","contact_tel":"301-594-4783","contact_email":"leesonia@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The Office of Disease Prevention and participating ICOs are issuing this Notice to communicate our interest in research on electronic nicotine delivery systems (ENDS). Research on alternative nicotine and tobacco delivery systems [e.g., heated tobacco products (also called heat-not-burn)] will also be considered. Research with a focus on other non-combustible nicotine and tobacco products will be considered on a case-by-case basis. Studies should examine population-based, clinical, and applied prevention of disease, including etiology and epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations. Studies exclusively examining smokeless tobacco or combustible tobacco products (e.g., cigarettes, cigars) will be considered non-responsive.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"107763","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-023.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects","revision_date":"09-Dec-2021","deadline_note":"This notice applies to due dates on or after December 2, 2021 and subsequent receipt dates through May 09, 2024.","sponwebsite":null,"deadline_date":["07-May-2023","05-Oct-2023","07-Jan-2023","16-Oct-2023","10-Mar-2023","05-Feb-2023","16-Feb-2023","07-May-2024","05-Jun-2023","07-Jan-2024","16-Feb-2024","16-Jun-2023","07-Mar-2024","05-Nov-2023","05-Feb-2024","07-Mar-2023"],"contact":"Rachel Grana Mayne, PhD, MPH","contact_tel":"240-276-5899","contact_email":"rachel.mayne@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Notice of Special Interest (NOSI) is to stimulate dissemination and implementation research to support innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based preventive interventions to support children&rsquo;s mental, emotional, and behavioral (MEB) health in school settings. This NOSI encourages applications which focus on dissemination and implementation research to deliver interventions in the school setting that will promote healthy MEB development and/or prevent MEB disorders. Applications should include a focus on one of the following: (1) primary/universal prevention MEB programs designed to promote healthy MEB development by decreasing risk factors and increasing protective factors to prevent onset of an MEB disorder; or (2) secondary/selective prevention programs designed to support screening and early identification of MEB disorders to slow progression with early intervention. Applications focused on tertiary/indicated treatment of MEB disorders will be considered non-responsive to this Notice.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"110102","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AT-22-004.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI):  Dissemination and Implementation Research to Advance Mental, Emotional, and Behavioral Health Preventive Interventions in School Settings","revision_date":"30-Mar-2022","deadline_note":"This notice applies to due dates on or after June 5th, 2022 and subsequent receipt dates through June 5, 2024.","sponwebsite":null,"deadline_date":["07-Jan-2023","05-Feb-2023","15-Feb-2023","16-Feb-2023","17-Feb-2023","07-May-2023","05-Jun-2023","15-Jun-2023","16-Jun-2023","07-Sep-2023","05-Oct-2023","16-Oct-2023","17-Oct-2023","07-Jan-2024","05-Feb-2024","15-Feb-2024","16-Feb-2024","07-May-2024","05-Jun-2024"],"contact":"Beda Jean-Francois, Ph.D.","contact_tel":"202-313-2144","contact_email":"Beda.Jean-Francois@nih.gov"},{"synopsis":"<br /><p>National Cancer Institute (NCI) invites applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.&nbsp;</p><s2s></s2s>","id":"106264","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":400000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-323.html","sponsor_type":"US Federal","prog_title":"Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) ","revision_date":"02-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 16, 2021. The sponsor will not accept letters of intent under this FOA. The deadlines for receipt of full applications are: October 16, February 16, and June 16 annually, by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["16-Mar-2024","16-Mar-2023","16-Jul-2023","16-Jul-2024","16-Feb-2023","16-Oct-2023","16-Nov-2023","16-Jun-2023","16-Feb-2024","16-Jun-2024"],"contact":"Anu Sharman, Ph.D.","contact_tel":"240-276-6250","contact_email":"sharmananu@nih.gov"},{"synopsis":"<br /><p>This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These small research grants (R03) will support projects on cancer health disparities that can be carried out in a short period of time with limited resources. The projects should propose innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses.&nbsp;</p><s2s></s2s>","id":"106265","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":100000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-324.html","sponsor_type":"US Federal","prog_title":"Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) ","revision_date":"02-Sep-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 16, 2021. The sponsor will not accept letters of intent under this FOA. The deadlines for receipt of full applications are: October 16, February 16, and June 16 annually, by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2024.","sponwebsite":null,"deadline_date":["16-Oct-2023","16-Nov-2023","16-Jun-2024","16-Feb-2024","16-Mar-2023","16-Mar-2024","16-Feb-2023","16-Jul-2023","16-Jul-2024","16-Jun-2023"],"contact":"Anu Sharman, Ph.D.","contact_tel":"240-276-6250","contact_email":"sharmananu@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) encourages research grant applications focused on palliative care in geriatric populations. This NOSI covers studies in a variety of settings including hospitals (and specific sites within hospitals including specialty medical or surgical wards, intensive care units, and emergency departments), post-acute care settings, outpatient clinics and doctors' offices, patients' homes and other residential settings, long-term care facilities, hospices, and other healthcare or community settings. This NOSI encourages both prospective studies and analyses of existing datasets, health and medical records, claims data, or other sources. Leveraging ongoing cohorts, intervention studies, networks, data and specimen repositories, and other existing research resources and infrastructure is encouraged. Study designs may include observational approaches, quasi-experimental designs, and interventional studies.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"114481","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"16-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-AG-22-048.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Advancing the Science of Geriatric Palliative Care ","revision_date":"02-Dec-2022","deadline_note":"This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2023. The first available due date is February 16, 2023.","sponwebsite":null,"deadline_date":["10-Mar-2023","07-Sep-2023","16-Feb-2023","05-Jun-2023","10-Jul-2023","16-Jun-2023","07-May-2023"],"contact":"Basil Eldadah, M.D., Ph.D.","contact_tel":"301-496-6761","contact_email":"eldadahb@nia.nih.gov"},{"synopsis":"<br /><p>The purpose of this funding opportunity announcement (FOA) is to support developmental/exploratory studies in preparation for health promotion, disease prevention, treatment, or treatment services research to improve health in Native American (NA) populations.&nbsp; Applications may include 1) etiologic research, where there is a significant gap in knowledge, that will directly inform intervention development or adaptations, 2) research to develop and pilot test new or adapted interventions for feasibility, acceptability, and scalability, 3) research to test the short-term efficacy of interventions, 4) where a sufficient body of knowledge on intervention efficacy exists, research on strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions.</p>","id":"098154","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"17-Apr-2023 [Optional] [LOI/Pre-App]","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-214.html","sponsor_type":"US Federal","prog_title":"Research to Improve Native American Health (R21 Clinical Trials Optional)","revision_date":"25-May-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 17, 2021. The deadline for receipt of optional letters of intent is 30 days before the application due date. The deadline for receipt of standard full applications is May 17, 2021; 2022; and 2023. AIDS Application Due Date(s): September 7, 2021, September 7, 2022, September 7, 2023, by 5:00 PM local time of applicant organization.This FOA will expire on September 8, 2023.","sponwebsite":null,"deadline_date":["07-Sep-2023","17-May-2023","17-Apr-2023 [Optional] [LOI/Pre-App]"],"contact":"Shobha Srinivasan, Ph.D.","contact_tel":"240-276-6938","contact_email":"ss688k@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This initiative will support innovative, collaborative, and multi-disciplinary research designed to study the effective adaptation, integration, and implementation of recommended guidelines of care of persons with multiple chronic conditions (MCCs) from populations that experience health disparities. Projects would be expected to involve more than one component and/or more than one level of influence within existing or newly proposed health care models. The goal of this initiative is attainment of optimal treatment and health outcomes goals to advance health care towards health equity.&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"108364","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-092.html","sponsor_type":"US Federal","prog_title":"Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional)","revision_date":"12-Jan-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after . The deadlines for receipt of standard applications under this announcement are: March 18, 2022, and then standard dates of February 5, and June 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2024. </p>","sponwebsite":null,"deadline_date":["07-Sep-2023","05-Feb-2024","05-Feb-2023","05-Jun-2023","07-May-2023","05-Jun-2024","07-May-2024","07-Sep-2024"],"contact":"Larissa AvilÃ©s-Santa, MD, MPH","contact_tel":"301-827-6924","contact_email":"avilessantal@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This funding opportunity announcement (FOA) invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of projects submitted under this FOA include mechanistic studies that are classified as clinical trials. Mechanistic studies are defined as studies with the objective to understand the mechanism(s) of action of an intervention, a biological or behavioral process, or the pathophysiology of a disease/condition. See&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-AT-20-001.html\">NOT-AT-20-001</a>&nbsp;and&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-AT-20-006.html\">NOT-MH-19-006</a>&nbsp;for examples of clinical trials that are/are not considered mechanistic studies. Clinical trials that propose to influence a clinical outcome, test safety or feasibility of an intervention, demonstrate the clinical efficacy or effectiveness of an intervention, or analyze the effect size of an intervention on clinical outcomes are ineligible for this FOA. Types of studies that should submit under this FOA include clinical trials that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Researchers proposing basic science experimental studies involving human participants should consider this FOA&rsquo;s companion for basic experimental studies with humans,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-349.html\">PAR-21-349</a>, &ldquo;Research on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required).&rdquo; Applications proposing studies that include, but are not limited to, model animal research or observational studies involving humans should submit under the companion FOA,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-350.html\">PAR-21-350</a>, \"Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed).</span></span>","id":"106790","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"21-Jun-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-352.html","sponsor_type":"US Federal","prog_title":"Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required)","revision_date":"06-Oct-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 21, 2022. The deadline for receipt of standard applications under this announcement is June 21 annually, by 5 p.m. local time of the applicant organization. This program will expire on June 22, 2024.","sponwebsite":null,"deadline_date":["21-Jun-2023","21-Jun-2024"],"contact":"William Elwood, PhD","contact_tel":"301-402-0116","contact_email":"william.elwood@nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications from investigators who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of basic psychological processes, sociological processes, and/or biomedical pathways&mdash;expertise that is beyond and enhances their current areas of expertise. The program will support career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct independent research projects that more thoroughly investigate interrelationships among behavioral, biological, endocrine, epigenetic, immune, inflammatory, neurological, psychological, and/or social processes. Eligible candidates are independent investigators at mid-career faculty rank or level.</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Applicants may propose research career development projects that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena (see,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-212.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">NOT-OD-18-212</a>). These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind.Applicants who plan to gain research experience within an existing clinical trial or basic experimental study with humans led by another investigator, or who propose to gain research experience in purely basic human or model animal research, or in data sciences, must apply to companion FOA, PAR--20-211,Independent Clinical Trials Not Allowed.</span></span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement is for basic science experimental studies involving humans, referred to in<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-212.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">NOT-OD-18-212</a>as &ldquo;prospective basic science studies involving human participants.&rdquo; These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind.</span></span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"095519","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"17-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-226.html","sponsor_type":"US Federal","prog_title":"Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)","revision_date":"05-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 16, 2021. The deadline for receipt of standard applications under this announcement is March 17 annually, by &nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on March 18, 2023.&nbsp;","sponwebsite":null,"deadline_date":["17-Mar-2023"],"contact":"William Elwood, PhD","contact_tel":"301-402-0116","contact_email":"william.elwood@nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications from investigators who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of basic psychological processes, sociological processes, and/or biomedical pathways&mdash;expertise that is beyond and enhances their current areas of expertise. The program will support career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct independent research projects that more thoroughly investigate interrelationships among behavioral, biological, endocrine, epigenetic, immune, inflammatory, neurological, psychological, and/or social processes. Applicants may propose research that involves non-human animals, secondary data analyses, or other career development projects that do not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants are permitted to propose research experience within a clinical trial led by a mentor or co-mentor. Eligible candidates are independent investigators at mid-career faculty rank or level.</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study,or an ancillary study to a clinical trial.Applicants proposing Basic Experimental Studies with Humans (BESH) should apply to the companion FOA PAR-20-226. .</span></p>","id":"095511","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"17-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-211.html","sponsor_type":"US Federal","prog_title":"Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)","revision_date":"04-Nov-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 16, 2021. The deadline for receipt of standard applications under this announcement is March 17 annually, by &nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on March 18, 2023.&nbsp;","sponwebsite":null,"deadline_date":["17-Mar-2023"],"contact":"William Elwood, PhD","contact_tel":"301-402-0116","contact_email":"william.elwood@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, interventions, methodologies, models, or applications that could have a major impact on a field of cancer research (e.g. epidemiologic, biomedical, behavioral, health care delivery or clinical).</span><br /></p>","id":"106892","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"07-Jun-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-341.html","sponsor_type":"US Federal","prog_title":"Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)","revision_date":"07-Jul-2022","deadline_note":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after </span>May 07, 2022<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. The deadlines for receipt of applications under this announcement are: </span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">June 7; October 7, 2022; June 7, 2023; October 9, 2023; June 7, 2024; and October 8, 2024, by 5:00 PM local time of applicant organization.&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This program will expire on </span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">October 9, 2024.</span>","sponwebsite":null,"deadline_date":["09-Oct-2023","07-Jun-2024","08-Oct-2024","07-Jun-2023"],"contact":"Mukesh Verma, Ph.D.","contact_tel":"240-276-6889","contact_email":"vermam@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This funding opportunity announcement (FOA) seeks to support research that examines the impact of leveraging health information technology (health IT) to reduce disparities in access to and utilization of health care services, patient-clinician communication, and health outcomes for populations that experience health disparities in the U.S.</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"110112","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-145.html","sponsor_type":"US Federal","prog_title":"Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)","revision_date":"31-Mar-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 05, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of Renewal/Resubmission/Revision (as allowed) applications are: March 5, Junly5, and November 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on May 08, 2025.","sponwebsite":null,"deadline_date":["05-Jun-2024","05-Oct-2023","07-Sep-2023","07-Jan-2024","05-Oct-2024","07-Jan-2025","07-May-2025","07-Jan-2023","07-May-2023","05-Feb-2023","07-Sep-2024","05-Feb-2025","07-May-2024","05-Jun-2023","05-Feb-2024"],"contact":"Yewande A. Oladeinde, Ph.D.","contact_tel":"301-402-4307","contact_email":"beda.jean-francois@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this initiative is to advance the science of minority health and health disparities by supporting research&nbsp;on family health and well-being and resilience. The NIMHD Research Framework recognizes family health, family well-being, and family resilience as critically important areas of research to decrease disparities and promote equity.&nbsp;</span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"107841","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-358.html","sponsor_type":"US Federal","prog_title":"Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)","revision_date":"07-Feb-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 05, 2022. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by 5:00 PM local time of applicant organization. The deadlines for Renewal/Resubmission/Revision applications (as allowed) are: March 5, July 5, and November 5 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on May 08, 2025.</p>","sponwebsite":null,"deadline_date":["07-Sep-2023","05-Feb-2024","05-Oct-2024","05-Jun-2024","07-May-2023","05-Feb-2023","07-Sep-2024","07-Jan-2025","07-Jan-2024","07-Jan-2023","07-May-2025","07-May-2024","05-Jun-2023","05-Feb-2025"],"contact":"Deborah E. Linares, PhD, MA","contact_tel":"301-402-2516","contact_email":"Deborah.Linares@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R&amp;D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see&nbsp;<a href=\"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf\">PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Parent Funding Opportunity Announcement does not accept clinical trials.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"111677","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf","sponsor_type":"US Federal","prog_title":"PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)","revision_date":"02-Nov-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. A Applications may be submitted on or after August 05, 2022. The deadlines for receipt of standard applications under this announcement are: January 5,&nbsp; April 5, and September 5 annually. by 5:00 PM local time of applicant organization. This program will expire on April 6, 2023.&nbsp;","sponwebsite":"https://grants.nih.gov/grants/guide/pa-files/PA-22-178.html","deadline_date":["05-Jan-2023","05-Apr-2023"],"contact":null,"contact_tel":"301-435-2688","contact_email":"SEEDinfo@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research.&nbsp; These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.</span>","id":"097475","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"17-Feb-2023","total_funding_limit":100000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-257.html","sponsor_type":"US Federal","prog_title":"Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)","revision_date":"27-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems.The open date (earliest submission date) is September 5, 2017. The deadlines for receipt of standard R01 applications under this announcement are: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, and June 19 2023, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on July 20, 2023.","sponwebsite":null,"deadline_date":["19-Jun-2023","17-Feb-2023"],"contact":"Joy Boyer","contact_tel":"301-402-4997","contact_email":"boyerj@mail.nih.gov"},{"synopsis":"<p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The goal of this FOA is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects should align with NIDA funding priorities detailed here (</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://www.drugabuse.gov/funding/funding-priorities\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">https://www.drugabuse.gov/funding/funding-priorities</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">) or within the NIDA Strategic Plan (</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">). This award will facilitate the entry of promising new investigators into the field of substance use/substance use disorder (SU(D) research, enhancing the pool of highly talented SU(D) researchers. Applications are particularly encouraged from those who can contribute to diversifying the research workforce as described in the Notice of NIH's Interest in Diversity (</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">NOT-OD-20-031</a></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">).</span></p><s2s></s2s>","id":"094123","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":100000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-208.html","sponsor_type":"US Federal","prog_title":"Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional)","revision_date":"09-Jul-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 16, 2020. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2023.","sponwebsite":null,"deadline_date":["07-May-2023","16-Feb-2023","07-Jan-2023"],"contact":"Aria Crump, Sc.D.","contact_tel":"301-435-0881","contact_email":"acrump@nida.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this funding opportunity is to provide an avenue for researchers to pursue funding to conduct research addressing these and other emerging and existing COVID-related issues among pregnant and lactating people, infants, children and adolescents, and individuals with physical and/or intellectual disabilities.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"110057","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-22-002.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities","revision_date":"29-Mar-2022","deadline_note":"This notice applies to due dates on or after June 5, 2022 and subsequent receipt dates through June 6, 2024.","sponwebsite":null,"deadline_date":["07-May-2023","07-Jan-2024","07-Jan-2023","05-Jun-2023","05-Jun-2024","16-Feb-2024","16-Jun-2023","05-Feb-2023","07-May-2024","05-Feb-2024","07-Sep-2023","05-Oct-2023","16-Oct-2023","16-Feb-2023"],"contact":"Robert Tamburro, MD, MSc","contact_tel":"301-480-2619","contact_email":"robert.tamburro@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this NOSI is to encourage research on the efficacy of interventions that address nutrition security and the mechanisms of food insecurity on a variety of health outcomes.&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">It also calls for the development of new measures for nutrition security and assessment of food insecurity that are broadly applicable. . It was developed by the&nbsp;<a href=\"https://dpcpsi.nih.gov/onr\">Office of Nutrition Research</a>&nbsp;(ONR) Implementation Working Group on&nbsp;<a href=\"https://dpcpsi.nih.gov/onr/iwg/nutrition-health-disparities\">Nutrition and Health Disparities</a>&nbsp;in collaboration with NIH Institutes and Centers (ICs) and Offices in support of the goals and objectives of the&nbsp;<a href=\"https://dpcpsi.nih.gov/onr/strategic-plan\">Strategic Plan for NIH Nutrition Research</a>.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"111986","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"09-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-135.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity","revision_date":"22-Jun-2022","deadline_note":"This notice applies to due dates on or after October 5, 2022 and subsequent receipt dates through November 29, 2024.","sponwebsite":null,"deadline_date":["03-Oct-2023","07-Feb-2023","15-Feb-2024","05-Feb-2024","03-Nov-2023","11-Dec-2023","16-Feb-2023","16-Jun-2024","07-Sep-2023","05-Feb-2023","09-Dec-2022","05-Jun-2023","08-Mar-2023","07-Jan-2023","07-Mar-2023","16-Oct-2023","15-Apr-2023","15-Jun-2023","05-Oct-2024","07-May-2023","05-Oct-2023","06-Feb-2024","17-Oct-2023","15-Feb-2023","06-Jun-2023","05-Jun-2024","07-May-2024","07-Jan-2024","07-Sep-2024","16-Feb-2024","15-Jan-2023","07-Jun-2024","07-Mar-2024","05-Nov-2023","16-Jun-2023","16-Oct-2024","08-Oct-2024","07-Jun-2023","09-Oct-2023"],"contact":"Marya Levintova, PhD  ","contact_tel":"301-496-9535","contact_email":"marya.levintova@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice of Special Interest (NOSI) is being issued by the NIH Adherence Network through the Office of Behavioral and Social Sciences Research (OBSSR) with participation from multiple NIH Institutes, Centers, and Offices. This NOSI calls for research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes. Applications may address healthcare regimen initiation, implementation, and/or persistence by patients. Descriptive and intervention research may address adherence determinants at one or more levels of ecologic influence, including the patient, caregiver/family, provider, healthcare system, and community levels. The specific research interests of participating NIH Institutes and Centers are detailed within.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"103419","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"14-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-100.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health","revision_date":"01-Jul-2022","deadline_note":"This notice applies to due dates on or after May 7, 2021 and subsequent receipt dates through June 8, 2024.&nbsp;","sponwebsite":null,"deadline_date":["15-Feb-2024","14-Dec-2022","15-Feb-2023","05-Feb-2023","05-Oct-2023","16-Feb-2024","05-Feb-2024","07-Jan-2023","05-Jun-2023","15-Jun-2023","17-Oct-2023","07-Sep-2023","07-May-2024","07-May-2023","10-Aug-2023","16-Jun-2023","05-Jun-2024","16-Oct-2023","07-Jan-2024","16-Feb-2023"],"contact":"Wendy Nelson, PhD, MPH ","contact_tel":"240-276-6971","contact_email":"nelsonw@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop,&nbsp;and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (&ldquo;de-implement&rdquo;) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">All applications must be within the scope of the mission of one of the Institutes/Centers listed above.</span></p>","id":"111040","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html","sponsor_type":"US Federal","prog_title":"Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)","revision_date":"25-May-2022","deadline_note":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after </span>May 16, 2022<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. Optional letters of intent may be submitted 30 days prior to the anticipated receipt date. The deadlines for receipt of standard applications under this announcement are: February </span>16<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">, June </span>16<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">, and October </span>16<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"> annually, by </span>5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. T</span>he deadlines for receipt of Renewal / Resubmission / Revision (as allowed) applications under this announcement are: March 16, July 16, and November 16 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by </span>5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. This program will expire on May 8, 2025.</span></p>","sponwebsite":null,"deadline_date":["16-Feb-2025","16-Feb-2023","07-May-2025","16-Oct-2023","07-Jan-2025","16-Feb-2024","16-Jun-2023","07-May-2023","16-Oct-2024","16-Jun-2024","07-Sep-2024","07-Jan-2023","07-Sep-2023","07-May-2024","07-Jan-2024"],"contact":"Gila Neta, Ph.D.","contact_tel":"240-276-6785","contact_email":"gila.neta@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop,&nbsp;and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (&ldquo;de-implement&rdquo;) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">All applications must be within the scope of the mission of one of the Institutes/Centers listed above.</span></p>","id":"110996","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":100000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-160.html","sponsor_type":"US Federal","prog_title":"Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)","revision_date":"09-May-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 16, 2022. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually, by 5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of&nbsp;Renewal / Resubmission / Revision (as allowed) applications are: March 16, July 16, and November 16 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 08, 2025, by 5:00 PM local time of applicant organization. This FOA will expire on September 8, 2025.</p>","sponwebsite":null,"deadline_date":["16-Jun-2025","16-Feb-2025","07-Sep-2024","07-Sep-2023","07-May-2023","16-Jun-2023","16-Feb-2024","07-Sep-2025","07-May-2025","16-Oct-2023","16-Jun-2024","07-Jan-2024","07-May-2024","16-Feb-2023","07-Jan-2023","16-Oct-2024","07-Jan-2025"],"contact":"Gila Neta, PhD","contact_tel":"240-276-6785","contact_email":"Gila.Neta@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to encourage theoretically-driven pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) services research examining questions specific to the prevention of substance use. The latter may include pilot studies of strategies or approaches to intervention, and/or other service system-based research to address areas such as economics, funding, service quality and engagement. In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through this FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and substance-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.</span>","id":"101618","spon_name":"National Institute on Drug Abuse/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":450000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-21-110.html","sponsor_type":"US Federal","prog_title":"Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)","revision_date":"07-Apr-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 16, 2021. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 08, 2024.","sponwebsite":null,"deadline_date":["16-Jun-2023","07-Jan-2024","07-Sep-2023","16-Oct-2023","16-Feb-2023","07-May-2023","07-Jan-2023"],"contact":"Amy B. Goldstein, PhD","contact_tel":"301-827-4124","contact_email":"amy.goldstein@nih.gov"},{"synopsis":"<div data-index=\"15\"><div><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications for new institutional training programs (predoctoral, postdoctoral or both) in Artificial Intelligence (AI) for Precision Nutrition (AIPrN) focused on the integration of precision nutrition, AI, machine learning (ML), systems biology, systems science, Big Data, and computational analytics. The goal is to build a future workforce that will be able to use growing data resources to tackle complex biomedical challenges in nutrition science that are beyond human intuition. It is expected that such research will lead to the development of innovative solutions to combat diet-related chronic diseases and nutrition disparities within the mission areas of the participating NIH Institutes and Offices. The vision for the AIPrN training program is to support the development of a diverse research workforce with advanced competencies in AI, ML, and data science analytics to apply to an increasingly complex landscape of Big Data including molecular, organismal, community and societal-levels related to nutrition and diet-related conditions.</span></p></div></div><div data-index=\"16\"><div><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.</span></p></div></div><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"113560","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"08-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-027.html","sponsor_type":"US Federal","prog_title":"RFA-OD-22-027 -- Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) â€“ Institutional Research Training Programs (T32)","revision_date":"07-Nov-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after November 08, 2022. The deadline for receipt of optional letters of intent is November 08, 2022. The deadline for receipt of full applications is December 08, 2022, by 5:00 PM local time of applicant organization.</p>","sponwebsite":null,"deadline_date":["08-Dec-2022"],"contact":"Christopher Lynch, PhD ","contact_tel":"301-827-3988 ","contact_email":"christopher.lynch@nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.&nbsp; Applications may propose studies using either single or mixed methods.&nbsp; Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.</span>","id":"097436","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"17-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-254.html","sponsor_type":"US Federal","prog_title":"Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)","revision_date":"16-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems.The open date (earliest submission date) is September 5, 2017. The deadlines for receipt of standard R01 applications under this announcement are: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, and June 19 2023, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on July 20, 2023.","sponwebsite":null,"deadline_date":["19-Jun-2023","17-Feb-2023"],"contact":"Joy Boyer","contact_tel":"301-402-4997","contact_email":"boyerj@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.&nbsp; These applications should propose single or mixed methods studies that break new ground, extend previous discoveries in new directions or develop preliminary data in preparation for larger studies. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.</span>","id":"097437","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"17-Feb-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-255.html","sponsor_type":"US Federal","prog_title":"Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)","revision_date":"09-Jul-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems.The open date (earliest submission date) is September 5, 2017. The deadlines for receipt of standard R01 applications under this announcement are: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, and June 19 2023, by&nbsp;5:00 PM local time of applicant organization.&nbsp;This program will expire on July 20, 2023.","sponwebsite":null,"deadline_date":["17-Feb-2023","19-Jun-2023"],"contact":"Joy Boyer","contact_tel":"301-402-4997","contact_email":"boyerj@mail.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this NOSI is to solicit projects on preventive interventions that address cardiometabolic risk factors in populations that experience health disparities.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"111858","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-154.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Preventive Interventions to Address Cardiometabolic Risk Factors in Populations that Experience Health Disparities","revision_date":"15-Jun-2022","deadline_note":"This notice applies to due dates on or after October 5, 2022 and subsequent receipt dates through September 8, 2025.&nbsp;","sponwebsite":null,"deadline_date":["07-Jan-2023","05-Feb-2023","07-Feb-2023","16-Feb-2023","17-Feb-2023","07-Mar-2023","17-Mar-2023","07-May-2023","05-Jun-2023","06-Jun-2023","07-Jun-2023","16-Jun-2023","07-Sep-2023","05-Oct-2023","06-Oct-2023","09-Oct-2023","16-Oct-2023","05-Nov-2023","07-Jan-2024","05-Feb-2024","06-Feb-2024","16-Feb-2024","07-Mar-2024","07-May-2024","05-Jun-2024","07-Jun-2024","16-Jun-2024","07-Sep-2024","05-Oct-2024","08-Oct-2024","16-Oct-2024","07-Jan-2025","05-Feb-2025","16-Feb-2025","07-May-2025"],"contact":"Jennifer Alvidrez, PhD","contact_tel":"301-827-0071","contact_email":"Jennifer.alvidrez@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this trans-NIH Notice of Special Interest (NOSI) is to inform potential applicants that the National Institute of Biomedical Imaging and Bioengineering and participating Institutes and Centers (ICs) invite SBIR/STTR applications to develop technologies or tools to quantitatively predict or indicate an increased risk for maternal morbidity and mortality (MMM).This NOSI is part of the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (<a href=\"https://www.nih.gov/research-training/medical-research-initiatives/improve-initiative\">IMPROVE</a>) initiative, which supports research to reduce preventable causes of maternal deaths and improve health for women before, during, and after delivery.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"102356","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-EB-21-001.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health","revision_date":"01-Dec-2022","deadline_note":"This notice applies to due dates on or after April 5, 2021 and subsequent receipt dates through April 5, 2023.&nbsp; Deadlines for the receipt of full applications are:&nbsp;April 5, 2021, September 5, 2021, January 5, 2022, April 5, 2022, September 5, 2022, January 5, 2023, April 5, 2023, by 5:00 PM local time of applicant organization.&nbsp; This FOA will expire on April 6, 2023.","sponwebsite":null,"deadline_date":["05-Apr-2023","05-Jan-2023"],"contact":"Ilana Goldberg, Ph.D.","contact_tel":"301-402-3465","contact_email":"ilana.goldberg@nih.gov"},{"synopsis":"The National Institutes of Health (NIH) hereby notify Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.&nbsp; Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award.&nbsp;Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA<br />","id":"077858","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-18-935.html","sponsor_type":"US Federal","prog_title":"Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -  Clinical Trial Optional)","revision_date":"25-Jan-2022","deadline_note":"<p>Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA</p><p>Open dates may vary by awarding IC. See Urgent Guide Notices for applicable Application Due Dates.</p><p>This FOA will expire on October 25, 2022.</p><p>Per NOT-MH-20-025 competitive revision applications&nbsp;to improve the treatment and management of common co-occurring conditions and suicide risk in people affected by the opioid crisis are due by April 7, 2020.</p><p>NOTE: Per NOT-AI-20-030 applications under the NOSI for&nbsp;research on the 2019 novel Coronavirus (2019-nCoV) will be accepted on a rolling basis through February 6, 2021.</p><p><span style=\"font-size:small;\">NOTE: Per NOT-HL-20-757 applications for administrative supplements for&nbsp;</span><span style=\"color:#333333;font-size:small;background-color:#ffffff;\">research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will be accepted on a rolling basis between March 17, 2020 and May 15, 2020.</span></p><p>NOTE: Per NOT-DA-20-047&nbsp;applications for administrative supplements for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19) will be accepted on a rolling basis through March 31, 2021.</p><p>NOTE: Per NOT-GM-20-025 applications for administrative supplements for&nbsp;research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19)<span style=\"color:#333333;font-family:Helvetica Neue, Helvetica, Arial, sans-serif;\"><span style=\"font-size:13.6px;background-color:#ffffff;\"></span></span>will be accepted on a rolling basis through February 5, 2021.</p><p>NOTE: Per NOT-HG-20-030 applications for Competitive Revisions to support genomic research on SARS-CoV-2 and COVID-19 disease&nbsp;will be accepted on a rolling basis from April 1 through May 15, 2020.</p><p>NOTE: Per NOT-AG-20-022 applications for Competitive Revisions to support research on Coronavirus Disease 2019 (COVID-19) will be accepted on a rolling basis from April 6, 2020 through May 15, 2020.</p><p>NOTE: Per NOT-CA-20-043 applications for&nbsp;the development of prophylactic, therapeutic and diagnostic for Coronavirus Disease 2019 (COVID-19) are due by June 25, 2020.</p><p>NOTE: Per NOT-AT-20-011 applications for administrative supplements for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19) will be accepted on a rolling basis through October 6, 2020.</p><p>NOTE: Per NOT-CA-20-042 applications for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa will be accepted on a rolling basis from April 14, 2020 through June 25, 2020.</p><p>NOTE: Per NOT-MD-20-019 applications for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations will be accepted between July 15, 2020 and May 1, 2021.</p><p>NOTE: Per NOT-MH-20-047 applications for &nbsp;research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics&nbsp;will be accepted on a rolling basis through April 15, 2021.</p><p>NOTE: Per NOT-OD-20-097 Napplications for&nbsp;social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19&nbsp;will be accepted on a rolling basis through March 31, 2021.</p><p>NOTE: Per NOT-AA-20-011 applications&nbsp;to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes will be accepted on a rolling basis through April 15, 2021.</p><p>NOTE: Per NOT-DE-20-022 applications for research on Coronavirus Disease 2019 (COVID-19) which place a high priority on topics that would be of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices are due by&nbsp;June 1, 2020, and November 2, 2020.</p><p>NOTE: Per NOT-GM-20-033 applications to create a registry of COVID-19 patients across IDeA states that includes a comprehensive set of deidentified clinical data elements are due by June 18, 2020.</p><p>NOTE: Per NOT-AT-20-012 applications for&nbsp;research on the effects of natural products alone or in combination with other complementary and integrative health approaches on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) will be accepted on a rolling basis through August 17, 2020.</p>","sponwebsite":null,"deadline_date":null,"contact":null,"contact_tel":"301-945-7573","contact_email":"GrantsInfo@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Innovation Research (SBIR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services that have the potential to&nbsp;advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD.</span>","id":"111974","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAS-22-196.html","sponsor_type":"US Federal","prog_title":"Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)","revision_date":"01-Jul-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after December 05, 2022. The deadlines for receipt of standard applications under this announcement are: January 5, April 5, and September 5 annually. This program will expire on September 06, 2025.","sponwebsite":null,"deadline_date":["05-Jan-2023","05-Apr-2023","05-Sep-2023","05-Jan-2024","05-Apr-2024","05-Sep-2024","05-Jan-2025","05-Apr-2025","05-Sep-2025"],"contact":"Zane Martin, Ph.D.","contact_tel":"301-827-7130","contact_email":"zane.martin@nih.gov"},{"synopsis":"<br /><p>&nbsp;</p>The purpose of this funding opportunity announcement (FOA) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where there is a significant gap in knowledge, that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests the efficacy or effectiveness of health promotion and disease prevention interventions, 3) research that tests culturally informed treatment or recovery interventions and 4) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions.<p>&nbsp;</p><s2s></s2s>","id":"098155","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"17-Apr-2023 [Optional] [LOI/Pre-App]","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-238.html","sponsor_type":"US Federal","prog_title":"Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)","revision_date":"06-May-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 17. The deadline for receipt of optional letters of intent is 30 days before the application due date. The deadline for receipt of standard full applications is May 17 annually. AIDS Application Due Dates: September 7, 2021; 2022; and 2023. This FOA will expire on September 8, 2023.","sponwebsite":null,"deadline_date":["17-May-2023","17-Apr-2023 [Optional] [LOI/Pre-App]","07-Sep-2023"],"contact":"Shobha Srinivasan, Ph.D.","contact_tel":"240-276-6938","contact_email":"ss688k@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The ORWH and participating organizations and institutes seek applications for Specialized Centers of Research Excellence (SCORE) on Sex Differences. The Centers of Excellence will support interdisciplinary approaches to advance translational research on sex differences. Each SCORE institution should develop a research agenda bridging basic and clinical research underlying a health issue that is pertinent to improving the health of women.</span>","id":"112727","spon_name":"Office of Research on Women's Health/NIH/DHHS","NextDeadlineDate":"16-Jul-2024 [Optional] [LOI/Pre-App]","total_funding_limit":7500000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-014.html","sponsor_type":"US Federal","prog_title":"RFA-OD-22-014 --Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)","revision_date":"23-Aug-2022","deadline_note":"<p>Applications must be submitted through NIH's Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted in response to this announcement on or after August 30, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are:&nbsp;September 30, 2022 and August 15, 2024, by 5:00 PM local time of applicant organization. This FOA will expire on&nbsp;August 16, 2024.</p>","sponwebsite":null,"deadline_date":["16-Jul-2024 [Optional] [LOI/Pre-App]","15-Aug-2024"],"contact":"Rajeev K. Agarwal, Ph.D.","contact_tel":"301-451-7058","contact_email":"rajeev.agarwal@nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">NOTE:&nbsp;</span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"><strong style=\"box-sizing:border-box;\"><em style=\"box-sizing:border-box;\">The following Institutes/Centers only accept&nbsp;</em></strong><a href=\"https://grants.nih.gov/grants/glossary.htm#MechanisticStudy\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">mechanistic studies</a><strong style=\"box-sizing:border-box;\"><em style=\"box-sizing:border-box;\">&nbsp;that meet NIH's definition of a&nbsp;</em></strong><a href=\"https://grants.nih.gov/grants/glossary.htm#ClinicalTrial\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">clinical trial</a><strong style=\"box-sizing:border-box;\"><em style=\"box-sizing:border-box;\">. </em></strong></span></span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">National Heart, Lung, and Blood Institute (<a href=\"http://www.nhlbi.nih.gov/\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">NHLBI</a>)</span></span><br style=\"box-sizing:border-box;\" /><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">National Institute of Arthritis and Musculoskeletal and Skin Diseases (<a href=\"http://www.niams.nih.gov/\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">NIAMS</a>)</span></span><br style=\"box-sizing:border-box;\" /><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">National Institute of Neurological Disorders and Stroke (<a href=\"http://www.ninds.nih.gov/\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">NINDS</a>)</span></span><br style=\"box-sizing:border-box;\" /><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">National Center for Complementary and Integrative Health (<a href=\"http://www.nccam.nih.gov/\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">NCCIH</a>)</span></span><br style=\"box-sizing:border-box;\" /><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">National Institute of Mental Health (<a href=\"http://www.nimh.nih.gov/\" target=\"_blank\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">NIMH</a>)</span></span></p>","id":"093897","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-183.html","sponsor_type":"US Federal","prog_title":"Research Project Grant (Parent R01 Clinical Trial Required)","revision_date":"07-Feb-2022","deadline_note":"<p><span style=\"font-family:Tahoma, Geneva, sans-serif;font-size:small;\">Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after </span><span style=\"color:#333333;font-family:Tahoma, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">May 05, 2020</span><span style=\"font-family:Tahoma, Geneva, sans-serif;font-size:small;\">. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on </span><span style=\"color:#333333;font-family:Tahoma, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">May 08, 2023.</span></p><p><span style=\"font-family:Tahoma, Geneva, sans-serif;font-size:small;\">NOTE: Per NOT-OD-20-089 applications for administrative supplements to existing R01 and R21 programs&nbsp;to expand their focus to include firearms research are due by May 15, 2020.</span></p><p>NOTE: Per NOT-ES-20-018 applications to investigate the mechanisms controlling the resolution of inflammation in chronic disease states will be accepted on&nbsp;due dates on or after October 1, 2020 and subsequent receipt dates through May 31, 2024.</p>","sponwebsite":null,"deadline_date":["07-May-2023","05-Feb-2023","07-Jan-2023"],"contact":null,"contact_tel":null,"contact_email":"grantsinfo@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (&ldquo;de-implement&rdquo;) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">All applications must be within the scope of the mission of one of the Institutes/Centers listed above.</span></p>","id":"111036","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-105.html","sponsor_type":"US Federal","prog_title":"Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)","revision_date":"19-Jul-2022","deadline_note":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after </span>May 15, 2022<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. Optional letters of intent may be submitted 30 days prior to the anticipated receipt date. The deadlines for receipt of standard applications under this announcement are: June 15, 2022, and then standard dates of February 5, June 5, and October 5 annually, by </span>5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. T</span>he deadlines for receipt of Renewal / Resubmission / Revision (as allowed) applications under this announcement are: March 5, July 5, and November 5 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by </span>5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. This program will expire on May 8, 2025.</span></p>","sponwebsite":null,"deadline_date":["05-Feb-2024","07-Sep-2024","07-May-2025","05-Jun-2023","05-Oct-2023","07-Sep-2023","07-Jan-2025","07-Jan-2024","07-May-2024","05-Feb-2023","05-Feb-2025","07-Jan-2023","07-May-2023","05-Oct-2024","05-Jun-2024"],"contact":"Gila Neta, Ph.D.","contact_tel":"240-276-6785","contact_email":"gila.neta@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R&amp;D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see&nbsp;<a href=\"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf\">PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Parent Funding Opportunity Announcement does not accept clinical trials.</span></p>","id":"111674","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf","sponsor_type":"US Federal","prog_title":"PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)","revision_date":"02-Nov-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 05, 2022. The deadlines for receipt of standard applications under this announcement are: January 5, April 5, and September 5 annually, by 5:00 PM local time of applicant organization. This program will expire on April 6, 2023.","sponwebsite":"https://grants.nih.gov/grants/guide/pa-files/PA-22-176.html","deadline_date":["07-Jan-2023","05-Apr-2023"],"contact":null,"contact_tel":"301-435-2688","contact_email":"SEEDinfo@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\"></span></span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R&amp;D mission(s) of the NIH and CDC awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see&nbsp;<a href=\"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf\">PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA</a>).</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed.&nbsp;The proposed project must be related to the programmatic interests of one or more of the participating NIH and CDC Institutes and Centers (ICs) based on their scientific missions.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"111675","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://seed.nih.gov/sites/default/files/HHS_Program_Descriptions.pdf","sponsor_type":"US Federal","prog_title":"PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)","revision_date":"02-Nov-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 05, 2022. The deadlines for receipt of standard applications under this announcement are: January 5, April 5, and September 5 annually, by 5:00 PM local time of applicant organization. This program will expire on April 6, 2023.","sponwebsite":"https://grants.nih.gov/grants/guide/pa-files/PA-22-177.html","deadline_date":["05-Jan-2023","05-Apr-2023"],"contact":null,"contact_tel":"301-435-2688","contact_email":"SEEDinfo@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The National Institutes of Health (NIH) hereby notify Principal Investigators on specific types of NIH research grants, listed in the Urgent Notice of Special Interest that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.&nbsp; Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award.</span><br />","id":"114025","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-23-044.html","sponsor_type":"US Federal","prog_title":"Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -  Clinical Trial Optional)","revision_date":"07-Nov-2022","deadline_note":"<p>Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA</p><p>Open dates may vary by awarding IC. See Urgent Guide Notices for applicable Application Due Dates.</p><p>This FOA will expire on October 26, 2025.</p><p>&nbsp;</p>","sponwebsite":null,"deadline_date":null,"contact":null,"contact_tel":"301-945-7573","contact_email":"GrantsInfo@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Technology Transfer Research (STTR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services that have the potential to&nbsp;advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD.</span>","id":"111975","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAS-22-197.html","sponsor_type":"US Federal","prog_title":"Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)","revision_date":"01-Jul-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after December 05, 2022. The deadlines for receipt of standard applications under this announcement are: January 5, April 5, and September 5 annually. This program will expire on September 06, 2025.","sponwebsite":null,"deadline_date":["05-Jan-2023","05-Apr-2023","05-Sep-2023","05-Jan-2024","05-Apr-2024","05-Sep-2024","05-Jan-2025","05-Apr-2025","05-Sep-2025"],"contact":"Zane Martin, Ph.D.","contact_tel":"301-827-7130","contact_email":"zane.martin@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">SuRE is a research capacity building program designed to develop and sustain research excellence in U.S. higher education institutions that receive limited NIH research support and serve students from groups underrepresented in biomedical research (see&nbsp;<span style=\"text-decoration:underline;\"><a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html\">NOT-OD-20-031)</a></span>&nbsp;with an emphasis on providing students with research opportunities and enriching the research environment at the applicant institutions.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of SuRE-First awards is to support research grants for faculty investigators who have not had prior independent external research grants.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">&nbsp;</span></span></p>","id":"102907","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":500000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-173.html","sponsor_type":"US Federal","prog_title":"Support for Research Excellence â€“ First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)","revision_date":"24-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after August 28, 2021. The deadline for receipt of standard applications under this announcement is September 28 annually, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is January 7 annually, by 5:00 PM local time of applicant organization. This program will expire on January 8, 2023. </p>","sponwebsite":null,"deadline_date":["07-Jan-2023","28-Sep-2023","07-Jan-2024"],"contact":"Irina N. Krasnova, Ph.D.","contact_tel":null,"contact_email":"irina.krasnova@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This funding opportunity announcement (FOA) invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of projects submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena related to social connectedness and isolation. NIH considers such studies as Basic Experimental Studies with Humans (BESH) that are prospective basic science studies involving human participants that meet the NIH definition of basic research and fall within the NIH definition of clinical trials (see, e.g.,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-024.html\">NOT-OD-19-024</a>). Applications should not propose a goal of clinical outcomes or products. Applications that propose&nbsp;studies including model animal research or observational studies involving humans should submit under the companion FOA,&nbsp;<a href=\"https://public.era.nih.gov/foa/foaHome.era?foaId=14934&amp;requestFrom=FOAListTable\">PAR-21-350</a>&nbsp;\"Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed).</span></span>","id":"106783","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"21-Jun-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-349.html","sponsor_type":"US Federal","prog_title":"Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)","revision_date":"06-Oct-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 21, 2022. The deadline for receipt of standard applications under this announcement is June 21 annually, by 5 p.m. local time of the applicant organization. This program will expire on June 22, 2024.","sponwebsite":null,"deadline_date":["21-Jun-2023","21-Jun-2024"],"contact":"William Elwood, PhD","contact_tel":"301-402-0116","contact_email":"william.elwood@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This funding opportunity announcement (FOA) invites research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Both animal model and human subjects research projects are welcome; however, clinical trials are not allowed.&nbsp;Researchers proposing Basic Experimental Studies with Humans (BESH) should consider the companion FOA,&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-349.html\">PAR-21-349</a>, \"Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)\".</span></span>","id":"106784","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"21-Jun-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-350.html","sponsor_type":"US Federal","prog_title":"Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)","revision_date":"06-Oct-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 21, 2022. The deadline for receipt of standard applications under this announcement is June 21 annually, by 5 p.m. local time of the applicant organization. This program will expire on June 22, 2024.","sponwebsite":null,"deadline_date":["21-Jun-2023","21-Jun-2024"],"contact":"William Elwood, PhD","contact_tel":"301-402-0116","contact_email":"william.elwood@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">SuRE is a research capacity building program designed to develop and sustain research excellence in U.S. higher education institutions that receive limited NIH research support and serve students from groups underrepresented in biomedical research&nbsp;<a href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html\"><span style=\"text-decoration:underline;\">NOT-OD-20-031</span></a>&nbsp;with an emphasis on providing students with research opportunities and enriching the research environment at the applicant institutions.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of SuRE awards is to provide research grant support for faculty investigators who have&nbsp;prior experience in leading externally-funded, independent research but&nbsp;are not currently funded by any&nbsp;<a href=\"https://grants.nih.gov/grants/glossary.htm#ResearchProjectGrantRPG\">NIH Research Project Grants</a>&nbsp;with the exception of SuRE or SuRE-First awards.</span></span></p>","id":"102906","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"26-May-2023","total_funding_limit":400000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-169.html","sponsor_type":"US Federal","prog_title":"Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)","revision_date":"20-Oct-2022","deadline_note":"<p>Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after April 26, 2021. The deadline for receipt of standard applications under this announcement is May 26 annually, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is September 7 annually, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2023. </p>","sponwebsite":null,"deadline_date":["26-May-2023","07-Sep-2023"],"contact":"Irina N. Krasnova, Ph.D.","contact_tel":null,"contact_email":"irina.krasnova@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This funding opportunity announcement (FOA) invites basic and/or methodological research projects that seek to illuminate or measure independent and interdependent health-related effects within dyads. For the purpose of this FOA, a&nbsp;<em>dyad</em>&nbsp;is a unit of two individuals whose interactions and influences on one another are nested within larger social contexts and networks. Both animal and human subjects research projects are welcome. Types of projects submitted under this FOA include but are not limited to, observational studies involving humans, or existing/synthesized datasets studies. &nbsp;Researchers proposing basic science experimental studies involving human participants (i.e., experimentally manipulate independent variables) should consider the companion FOA&nbsp;<a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-21-280.html\">PAR-21-280</a>\" Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Basic Experimental Studies with Humans).&rdquo;</span></span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"105351","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-281.html","sponsor_type":"US Federal","prog_title":"Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)","revision_date":"21-Jan-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 05, 2022. The deadline for receipt of standard applications under this announcement is March 5 annually, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications May 7 annually, by 5:00 PM local time of applicant organization. This program will expire on May 08, 2022. ","sponwebsite":null,"deadline_date":["05-Mar-2023","07-May-2023"],"contact":"William Elwood, PhD","contact_tel":"301-402-0116","contact_email":"william.elwood@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">This funding opportunity announcement (FOA) invites basic and/or methodological research projects that illuminate and/or measure independent and interdependent health-related effects within dyads across relationships and settings. For the purpose of this FOA, a&nbsp;<em>dyad</em>&nbsp;is a unit of two individuals whose interactions and influences on one another are nested within larger social contexts and networks. Dyads are social relationships that extend beyond the individual and have strong bidirectional influences on physical and mental health. For the purpose of this FOA,&nbsp;<em>independent effects&nbsp;</em>are those effects that affect each member of the dyad individually (i.e., by nature of being part of the dyad), whereas&nbsp;<em>interdependent effects</em>&nbsp;are those that affect one member of the dyad&nbsp;<em>contingent upon the other member of the dyad</em>&nbsp;(i.e., not only because the individual is part of a dyad but also because being part of the dyad has an effect on the other individual within the dyad as well).</span></span><br /><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"105350","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Mar-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-280.html","sponsor_type":"US Federal","prog_title":"Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)","revision_date":"09-Aug-2021","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after February 05, 2022. The deadlines for receipt of standard applications under this announcement March 5 annually, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications May 7 annually, by 5:00 PM local time of applicant organization. This program will expire on May 08, 2023. ","sponwebsite":null,"deadline_date":["05-Mar-2023","07-May-2023"],"contact":"William Elwood, PhD","contact_tel":"301-402-0116","contact_email":"william.elwood@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this funding opportunity is to provide an opportunity for funded researchers in these various fields to pursue supplemental funding to conduct research addressing these emerging and other existing COVID-related issues among pregnant and lactating people, infants, children and adolescents, and individuals with physical and/or intellectual disabilities. The goal of this NOSI is to not replace or to compete with the various COVID-related funding opportunities currently available. Instead, the purpose is to complement them by offering a funding opportunity for currently funded investigators to address key issues not currently covered by available COVID-related funding announcements among these populations. It is hoped that the use of administrative supplements will foster research in these key areas in the most timely manner. Research projects addressing issues that are the focus of currently available or future COVID funding opportunity announcements will be encouraged to submit to those announcements. Also, applicants responding to this NOSI are strongly encouraged to describe plans for the rapid sharing of data and results as well as innovative data analytics approaches. The sharing of COVID-related data and resources and the effective communication of results are a high priority of the NIH.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"110578","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-HD-22-003.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities","revision_date":"20-Apr-2022","deadline_note":"This NOSI will expire on June 6, 2024.","sponwebsite":null,"deadline_date":["07-May-2024","07-May-2023","05-Jun-2024","05-Feb-2023","07-Jan-2023","07-Jan-2024","07-Sep-2023","05-Jun-2023","16-Feb-2023","16-Jun-2023","16-Oct-2023","05-Oct-2023","16-Feb-2024","05-Feb-2024"],"contact":"Robert Tamburro, MD, MSc","contact_tel":"301-480-2619","contact_email":"robert.tamburro@nih.gov"},{"synopsis":"The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) develop, integrate, optimize, validate, translate or accelerate adoption of promising tools, methods and techniques: a) that fulfill an unmet need and address specific research or clinical problem in basic, translational, and/or clinical science and practice, b) capable of enhancing our understanding of health and disease, and/or c) improve practice of medicine. Applications may propose design-directed, developmental, discovery-driven, or hypothesis-driven research, and this FOA is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science.&nbsp; &nbsp;&nbsp;","id":"113232","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-242.html","sponsor_type":"US Federal","prog_title":"Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) ","revision_date":"24-Oct-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 1, 2022. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2025. ","sponwebsite":null,"deadline_date":["07-Jan-2025","07-Sep-2023","05-Feb-2025","07-Jan-2023","05-Jul-2024","07-Jan-2024","07-Sep-2024","05-Nov-2024","05-Feb-2023","05-Jul-2023","05-Oct-2023","05-Jul-2025","05-Jun-2024","05-Nov-2023","07-May-2025","05-Mar-2023","05-Jun-2025","05-Mar-2024","07-May-2023","05-Oct-2024","05-Mar-2025","05-Jun-2023","07-Sep-2025","07-May-2024","05-Feb-2024"],"contact":"Rao Divi, Ph.D.","contact_tel":"240-276-6913","contact_email":"divir@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (&ldquo;de-implement&rdquo;) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">All applications must be within the scope of the mission of one of the Institutes/Centers listed above.</span></p>","id":"111039","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":275000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-109.html","sponsor_type":"US Federal","prog_title":"Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)","revision_date":"11-May-2022","deadline_note":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after </span>May 16, 2022<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. Optional letters of intent may be submitted 30 days prior to the anticipated receipt date. The deadlines for receipt of standard applications under this announcement are: February </span>16<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">, June </span>16<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">, and October </span>16<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"> annually, by </span>5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. T</span>he deadlines for receipt of Renewal / Resubmission / Revision (as allowed) applications under this announcement are: March 16, July 16, and November 16 annually, by&nbsp;5:00 PM local time of applicant organization.&nbsp;<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually, by </span>5:00 PM local time of applicant organization<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">. This program will expire on May 8, 2025.</span></p>","sponwebsite":null,"deadline_date":["07-Jan-2025","07-May-2025","16-Feb-2025","07-Sep-2024","16-Oct-2023","07-Sep-2023","16-Jun-2024","07-Jan-2023","16-Jun-2023","07-May-2024","16-Feb-2023","16-Feb-2024","07-May-2023","07-Jan-2024","16-Oct-2024"],"contact":"Gila Neta, Ph.D.","contact_tel":"240-276-6785","contact_email":"gila.neta@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.</span>","id":"102748","spon_name":"National Cancer Institute/NIH/DHHS","NextDeadlineDate":"07-Mar-2023","total_funding_limit":1250000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-190.html","sponsor_type":"US Federal","prog_title":"Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)","revision_date":"11-Jul-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 08, 2021. The deadlines for receipt of full applications are: November 8, 2021; March 7, 2022; November 8, 2022; March 7, 2023; November 5, 2023; and March 7, 2024, by 5:00 PM local time of applicant organization. This FOA will expire on March 8, 2024.","sponwebsite":null,"deadline_date":["07-Mar-2023","07-Mar-2024","05-Nov-2023"],"contact":"Scott Rogers, MPH ","contact_tel":"240-276-6932 ","contact_email":"rogerssc@mail.nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Education Program (U25) supports research education activities in the mission areas of the NIH.&nbsp; The overarching goal of this&nbsp;U25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research&nbsp;</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:</span></p><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Courses for Skills Development</em></strong></span></li></ul><ul><li><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"><strong><em>Mentoring Activities</em></strong></span></li></ul><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applications are encouraged from organizations of biomedical researchers (e.g., scientific societies) with a membership of scientists conducting research within the mission areas of participating NIH Institutes and Centers, experience serving as a centralized entity to enhance scientific communication and networking among scientists conducting research, an established record of providing professional development and networking activities for the next generation of biomedical researchers, and a demonstrated commitment to enhancing the diversity of the biomedical research workforce.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The program provides support for well-designed courses for skills development and mentoring activities to prepare cohorts of postdoctoral and early-career faculty scholars supported by&nbsp;<a href=\"https://www.nigms.nih.gov/training/careerdev/Pages/MOSAIC.aspx\">MOSAIC K99/R00 awards</a>&nbsp;to transition into, succeed, and advance in independent, tenure-track or equivalent,&nbsp;research-intensive faculty careers.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Awardee organizations must provide career development and mentoring activities aligned with and appropriate for the disciplinary backgrounds of scholars supported through the MOSAIC K99/R00 program. Areas of programmatic need will be indicated through Notices of Special Interest (NOSIs) released annually by NIH. Applications that do not address the program areas of need specified in the NOSI will be considered non-responsive and will not be reviewed.</span></p>","id":"106065","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"15-Nov-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-277.html","sponsor_type":"US Federal","prog_title":"Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)","revision_date":"19-Aug-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 18, 2021. Optional letters of intent will not be accepted under this FOA. The deadlines for receipt of full applications are: December 14, 2021; November 15, 2022; and November 15, 2023,&nbsp;by 5:00 PM local time of applicant organization.&nbsp;This FOA will expire on November 16, 2023.","sponwebsite":null,"deadline_date":["15-Nov-2023"],"contact":"Kenneth D. Gibbs, Jr., Ph.D.","contact_tel":null,"contact_email":"kenneth.gibbs@nih.gov"},{"synopsis":"<p><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications on the influence and intersection of sex and gender in health and disease, including: (1) research applications that examine sex and gender factors and their intersection in understanding health and disease; and (2) research that addresses one of the five objectives from Strategic Goal 1 of the 2019-2023&nbsp;<a href=\"https://orwh.od.nih.gov/sites/orwh/files/docs/ORWH_Strategic_Plan_2019_02_21_19_V2_508C.pdf\">Trans-NIH Strategic Plan for Women's Health Research</a>&nbsp;\"Advancing Science for the Health of Women.\" The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Women&rsquo;s Health (ORWH) and the scientific partnering Institutes and Centers across NIH</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span></p>","id":"113710","spon_name":"Office of Research on Women's Health/NIH/DHHS","NextDeadlineDate":"19-Dec-2022","total_funding_limit":1400000,"programurl":"https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-028.html","sponsor_type":"US Federal","prog_title":"RFA-OD-22-028 -- The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)","revision_date":"14-Oct-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems Applications may be submitted in response to this announcement on or after November 21, 2022. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are December 19, 2022; November 22, 2023; and November 22, 2024, by 5:00 PM local time of applicant organization. ","sponwebsite":null,"deadline_date":["19-Dec-2022","23-Oct-2023 [Optional] [LOI/Pre-App]","22-Nov-2023","23-Oct-2024 [Optional] [LOI/Pre-App]","23-Nov-2024"],"contact":"Chyren Hunter, Ph.D.","contact_tel":"301-496-7849","contact_email":"Hunterc@mail.nih.gov"},{"synopsis":"<span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative health services research that can directly and demonstrably contribute to the improvement of minority health and/or the reduction of health disparities at the health care system-level as well as within clinical settings.</span>","id":"100056","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"17-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-310.html","sponsor_type":"US Federal","prog_title":"Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)","revision_date":"28-Jan-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after October 27, 2020. The sponsors will not accept letters of intent under this FOA. The deadlines for receipt of full applications are: November 27, 2020; March 17, 2021; November 17, 2021; March 17, 2022; November 17 2022; and February 17, 2023, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS and AIDS-related full applications are:&nbsp;November 27, 2021; March 17, 2021; November 17, 2021; March 17, 2022; November 17, 2022; and March 17, 2023,&nbsp;by 5:00 PM local time of applicant organization.&nbsp; This FOA will expire on March 28, 2023.","sponwebsite":null,"deadline_date":["17-Feb-2023","17-Mar-2023"],"contact":"Rada K. Dagher, PhD","contact_tel":"301-451-2187","contact_email":"rada.dagher@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The National Institute of Environmental Health Science (NIEHS), in partnership with Fogarty International Center (FIC), National Institute of Minority Health and Health Disparities (NIMHD),&nbsp;<em>Eunice Kennedy Shriver&nbsp;</em>National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), National Institute of Nursing Research (NINR), National Heart Blood and Lung Institute (NHBLI) and National Institute of Allergy and Infectious Disease (NIAID), is leading an NIH-wide&nbsp;<a href=\"http://www.nih.gov/climateandhealth\">Climate Change and Health Initiative (CCHI)&nbsp;</a>with the goals of: reducing the health threats posed by climate change across the lifespan; improving the health of people who disproportionately affected by climate change impacts; and building health resilience among individuals, communities, and nations around the world. As a part of this CCHI, this NOSI encourages Phase I (R43), Direct to Phase II (R44) and Fast-track (R44) SBIR grant applications from SBCs to develop commercializable tools, resources, and approaches to capture the effects of climate change and the associated impacts of extreme weather events on human health and to support adaptation or mitigation strategies to minimize health hazards and impacts from climate change. Technologies may include new approaches for detecting climate change-associated exposures, including temperature and air quality, training tools on climate change and mitigation strategies for patients with underlying health conditions, intervention approaches for reducing contaminants water or in indoor air, modeling and prediction tools for climate-change-related weather events and related health effects, and technologies for delivery of health care, including mental health services to communities during extreme weather events.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"111688","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-ES-22-010.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Innovative Technologies for Research on Climate Change and Human Health (R43/R44 Small Business Innovation Research (R43/R44 Clinical Trial Optional)","revision_date":"05-Jun-2022","deadline_note":"This notice applies to due dates on or after September 5, 2022 and subsequent receipt dates through April 5, 2023.&nbsp;","sponwebsite":null,"deadline_date":["05-Apr-2023","05-Jan-2023"],"contact":"Daniel Shaughnessy, PhD","contact_tel":"984-287-3321","contact_email":"shaughn1@niehs.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The National Institute of Environmental Health Science (NIEHS), in partnership with Fogarty International Center (FIC), National Institute of Minority Health and Health Disparities (NIMHD),&nbsp;<em>Eunice Kennedy Shriver&nbsp;</em>National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), National Institute of Nursing Research (NINR), National Heart Blood and Lung Institute (NHBLI) and National Institute of Allergy and Infectious Disease (NIAID), is leading an NIH-wide&nbsp;<a href=\"http://www.nih.gov/climateandhealth\">Climate Change and Health Initiative (CCHI)&nbsp;</a>with the goals of: reducing the health threats posed by climate change across the lifespan. improving the health of people who are disproportionately affected by climate change impacts; and building health resilience among individuals, communities, and nations around the world. As a part of this CCHI, this NOSI encourages Phase I (R41), and Direct to Phase II (R42) STTR grant applications from SBCs to develop commercializable tools, resources, and approaches to capture the effects of climate change and the associated impacts of extreme weather events on human health and to support adaptation or mitigation strategies to minimize health hazards and impacts from climate change. Technologies may include new approaches for detecting climate change-associated exposures, including temperature and air quality, training tools on climate change and mitigation strategies for patients with underlying health conditions, intervention approaches for reducing contaminants water or in indoor air, modeling and prediction tools for climate-change-related weather events and related health effects, and technologies for delivery of health care, including mental health services to communities during extreme weather events.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"111689","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-ES-22-009.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Innovative Technologies for Research on Climate Change and Human Health Small Business Technology Transfer (R41/R42 Clinical Trial Optional) Notice Number:","revision_date":"05-Jun-2022","deadline_note":"This notice applies to due dates on or after September 5, 2022 and subsequent receipt dates through April 5, 2023.&nbsp;","sponwebsite":null,"deadline_date":["05-Apr-2023","05-Jan-2023"],"contact":"Daniel Shaughnessy, PhD","contact_tel":"984-287-3321","contact_email":"shaughn1@niehs.nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Notice calls for research on the health of sexual and gender minority populations. SGM populations include, but are not limited to, individuals who identify as lesbian, gay, bisexual, asexual, transgender, Two-Spirit, queer, and/or intersex. Individuals with same-sex or -gender attractions or behaviors and those with a difference in sex development are also included. These populations also encompass those who do not self-identify with one of these terms but whose sexual orientation, gender identity or expression, or reproductive development is characterized by non-binary constructs of sexual orientation, gender, and/or sex.</span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"112346","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-MD-22-012.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM)","revision_date":"12-Jul-2022","deadline_note":"This notice applies to due dates on or after August 1, 2022 and subsequent receipt dates through August 1, 2025.","sponwebsite":null,"deadline_date":["13-Jun-2023","05-Feb-2025","06-Oct-2023","05-Jun-2025","16-Jun-2025","05-Jun-2024","07-Jan-2025","20-Jun-2024","06-Jun-2023","06-Apr-2023","12-Feb-2024","08-Aug-2023","04-Aug-2023","07-May-2024","12-Oct-2023","16-Oct-2024","13-Oct-2023","21-Feb-2023","05-Jun-2023","05-Oct-2023","08-Feb-2023","07-Sep-2023","07-Sep-2024","12-Oct-2024","06-Feb-2024","20-Jun-2023","09-Oct-2024","12-Feb-2025","12-Jun-2025","07-Jan-2023","12-Jun-2024","20-Feb-2024","08-Dec-2022","23-Feb-2023","12-Jun-2023","07-May-2023","29-Jun-2023","16-Jun-2023","22-Feb-2023","06-Feb-2023","22-Feb-2024","18-Oct-2023","09-Jun-2023","08-Apr-2024","07-Jan-2024","08-Jun-2023","14-Feb-2023","10-Feb-2023","08-Dec-2023","20-Oct-2023","07-Feb-2023","08-Apr-2023","16-Feb-2024","16-Jun-2024","10-Oct-2023","05-Oct-2024","16-Feb-2023","13-Mar-2023","26-Oct-2023","12-Feb-2023","05-Dec-2022","05-Feb-2023","06-Jun-2024","16-Oct-2023","16-Feb-2025","05-Feb-2024","07-May-2025"],"contact":"Crystal L. Barksdale, PhD MPH","contact_tel":"301-827-4228","contact_email":"crystal.barksdale@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span>The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for health professional, undergraduate and graduate students and enhancing the research environment at applicant institutions.</p><p>Eligible institutions must award baccalaureate or advanced science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&amp;A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the schools and colleges within the institution as a whole.</p><p>Help determining the Organization Funding Level can be found&nbsp;<a href=\"https://grants.nih.gov/grants/funding/Determing-Organization-Funding-Levels-R15-Eligibility.pdf\">here&nbsp;</a>or&nbsp;<a href=\"https://grants.nih.gov/grants/funding/r15.htm\">https://grants.nih.gov/grants/funding/r15.htm</a>.</p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span>","id":"108357","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":300000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-22-060.html","sponsor_type":"US Federal","prog_title":"Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)","revision_date":"21-Mar-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after January 25, 2022. The deadlines for receipt of standard applications under this announcement are: February 25, June 25, and October 25 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2025. ","sponwebsite":null,"deadline_date":["25-Oct-2023","07-May-2024","25-Oct-2024","25-Feb-2023","07-Sep-2023","25-Jun-2023","07-Sep-2024","07-Jan-2023","25-Feb-2024","07-Jan-2025","07-Jan-2024","25-Jun-2024","07-May-2023"],"contact":"Lisa Chadwick","contact_tel":"301-435-7275","contact_email":"lisa.chadwick@nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement (FOA) invites applications that seek to support the identification of shared mechanisms and development of innovative interventions to address multimorbidity or multiple chronic conditions (MCCs) and its consequences. Intervention research supported by this initiative should be designed to study: (1) mechanisms or pathways that prevent MCCs, including the identification of early biomarkers, behavioral pathways, and individual and contextual risk factors and interactions that contribute to the development of common MCCs; (2) targeted therapies and management, including self-management, of MCCs to delay progression and prevent onset of new diseases; and (3) innovative health care partnership models for managing or treating MCCs. Studies may include shared mechanisms, and assessments of interactions between risk factors and interventions that address MCCs at different periods of the lifespan in diverse populations. Use of innovative technologies to assess and intervene on risk factors and pathways are encouraged. Studies may also include those that make use of existing data and/or data linkages to explore new research questions that may be helpful in understanding the impact of mechanisms in isolation or in combination. Of particular interest are interventions that target prevention and treatment of multiple chronic health conditions, including study designs that address therapeutic targets for preventing co-occurring MCCs.</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Prospective applicants whose research interests relate to developing improved measures and methods for understanding multimorbidity, including but not limited to measures/tools to support basic mechanistic discovery of shared MCC pathways and identification and initial evaluation of MCC shared signatures, should see&nbsp;</span><a href=\"https://grants.nih.gov/grants/guide/pa-files/PAR-20-179.html\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">PAR-20-179.</span></a></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"093638","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-20-180.html","sponsor_type":"US Federal","prog_title":"Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)","revision_date":"01-Dec-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after September 05, 2020. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2024.","sponwebsite":null,"deadline_date":["07-Sep-2023","05-Feb-2023","07-Jan-2024","05-Oct-2023","07-Jan-2023","05-Jun-2023","07-May-2023"],"contact":"David L. Tilley, MPH, MS, CPH","contact_tel":"301-827-6014","contact_email":"david.tilley@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The National Institute of Environmental Health Science (NIEHS), in partnership with Fogarty International Center (FIC), National Institute of Minority Health and Health Disparities (NIMHD),&nbsp;<em>Eunice Kennedy Shriver</em>&nbsp;National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), National Institute of Nursing Research (NINR), National Heart Blood and Lung Institute (NHBLI) and National Institute of Allergy and Infectious Disease (NIAID) is leading an NIH-wide&nbsp;<a href=\"http://www.nih.gov/climateandhealth\">Climate Change and Health Initiative (CCHI)</a>&nbsp;with the goals of: reducing the health threats posed by climate change across the lifespan; improving the health of people who are at increased risk from or disparately affected by climate change impacts; and building health resilience among individuals, communities, nations around the world, thereby increasing health equity. As a part of this CCHI, this NOSI encourages applications that address the impact of climate change on health and well-being over the life course, including the health implications of climate change in the United States and globally.</span></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\"></span>","id":"111641","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"08-Dec-2022","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/notice-files/NOT-ES-22-006.html","sponsor_type":"US Federal","prog_title":"Notice of Special Interest (NOSI): Climate Change and Health","revision_date":"11-Nov-2022","deadline_note":"This notice applies to due dates on or after July 8, 2022 and subsequent receipt dates through May 8, 2025.","sponwebsite":null,"deadline_date":["08-Dec-2022","09-Dec-2022","20-Dec-2022","07-Jan-2023","25-Jan-2023","05-Feb-2023","12-Feb-2023","16-Feb-2023","21-Feb-2023","08-Mar-2023","10-Mar-2023","13-Mar-2023","08-Apr-2023","07-May-2023","25-May-2023","05-Jun-2023","12-Jun-2023","16-Jun-2023","19-Jun-2023","10-Jul-2023","13-Jul-2023","03-Aug-2023","08-Aug-2023","07-Sep-2023","25-Sep-2023","05-Oct-2023","12-Oct-2023","16-Oct-2023","19-Oct-2023","03-Nov-2023","13-Nov-2023","15-Nov-2023","08-Dec-2023","11-Dec-2023","07-Jan-2024","25-Jan-2024","05-Feb-2024","12-Feb-2024","16-Feb-2024","20-Feb-2024","11-Mar-2024","08-Apr-2024","07-May-2024","25-May-2024","05-Jun-2024","12-Jun-2024","16-Jun-2024","19-Jun-2024","09-Jul-2024","15-Jul-2024","08-Aug-2024","07-Sep-2024","25-Sep-2024","05-Oct-2024","12-Oct-2024","16-Oct-2024","21-Oct-2024","12-Nov-2024","15-Nov-2024","08-Dec-2024","09-Dec-2024","07-Jan-2025","25-Jan-2025","05-Feb-2025","12-Feb-2025","16-Feb-2025","19-Feb-2025","08-Apr-2025","07-May-2025"],"contact":"Claudia L. Thompson","contact_tel":"984-287-3330","contact_email":"thompso1@niehs.nih.gov"},{"synopsis":"<p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">This Funding Opportunity Announcement does not accept applications proposing clinical trial(s).</span></p><p class=\"Normal\" style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"color:#333333;font-family:Verdana, Geneva, sans-serif;font-size:small;background-color:#ffffff;\">Note: Not all NIH Institutes and Centers (ICs) participate in Parent Announcements. Applicants should carefully note which ICs participate in this announcement and view their respective areas of research interest at the R01 IC-Specific Scientific Interests and Contact website. ICs that do not participate in this announcement will not consider applications for funding.</span></p>","id":"093908","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"05-Feb-2023","total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-185.html","sponsor_type":"US Federal","prog_title":"NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)","revision_date":"22-Oct-2021","deadline_note":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after </span><span style=\"color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\">May 05, 2020.</span><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"> The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2023.</span></p><p><span style=\"font-size:small;line-height:115%;font-family:Verdana, Geneva, sans-serif;color:black;\">NOTE: Per NOT-OD-20-089 applications for administrative supplements to existing R01 and R21 programs&nbsp;to expand their focus to include firearms research are due by May 15, 2020.</span></p><p>NOTE: Per NOT-ES-20-018 applications to investigate the mechanisms controlling the resolution of inflammation in chronic disease states will be accepted on&nbsp;due dates on or after October 1, 2020 and subsequent receipt dates through May 31, 2024.<span style=\"font-size:small;line-height:115%;font-family:Verdana, Geneva, sans-serif;color:black;\"></span></p><p>NOTE: Per NOT-EB-20-015, applications will be accepted under NOT-EB-20-007 through August 28, 2020.&nbsp;Submissions received after this effective date will not be considered for this NOSI.</p>","sponwebsite":null,"deadline_date":["05-Feb-2023"],"contact":null,"contact_tel":null,"contact_email":"grantsinfo@nih.gov"},{"synopsis":"<p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions&nbsp;is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&amp;A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole.</span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:medium;\"><span style=\"font-size:small;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Help determining the Organization Funding Level can be found&nbsp;<a href=\"https://grants.nih.gov/grants/funding/Determing-Organization-Funding-Levels-R15-Eligibility.pdf%20or%20https://grants.nih.gov/grants/funding/r15.htm\">here</a>.</span></span></span></span></span></p>","id":"104245","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":"07-Jan-2023","total_funding_limit":300000,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PAR-21-155.html","sponsor_type":"US Federal","prog_title":"Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)","revision_date":"17-Feb-2022","deadline_note":"Applications submitted in response to this announcement must be submitted electronically either through Grants.gov, using the SF424 Research and Related (R&amp;R) forms and SF424 (R&amp;R) Application Guide, through the NIH Application Submission System &amp; Interface for Submission Tracking (ASSIST), or through qualified institutional system-to-system submission systems. Applications may be submitted on or after May 25, 2021. The deadlines for receipt of standard applications under this announcement are: February 25, June 25, and October 25 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 08, 2024.","sponwebsite":null,"deadline_date":["07-Jan-2024","07-Jan-2023","25-Feb-2024","25-Oct-2023","07-May-2023","25-Feb-2023","25-Jun-2023","07-May-2024","07-Sep-2023"],"contact":"Alexandra M. Ainsztein, Ph.D.","contact_tel":null,"contact_email":"alexandra.ainsztein@nih.gov"},{"synopsis":"<span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\"></span><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">The National Institutes of Health (NIH) hereby notify Program Directors/Principal Investigators (PD(s)/PI(s)) holding specific types of NIH research grants listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.&nbsp; Applications for administrative supplements are considered prior approval requests (as described in&nbsp;<a href=\"https://grants.nih.gov/grants/policy/nihgps/HTML5/section_8/8.1_changes_in_project_and_budget.htm#Need\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">Section 8.1.2.11 of the NIH Grants Policy Statement</a>) and will be routed directly to the Grants Management Officer of the parent award.</span></span></p><p style=\"box-sizing:border-box;margin-bottom:10px;color:#333333;font-family:'Helvetica Neue', Helvetica, Arial, sans-serif;font-size:13.6px;background-color:#ffffff;\"><span style=\"font-family:Verdana, Geneva, sans-serif;\"><span style=\"font-size:small;\">Although requests for administrative supplements may be submitted through this FOA, there is no guarantee that funds are available from the awarding IC or for any specific grant.<strong style=\"box-sizing:border-box;\">&nbsp;All applicants are encouraged to discuss potential</strong>&nbsp;<strong style=\"box-sizing:border-box;\">requests with the awarding IC.</strong>&nbsp;<strong style=\"box-sizing:border-box;\">Additionally, prior to submission, applicants must review the awarding IC's web site to ensure they meet the IC's requirements.&nbsp;&nbsp;</strong>A list of those web sites is available at<strong style=\"box-sizing:border-box;\">&nbsp;</strong><a href=\"https://grants.nih.gov/grants/guide/admin_supp/index.htm\" style=\"box-sizing:border-box;color:#428bca;text-decoration-line:none;\">https://grants.nih.gov/grants/guide/admin_supp/index.htm</a>.</span></span></p><p><span style=\"font-family:Verdana, Geneva, sans-serif;font-size:small;\">&nbsp;</span></p>","id":"100239","spon_name":"National Institutes of Health/DHHS","NextDeadlineDate":null,"total_funding_limit":0,"programurl":"https://grants.nih.gov/grants/guide/pa-files/PA-20-272.html","sponsor_type":"US Federal","prog_title":"Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)","revision_date":"20-Nov-2020","deadline_note":"Applications may be submitted on or after July 24, 2020. Due dates may vary by awarding IC.&nbsp; See the awarding&nbsp;IC's web site&nbsp;or applicable Notice of Special Interest (NOSI) for appropriate Application Due Dates. Applicants may also contact their respective awarding IC. This FOA will expire on July 24, 2023.","sponwebsite":null,"deadline_date":null,"contact":null,"contact_tel":null,"contact_email":"GrantsInfo@nih.gov"}]